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Abstract
Background and aim: Moderate alcohol consumption has been suggested to contribute to 
emotional well-being. However, the effects of moderate alcohol consumption on emotional 
well-being in common drinking situations and the influence of alcohol on physical well-being 
remain unclear. The aims of this thesis were 1) to further explore the acute effects of moderate 
alcohol consumption on emotional well-being and the association between habitual alcohol 
consumption and emotional well-being and 2) to provide more insight into physiological 
markers that may be related to alcohol-induced emotional well-being.
Methods: We compared the acute effects of alcohol (20-30 g) vs. alcohol-free drinks on 
mood, food reward and mental stress in three randomized crossover trials. To explore the 
short-term effects of alcohol on physiological markers of emotional well-being, we conducted 
four randomized crossover trials of 3-6 weeks in which 25-41 g alcohol/day, or no alcohol 
was consumed. In addition, we conducted a meta-analysis of 14 randomized intervention 
trials with at least 2 weeks of alcohol intervention. Finally, the association between long-term 
alcohol consumption and health-related quality of life was investigated with a bidirectional, 
longitudinal analysis among 92,448 U.S. women of the Nurses’ Health Study II cohort.
Results: Moderate alcohol consumption in an unpleasant ambiance resulted in higher 
happiness scores in women as compared to the consumption of alcohol-free drinks. 
Consumption of 20 gram alcohol increased subsequent intake and rewarding value of savoury 
foods in men, as measured by an increased implicit wanting and explicit liking of savoury 
foods. When alcohol was consumed by male volunteers immediately after a mental stressor, 
a reduced response of the stress hormones ACTH and cortisol, the inflammatory marker IL-8, 
and the percentage of monocytes in blood were observed. Furthermore, alcohol consumption 
was found to attenuate meal-induced NF-κB and to increase total antioxidant capacity in men. 
Four weeks of moderate alcohol consumption reduced circulating fetuin-A, while increasing 
urinary F2-isoprostanes in men. In women, short-term moderate alcohol consumption did 
not reduce fetuin-A but it tended to increase insulin sensitivity. Habitual moderate alcohol 
consumption was associated with a higher physical health-related quality of life 2 years 
later. Vice versa, higher physical health-related quality of life was associated with a higher 
alcohol intake 2 years later. Moderate alcohol consumption was not associated with mental 
health-related quality of life in either direction, although moderate alcohol consumption was 
associated with higher scores on the scales for social functioning and vitality. 
Conclusions: Moderate alcohol consumption may acutely improve emotional well-being 
by improving mood, increasing food reward and reducing mental stress. In the short-term, 
moderate alcohol consumption may attenuate meal-induced oxidative stress and circulating 
fetuin-A in men. In women, moderate alcohol consumption may improve insulin sensitivity. 
Habitual moderate alcohol consumption may be associated with a small increase in physical 
health related quality of life but not with mental health related quality of life in women.  
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Chapter 1
Alcohol consumption has been part of most cultures for thousands of years. As a consequence, 
we have become familiar with the possible negative consequences of drinking alcohol as well. 
At the same time, a combination of its mood effects and its predominant positive social and 
cultural associations have resulted in a rather wide-spread societal acceptance of alcohol 
consumption in moderation. Both short en long-term health effects of alcohol consumption 
have been researched for quite some time. In particular, the influence of alcohol consumption 
on chronic diseases, such as cardiovascular disease and type 2 diabetes, has received 
most attention during the last decades (1-3). However, alcoholic beverages are commonly 
not consumed for their long-term effects but most often because of their mood effects, such 
as relaxation and enhanced mood (4). In contrast to the large body of evidence on chronic 
diseases, the effects of alcohol on long-term emotional and physical well-being and their 
possible relations are less well understood (5, 6). 
Well-being, mood and physical health
The World Health Organization (WHO) defines health as ‘a complete state of physical, mental 
and social well-being and not merely the absence of disease or infirmity’ (7). However, research 
has thus far often been focused on measuring the absence of disease or physical impairment, 
or markers which are indicative for risk and health deterioration. More in agreement with 
the WHO definition of health, research is gaining more interest during the last decades 
in measuring positive indicators of physical and mental health. For example, the study of 
subjective well-being is a growing research field (8). 
Subjective well-being encompasses three components: evaluative well-being, hedonic well-
being and eudemonic well-being. Evaluative well-being is defined as satisfaction with life, such 
as thoughts about the quality of life and contentment with life. Hedonic well-being (sometimes 
referred to as affective well-being) includes negative and positive feelings, mood or emotions. 
Eudemonic well-being refers to judgements about the meaning and purpose of life (9, 10). 
Measures of subjective well-being are often divided in trait levels of well-being (e.g. life 
satisfaction) and transient (state level) affect, moods and emotions. Both life satisfaction 
and positive affect have been associated with better physical health outcomes (11, 12). 
For example, Steptoe and Wardle (2005) showed that people with higher positive affect 
have a lower fibrinogen response on stress (13). Positive affect has also been related to 
a lower incidence of stroke and more effective immune functions (12). Life satisfaction has 
been related to a lower risk on mortality from cardiovascular disease and renal failure (14). 
Likewise, subjective well-being has been related to an attenuated stress induced response in 
cortisol (11). These data suggest that well-being is directly related to a better immune function 
and responsivity to stress. 
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Long term effects of moderate alcohol consumption
Chronic alcohol intake has profound effects on health: excessive alacohol consumption has 
clear detrimental health effects, whereas moderate alcohol consumption (see text box for 
definitions) has been shown to contribute to a number of positive health outcomes (15). 
Health benefits of moderate alcohol consumption 
The association between alcohol and 
mortality has been extensively researcvvhed. 
The results of a meta-analysis of 34 
prospective studies showed a J-shaped 
association: mortality risk is lower in people 
drinking moderately, but it is higher in heavy 
alcohol consumers (16). Furthermore, a 
large prospective study in women showed 
that moderate alcohol consumption may 
contribute positively to successful aging (i.e. 
being free of 11 major chronic diseases and 
having no major impairments in cognitive, 
physical and mental health) (17).
An apparently protective effect of moderate 
alcohol consumption has been shown for 
specific diseases: moderate drinking is 
associated with a reduced risk for certain 
diseases, including cardiovascular diseases (1), type 2 diabetes (2) and dementia (18), in 
comparison to abstention or heavy alcohol consumption. 
These observations are supported by intervention studies revealing several potential 
biological mechanisms for the beneficial effects of alcohol on cardiovascular disease and 
type 2 diabetes. Moderate alcohol consumption increases HDL cholesterol and stimulates 
reverse cholesterol transport (19). Furthermore, it increases paraoxonase activity, it stimulates 
fibrinolysis (20) and decreases coagulation (21). Additionally, higher adiponectin levels (22, 
23) and anti-inflammatory effects (24, 25) may contribute to the protective effects of alcohol.
Parallel to the research on the association between alcohol and physical health, there is a 
large body of research on the association between alcohol and psychosocial health. Moderate 
alcohol consumption has been suggested to be beneficial for emotional and social well-
being. It may contribute to a reduced psychological distress, an increased sociability and an 
enhanced mood (4). Furthermore, cross-sectional studies suggest an association between 
What is moderate?
Moderate drinking is defined in the US 
Dietary Guidelines as no more than one 
drink daily for women and two for men (9). 
In the Netherlands, alcohol consumption 
is also advised to be no more than one 
standard unit per day for women and 
two standard units per day for men (10). 
However, there is no universal definition of 
one glass or one standard unit. In the United 
States, one glass contains approximately 
14 to 15 g alcohol depending on the type 
of beverage, whereas in the Netherlands 
one standard unit contains 10 g alcohol 
irrespective of the type of beverage (i.e. 
250 mL beer, 100 mL wine and 35 mL 
spirits).
12
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moderate alcohol consumption and higher health-related quality of life (26-31), subjective 
well-being (32), subjective health (33) and life satisfaction (28). However, these associations 
may be biased by reverse causation, and prospective data is scarce (34). 
Health risks of moderate alcohol consumption
Moderate alcohol consumption can also have harmful effects on health. Alcohol consumption 
increases the relative risk on breast cancer among women in a linear fashion by 8% per 
extra glass/day. This means that even at a low habitual alcohol intake, breast cancer risk 
is increased (35) compared to abstinence from alcohol. Additionally, alcohol consumption 
increases the risk on cancers of the upper digestive and respiratory tract in a dose-dependent 
manner (oral and pharyngeal cancer, oesophageal squamous cell carcinoma and laryngeal 
cancer) (36). 
The possible harmful effects of alcohol increase when consumption rises above moderation. 
With high intakes of alcohol (≥45 g/d) the risk on colorectal cancer increases with 40% 
(37). Also, a higher risk on liver cirrhosis and liver cancer (hepatocellular cancer) has been 
associated with excessive alcohol intake (38). Furthermore, alcohol consumption is positively 
associated with accidents and violence (39).
Acute effects of moderate alcohol consumption 
Pharmacokinetics of alcohol
Alcohol is rapidly absorbed after ingestion. Several factors influence the rate of absorption, 
such as the amount and concentration ingested, and the presence and properties of food in 
the stomach. Although some absorption occurs in the stomach (~5%), alcohol is primarily 
absorbed in the intestine. After absorption from the intestine, alcohol is transported via the portal 
vein to the liver, where a portion is directly metabolized. During this process, often called first-
pass metabolism, alcohol is converted into acetaldehyde by alcohol dehydrogenase (ADH). 
Acetaldehyde is highly toxic and rapidly converted into acetate by aldehyde dehydrogenase 
(ALDH) (40, 41). Most of the acetate is released in the blood and oxidized to CO2 and H2O 
in the citric acid cycle (Figure 1.1). A small portion of acetate is converted to carbohydrates, 
lipids or proteins and incorporated in tissues (42). 
When ingested on an empty stomach, peak blood concentrations are reached 30-60 min 
after alcohol consumption. When alcohol consumption is combined with food, the absorption 
rate of alcohol is slower. As alcohol shows capacity limited (‘zero-order’) metabolism, more 
alcohol can now be metabolized during first-pass metabolism, resulting in lower blood alcohol 
concentrations (BAC). As a consequence, a moderate dose of alcohol may result in an 
approximately two times lower BAC when consumed together with a meal (40, 41). The type 
of beverage also influences the BAC curve. Consumption of an equal amount of alcohol as 
spirits, wine or beer, showed that spirits induce the highest and earliest peak BAC, followed 
13
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by wine and then by beer (43). Alcohol contains a polar hydroxyl group, which makes it highly 
soluble in water. Therefore, the distribution of alcohol over the body mainly depends on the 
water content of organs and tissues (44).  
Acute effects on psychological well-being
The acute influence of moderate alcohol consumption on behaviour follows a biphasic pattern 
(Figure 1.2). During rising BACs primarily stimulatory effects occur, such as increased arousal, 
cheerfulness, social interaction and loss of inhibitions. During declining BACs more sedative 
effects are reported, such as relaxation and sleepiness (41, 45-47). Although stimulation and 
sedation are opposite effects, they can occur at the same time. This occurs mainly around 
peak BACs (46). The experience of stimulation and sedation also depends on the dose. Higher 
intakes tend to induce more sedation, while lower intakes induce more stimulation (48). 
These behavioural effects of alcohol consumption are mainly a result of alcohol’s interaction 
with the neuronal systems of the brain. Alcohol generally inhibits central nervous system 
activity. It primarily influences the gamma-aminobutyric acid (GABA) and glutaminergic 
neurotransmitter systems. Alcohol stimulates the activity of GABA, the main inhibitory 
neurotransmitter, and inhibits that of glutamate, the main excitatory neurotransmitter. 
Additionally, it enhances serotonergic, dopaminergic and opioid neurotransmission (49). 
Also, a role of endocannabinoids is suggested in the behavioural effects of alcohol (50, 
51). An experiment in rats showed that after oral alcohol self-administration, the dialysate 
2-arachidonoylglycerol (2-AG) concentrations increased and followed the same pattern as the 
blood alcohol concentration (52). 
Furthermore, alcohol consumption has been shown to acutely increase heart rate and skin 
conductance level during rising BACs (53-55). In addition, epinephrine levels were increased 
immediately after moderate drinking (56). This suggests that alcohol increases sympathetic 
nervous system activity during the initial stages following intake, which may be related to 
the higher arousal during rising BACs (57). Parasympathetic activity is decreased by alcohol 
shortly after consumption. However, from previous research it is not clear if this effect is limited 
to the rising part of the plasma curve (54). 
The tension-reducing effects of moderate alcohol doses have been attributed to a decrease in 
Figure 1.1. Alcohol metabolism by alcohol dehydrogenase and acetaldehyde dehydrogenase
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hypothalamic-pituitary-adrenal (HPA) axis activity after consumption. This would be in line with 
alcohol’s enhancing effects on GABA and its inhibiting effects on glutamate neurotransmission, 
resulting in a net inhibition of HPA-axis activity. The effect of alcohol on HPA-axis activity 
seems to be dose-dependent, with lower dosages of alcohol consumption reducing HPA-axis 
activity while higher doses (>0.8 g/kg) having a stimulating effect on HPA-axis activity (58). 
Rewarding effects of alcohol
The stimulatory effects of alcohol contribute to the rewarding properties of alcohol. People who 
experience relatively more stimulating effects and less sedative effects after drinking report 
more euphoria and liking of alcohol, and are thought to be more vulnerable to the addictive 
properties of alcohol. Indeed, heavier drinkers and binge drinkers experience more stimulant-
like effects as compared to light drinkers. This may increase the risk for drinking alcohol again 
and for developing alcohol-related problems (45, 59, 60). Although some sedative effects, like 
reduction of tension, can be experienced as pleasant, these are in general considered less 
pleasant than the stimulatory effects. Sedative effects can also motivate drinking behaviour. 
However, generally people start drinking primarily because of the stimulatory effects but when 
they become dependent on alcohol they drink more to reduce anxiety and tension feelings 
(46).  
The activation of the brain’s mesocorticolimbic reward circuit is primarily causing the 
Figure 1.2. The acute biphasic behavioural and neuroendocrine effects of moderate alcohol 
consumption. 
The stimulatory effects of alcohol have been related to increased activity of the dopaminergic, serotonergic and opioid 
neurotransmitter systems and increased sympathetic nervous system (SNS) activity. The sedative effects are caused 
by stimulation of gamma-aminobutyric acid (GABA) and inhibition of glutamate neurotransmission (46, 54). Moderate 
alcohol consumption attenuates hypothalamic-pituitary-adrenal (HPA) axis activity(58).
15
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stimulatory effects of alcohol. It is likely that multiple neurotransmitter systems are involved 
in the rewarding effects of alcohol, including the dopaminergic, opioidergic, glutamatergic, 
GABAergic and serotonergic systems (61). The addictive properties of alcohol are believed 
to be mainly driven by its enhancing effect on dopamine signalling, since dopamine is the 
main neurotransmitter mediating the motivation to drink (46, 62). According to the incentive 
sensitization theory of addiction, reward comprises two components: ‘liking’ and ‘wanting’. 
These can be divided both psychologically and neurologically. Psychologically, wanting refers 
to the motivation to approach and obtain a stimulus, and liking refers to the pleasantness 
of the stimulus or the pleasure derived from the stimulus. Neurologically, the dopamine 
system is mainly responsible for wanting, whereas opioid, GABA and endocannabinoid 
neurotransmission are assumed to be mainly involved in liking. The sensitization of wanting 
and the enhancement of dopamine are suggested to be responsible for compulsive drug use 
and the development of addiction (63-65). 
Acute effects on psychological distress
Because of the ability of alcohol to reduce tension, there has been a lot of interest in the 
influence of alcohol consumption on the stress response. In 1980, Levenson et al. proposed 
the stress-response dampening model of alcohol (53). They showed that alcohol consumption 
prior to a stressor (either electric shock or speech) reduced anxiety and heart rate during the 
stress response as compared to the placebo condition. Furthermore, a reduced activity of the 
HPA-axis has been reported after alcohol consumption, as measured by ACTH and cortisol 
hormones (66, 67). However, also an increased activation of the HPA axis by alcohol has 
been shown (68). The inconsistency in outcomes may be due to the higher dosages (0.75 
and 1.1 mL/kg) used in the latter study. Furthermore, Balodis et al. (2011) showed that the 
alcohol induced-reductions in the cortisol and tension score response to stress were of the 
same order of magnitude as those seen after the anticipation of alcohol only. This indicates 
that it is of high importance to take into account the expectation effects in addition to the 
pharmacological effects of alcohol consumption on stress response dampening (67).
Aims and outline of this thesis
Previous research shows that the acute effects of alcohol consumption on well-being are valid 
for low to moderate doses of alcohol and that these occur in a biphasic pattern. Previous data 
also suggest that the higher the stimulatory effects after consumption are, the more rewarding 
the drinking experience is. The tension reducing effects of alcohol were also effective during 
psychological distress. 
However, several knowledge gaps remain about the effects of moderate alcohol consumption 
on well-being and psychological distress during situations that are representative for 
more common consumption patterns, such as alcohol consumption with a meal and after 
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psychological stress. Additionally, long-term effects of alcohol on well-being have thus far 
mainly been measured by cross-sectional studies which demands for further substantiation 
by prospective observational studies. Furthermore, it is not understood to what extent acute 
psychological effects of alcohol consumption influence physical well-being.
We thus aimed to:
1. further explore the acute effects of moderate alcohol consumption on emotional well-
being and the association between habitual alcohol consumption and emotional well-
being. 
2. provide more insight in the influence of moderate alcohol consumption on physiological 
determinants and health outcomes related to emotional well-being.
How the chapters in this thesis contribute to these aims is shown in Figure 1.3. 
Acute moderate alcohol consumption and emotional well-being
Alcohol is commonly consumed around mealtimes. Therefore, we have investigated the 
influence of moderate alcohol consumption with dinner on mood and autonomic nervous 
system activity in women in chapter 2. In addition, we investigated whether alcohol influenced 
mood differently when consumed during a current pleasant or unpleasant mood. To bring 
people in these mood states, we developed a mood induction model by creating a pleasant or 
Figure 1.3. Schematic overview of the aims of this thesis and the contribution of the chapters to 
these aims.
17
General introduction
unpleasant meal ambiance. 
In chapter 3, we further examined the effects of mood changes induced by the meal ambiance 
and moderate alcohol consumption on plasma endocannabinoids (2-arachidonoylglycerol (2-
AG), anandamide (AEA)) and some N-acylethanolamine (NAE) congeners. Endocannabinoids 
have been suggested to play a role in the behavioural effects of alcohol. However, the effect 
of moderate alcohol consumption on plasma endocannabinoids in humans is not clear yet, 
especially not in relation to alcohol’s induced mood changes. 
Despite the well-known rewarding properties of alcohol, the influence of alcohol on the reward 
response of subsequent food intake has not been measured before. When alcohol is consumed 
before or with a meal, it increases food intake. In chapter 4 we investigated whether alcohol 
increases food intake by increasing food reward in men. In addition, we explored the role of 
gut or oral nutrient sensing in alcohol’s effect on food reward. 
Although several studies showed a stress-dampening effect of alcohol when consumed 
before a mental stressor, data on the influence of moderate alcohol consumption on the 
stress response when consumed after the stressor are limited. Therefore, we evaluated the 
physiological stress response of a mental stressor followed by alcohol consumption in men in 
chapter 5. We also explored the effect of alcohol consumption on the stress-induced immune 
response. 
These first three studies were all performed in a controlled setting (human intervention trials) 
and focused on the acute effects of moderate alcohol consumption on different aspects of 
emotional well-being: mood, reward and psychological distress. 
Acute and short-term moderate alcohol consumption and physical well-being
Emotional well-being has been related to a better immune function and stress-buffering 
capacity. To further explore the effect of moderate alcohol consumption on physiological 
determinants of emotional well-being, we investigated the influence of moderate alcohol 
consumption with a meal on postprandial levels oxidative capacity and NF-κB (nuclear 
transcription factor playing an important role in inflammation), and urinary F2-isoprostanes in 
men in chapter 6. This study was a randomized intervention trial and focused on the acute 
and short-term effects of alcohol on physical well-being. 
There is a clear association between habitual moderate alcohol consumption and a lower 
risk of type 2 diabetes. However, the acute effects of moderate drinking on inflammation and 
insulin sensitivity, two factors that might explain this relation, are not completely understood. 
To determine the effects of several weeks of moderate alcohol consumption on inflammation 
markers and insulin sensitivity, we conducted two studies. In chapter 7 we evaluated alcohol’s 
18
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influence on fetuin-A in three randomized intervention studies in both men and women. 
Additionally, we conducted a meta-analysis on intervention studies to evaluate the influence of 
short-term alcohol consumption (≥2 weeks) on insulin sensitivity and glycemic status (chapter 
8). 
Habitual alcohol consumption and emotional and physical well-being
A positive association between habitual moderate alcohol consumption and well-being has 
been suggested by cross-sectional studies. In chapter 9 we investigated the bidirectional 
associations between alcohol consumption and mental and physical health-related quality of 
life in women by the use of longitudinal analyses. 
19
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Abstract
Background: The pre-drinking mood state has been indicated to be an important factor in the 
mood effects of alcohol. However, for moderate alcohol consumption there are no controlled 
studies showing this association. Also, the mood effects of consuming alcohol combined with 
food are largely unknown. The aim of this study was to investigate the effects of moderate 
alcohol combined with a meal on ambiance-induced mood states. Furthermore effects on 
autonomic nervous system activity were measured to explore physiological mechanisms that 
may be involved in changes of mood state. 
Methods: In a crossover design 28 women (age 18-45 y, BMI 18.5-27 kg/m2) were randomly 
allocated to 4 conditions in which they received 3 glasses of sparkling white wine (30 
g alcohol) or alcohol-free sparkling white wine while having dinner in a room with either a 
pleasant or unpleasant created ambiance. Subjects filled out questionnaires (B-BAES, POMS 
and postprandial wellness questionnaire) at different times. Skin conductance and heart rate 
variability were measured continuously. 
Results: Moderate alcohol consumption increased happiness scores in the unpleasant, but 
not in the pleasant ambiance. Alcohol consumption increased happiness and stimulation 
feelings within 1 hour and increased sedative feelings and sleepiness for 2.5 hour. Skin 
conductance was increased after alcohol within 1 hour and was related to happiness and 
stimulation scores. Heart rate variability was decreased after  alcohol for 2 hours and was 
related to mental alertness.  
Conclusions: Mood inductions and autonomic nervous system parameters may be useful to 
evaluate mood changes by nutritional interventions. Moderate alcohol consumption elevates 
happiness scores in an unpleasant ambiance. However, drinking alcohol during a pleasant 
mood results in an equally positive mood state.  
Trial registration: Clinicaltrials.gov NCT01426022
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Introduction
Alcoholic beverages are amongst the oldest beverages and are commonly consumed 
because of their anticipated mood effects. Motivation for moderate alcohol consumption may 
vary from enhancing pleasure to reducing tension (1, 2). Mood and emotions are distinct 
phenomena, although the two are closely related. Whereas emotions are of short duration and 
often directed towards an object, moods are generally lasting longer and not object-related. 
Mood comprises a mixture of hedonic (pleasure-displeasure) and arousal (sleepy-activated) 
values (3). 
The effect of moderate alcohol consumption on mood may depend on several interacting 
factors, including the rise or decline of blood alcohol concentration (BAC) (4-6), the pre-
drinking mood state of the drinker (7) and factors such as the social context of drinking (8, 9), 
and expectancy of mood effects (10, 11). 
Alcohol has been shown to change mood in a biphasic pattern. During rising BACs alcohol 
has stimulating effects, reported by feelings of euphoria and elation, while during declining 
BACs alcohol has sedative effects, reported by relaxation and sleepiness (4-6). In Western 
countries alcohol is often consumed with a meal. Food consumption may also affect mood. 
Previous studies showed an increased calmness and sleepiness after food intake (12-15). 
Furthermore, food consumption may influence the mood effects of alcohol because it delays 
gastric emptying and alcohol absorption, resulting in a lower peak BAC (16, 17). Thus, the 
combination of food and alcohol consumption may affect mood differently from that of alcohol 
consumption only. To date, only two studies investigated the mood effects of combined food 
and alcohol consumption, and their results were inconsistent (18, 19). Lloyd and Rogers 
(1997) found that alcohol with a meal improved mood by increasing confidence and decreasing 
tension and confusion, while Markus et al. (2004) did not find any effect on mood.
Furthermore, the pre-drinking mood state has been indicated to play an important role in 
the mood effects of alcohol (7, 11). However, the effects of different pre-drinking moods 
on postprandial mood changes have not yet been compared in an intervention study. The 
most accurate method to measure mood is by self-report of feelings as mood is a subjective 
state. Nevertheless, specific physiological parameters associated with mood changes are 
increasingly being used in studies generally to validate subjective outcomes or to explore 
physiological mechanisms involved in mood regulation. However, for yet another reason 
this may be highly relevant, as incorporating the physiological dynamics underlying both 
mood effects and pharmacological activities of psychotropic substances like alcohol may 
be instrumental to further unravel the effects of such enhancers on mood.  With respect to 
alcohol, the relevant physiological parameters are likely to include measures of autonomic 
nervous system (ANS) activity as moderate alcohol consumption has been shown to increase 
the activity of the sympathetic division of the ANS (being related to emotional arousal), and to 
decrease the activity of the parasympathetic division of the ANS, associated with relaxation 
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(10, 20-25).  
The primary aim of this study was to evaluate the biphasic effects of moderate alcohol 
consumption with a meal on ambiance-induced mood, as measured by subjective responses 
and ANS activity. The secondary aim was to study the association between the effects of 
moderate alcohol consumption on subjective responses of mood and on ANS activity. We 
hypothesized that moderate alcohol consumption with a meal would amplify the pre-drinking 
mood state, resulting in a more positive mood in a positive induced mood state and in a 
more negative mood in a negative induced mood state. Furthermore, the induced mood 
was expected to influence the effect of alcohol on ANS activity, specifically by decreasing 
sympathetic outflow and increasing parasympathetic outflow in a positive induced mood and 
opposite effects in a negative induced mood.  
Materials and Methods
Ethics statement
The study was conducted at TNO (The Netherlands Organization for Applied Scientific 
Research) in Zeist, The Netherlands, and was performed according to the International 
Conference on Harmonisation Guidelines for Good Clinical Practice. The study also complied 
with the Declaration of Helsinki and was approved by an independent Medical Ethics 
Committee (METOPP, Tilburg, The Netherlands). Written informed consent was obtained from 
all subjects. The study is registered at ClinicalTrials.gov (NCT): NCT01426022. The protocol 
for this trial and supporting CONSORT checklist are available as supporting information 
(Protocol S1 and Checklist S1).
Subjects
Healthy women (28 women aged 18-43 years, BMI 22.1 ± 1.7 kg/m2) participated in the study 
(Figure 2.1). The subjects were recruited from a pool of volunteers at TNO in Zeist, The 
Netherlands. Eligible subjects did not use any medication, habitually consumed alcohol (3-20 
glasses/week) and had no (family) history of alcoholism. We chose women who were taking 
oral contraceptives, thus expecting to reduce possible effects of the menstrual cycle on mood. 
They were not tested in the week they were not taking oral contraceptives. The calculated 
sample size (power analysis) was 24 subjects, where α was 0.05 (two-sided), β was 0.80 and 
the effect size was 1.2, based on a previous study with Profile of Mood States (POMS) as 
outcome measure (14). Twenty-eight subjects were included to guarantee sufficient power, 
even in case drop out may occur. 
Experimental protocol 
The study used a randomized single-blind crossover design, with the intervention factors 
alcohol and ambiance. Subjects consumed 3 glasses of sparkling white wine (30 g alcohol; 
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Prosecco Santa Chiara, Italy) or alcohol-free sparkling white wine (<2 g alcohol; Vita Nova 
Sparkling Secco, The Netherlands) with a meal in either a pleasant or an unpleasant ambiance. 
The blood alcohol concentration was expected not to exceed 0.5‰, which is the Dutch legal 
limit of driving. Therefore, we considered consumption of 30 g alcohol together with a meal 
as a moderate dose. 
Each subject participated in all 4 experimental conditions, which occurred at least one week 
apart. Subjects were equally divided in 4 groups with different intervention orders according 
to a Latin square design (Figure 2.2). Allocation to intervention order was randomized 
according to body fat percentage and age by a computer-generated randomization scheme. 
Randomization and intervention order allocation were performed by statisticians of TNO.
Subjects were kept ignorant to the ultimate study aim; instead they were informed that the 
aim was to investigate the effect of different meal settings and alcohol on hormones and 
satiety. In addition, they were informed that the alcohol content of the beverages could vary 
per intervention day. Subjects were blinded to the alcohol intervention. They were instructed 
to refrain from drinking alcohol on the evening preceding each test day, to eat their standard 
breakfast and lunch on standard times on each test day and to refrain from eating and 
drinking anything except water 2 hours before testing. After connecting the electrodes for 
skin conductance and electrocardiography (ECG) measurements, a baseline measurement 
was performed for 2 min in a seated position. From that moment onwards, skin conductance 
and ECG were collected continuously until the end of the study day. Subjects relaxed for at 
least 15 min in a room where soft music was played before they went to the test rooms with 
Figure 2.1. Flow chart (CONSORT).
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either a pleasant or an unpleasant ambiance. In these rooms, subjects filled out computer 
questionnaires about their mood. Afterwards, they were asked to consume their first glass of 
sparkling white wine or alcohol-free white wine within 5 min. This moment is considered t=0. 
Immediately following their wine consumption the participants were served a meal consisting 
of a macaroni dish (2004 kJ, Apetito B.V., Denekamp, The Netherlands) with two more glasses 
of wine. The meal and 2 glasses of wine had to be finished in 15 min. BAC was measured 
with a breathalyzer (Alcotest 7410, Dräger Nederland, Zoetermeer, The Netherlands) before 
the first drink and 30 min, 60 min, 120 min and 150 min afterwards. Mood questionnaires 
were filled out before the first drink and at 20 min, 50 min, 110 and 140 min after. After the last 
questionnaire, a second baseline (recovery) measurement of 2 min was carried out for skin 
conductance and ECG. 
Minor changes were made in the study procedure after the second study day to reduce 
potential stress from e.g. number of blood collections. These changes were approved by the 
Medical Ethics Committee METOPP.
Mood induction by meal ambiance
Rooms with a pleasant or an unpleasant meal ambiance were created by environmental factors 
as lighting, music, cleanness, decoration and a film scene. The pleasant ambiance room was 
colourfully decorated, light was soft, and music was playing. The unpleasant ambiance was 
created by having very bright lighting, no music, a filled dustbin next to the table, no decoration 
and plastic cutlery and serving dish. Ambient temperature was similar in both rooms. The 
ambiances were enhanced by showing the participants either a happy or sad film scene from 
the animation films ‘Bambi’ (Walt Disney, 1942) and ‘The Lion King’ (Walt Disney, 1994). The 
scenes were approximately 2.5 min long and were shown during the first glass of wine or 
alcohol-free wine. The happy scenes were either the scene of ‘Bambi on the ice’ or the Lion 
King scene of ‘hakuna matata’. The sad scenes were the scene of ‘Bambi’s mother dying’ (26) 
or the ‘Lion Kings father dying’ (27). Subjects watched each film scene once. Subjects had 
Figure 2.2. Randomisation of the interventions according to a Latin Square design.
A: Unpleasant ambiance + 3 glasses of sparkling white wine
B: Pleasant ambiance + 3 glasses of sparkling white wine
C: Unpleasant ambiance + 3 glasses of alcohol-free sparkling white wine
D: Pleasant ambiance + 3 glasses of alcohol-free sparkling white wine
29
Alcohol, mood and autonomic nervous system
dinner individually and stayed in the room until all measurements were completed.
Mood questionnaires
Mood was measured with three different questionnaires, which were filled out on the computer 
using adaptive VAS software (28). Subjects practised the questionnaires once to familiarize. 
Profile of Mood States (POMS)
Changes in mood were measured using the short version of the ‘Profile of Mood States’ 
(POMS) questionnaire (29). The questionnaire was computer based and asked participants 
to answer questions on a five-point interval scale ranging from ‘strongly disagree’ to ‘strongly 
agree’. The POMS comprises 40 items for five different subscales for mood. The subscale 
Anger (7 items, score range 7-35), Depression (8 items, score range 8-40), Fatigue (6 items, 
score range 6-30) and Tension (6 items, score range 6-30) refer to a negative mood state, 
whereas the subscale Vigor (5 items, score range 5-25) refers to a positive mood state. 
We added two more positive mood subscales, Happiness (4 items, score range 4-20) and 
Calmness (4 items, score range 4-20) from the Brunel mood scale to make the questionnaire 
more balanced for negative and positive moods (30). 
Postprandial wellness questionnaire
The postprandial wellness questionnaire has been developed and described by Boelsma et 
al. (2010) to measure the combined effects of satiety feelings and wellness after a meal 
(visual analogue scale, 100-unit) (15). The recorded items were pleasantness, satisfaction, 
relaxation, sleepiness, physical energy, mental alertness, hunger, fullness, desire to eat and 
prospective food consumption. We added the items experienced body temperature and thirst. 
Biphasic Alcohol Effects Scale (B-BAES)
The stimulation and sedative effects of alcohol were measured with the brief version of 
the Biphasic Alcohol Effects Scale (B-BAES) (31, 32). The questionnaire comprises of two 
subscales, sedation and stimulation, with three items per subscale. The participants were 
asked to indicate ‘the extent to which the adjectives described their feelings’ on a visual 
analogue scale (100-unit) from ‘not at all’ to ‘extremely’. The questions were translated to 
Dutch and participants had to answer them on a visual analogue scale instead of on an 
11-point scale as in the original questionnaire. The B-BAES stimulation and sedation scores 
were calculated as the average of the scores on the three items within the subscale.
Autonomic nervous system measurements
Skin conductance and ECG data were collected and stored using a wireless multi-channel 
ambulatory system (Mobi-8, TMS International, The Netherlands), designed to measure 
different electro-physiological signals at the same time in both ambulatory and stationary 
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conditions. Data were analysed with BioTrace + Software for NeXus version 1.2.0.0 (Mind 
Media B.V., The Netherlands). 
Skin conductance level
As primary parameter of sympathetic activity, skin conductance level was measured 
continuously with two Ag/AgCL electrodes, which were positioned on the middle phalanx of 
the ring finger and on the middle phalanx of the index finger of the non-dominant hand after 
removal of any hand jewelry. Mean skin conductance level was calculated from 2 min time 
frames. The same frames were used for calculation of the ECG time-domain derivatives.  
Heart rate variability parameters
Heart rate and heart rate variability parameters were measured using continuous ECG 
monitoring. Three electrodes were attached on the upper body for the ECG measurement 
(pre-cordial lead, sampling rate 512 Hz).  
From the original ECG time series, inter beat intervals were calculated from R-R intervals. 
These are the intervals between two successive R-spikes of the QRS-complex in the ECG. 
Based on the inter beat intervals, the heart rate and root mean square of successive differences 
(RMSSD) were calculated. RMSSD is a time-domain measure that reflects the short-term 
variation of the inter beat intervals and is strongly related to parasympathetic nervous system 
activity (33, 34). In addition, frequency-domain measurements were determined from a power 
spectral density analysis computed by a 1024 point Fast Fourier Transformation (FFT) on 
the inter beat intervals. The following frequency-domain measurements were calculated: low 
frequency power (LF power, 0.04-0.15 Hz), high frequency power (HF power, 0.15-0.40 Hz) 
and the LF:HF ratio. HF power is an index of parasympathetic nervous system activity and 
strongly related to RMSSD. Both are mainly influenced by vagal activity. Heart rate variability 
analysis was performed according to the Task Force Guidelines (35). Time frames of 6 min 
were selected at time points when the questionnaires were filled out (4 time frames at -5 min, 
25 min, 55 min and 115 min) to be able to compare the outcomes of the questionnaires with 
the physiological responses. Each 6 min time frame was subdivided in 2 min time frames for 
calculation of skin conductance, heart rate and the time-domain heart rate variability parameter 
RMSSD. Inter beat intervals were manually checked and segments with ectopic beats were 
not used for analysis. As FFT’s mathematically require longer time series (e.g. as compared 
to time domain based parameters like RMSSD), heart rate variability parameters quantified 
within the frequency domain were calculated from the 6 min time frames. Consequently, skin 
conductance level, heart rate and RMSSD were calculated from 2 min time frames, whereas 
LF power, HF power and LF:HF ratio were calculated from 6 min time frames.  
Data analysis
Statistical analyses were performed using the SAS statistical software package (SAS version 
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8; SAS Institute, Cary, NC, USA). All variables were compared between interventions with a 
mixed analysis of variance model that included the fixed factors alcohol (alcohol vs. alcohol-
free), ambiance (pleasant vs. unpleasant ambiance), time and the interaction between alcohol 
and ambiance, time and alcohol, time and ambiance, and time, alcohol and ambiance. The 
factors subject and subject by period were added to the model as random factors. A post 
hoc Tukey-Kramer test was used if an intervention effect occurred, to correct for multiple 
testing. Pearson correlations were calculated within one of the four conditions (Figure 2.2). 
Changes over time in subjective feelings were correlated with changes over time in autonomic 
nervous system measurements for each subject. A Fisher’s z transformation was applied on 
the individual correlations, to correct for deviations from the normal distribution and a 95% 
confidence interval was calculated.  
The measurements on the first study day of the first 11 subjects were considered not valid 
because of logistic problems that occurred, and were therefore excluded from the analyses. 
Except for baseline characteristics, all values are expressed as means and standard errors of 
the mean. Error bars in figures express standard errors of the mean.
Results
Subject baseline characteristics
Subjects were recruited and enrolled in the trial between September and December 2011 
(Figure 2.1). Baseline characteristics of the participants are shown in Table 2.1.
Table 2.1. Baseline characteristics of the participants (n=28).
Variable Valuea
Age (y) 22 [18 – 43]
Alcohol consumption
   3-6 drinks/week 61%
   7-14 drinks/week 36%
   15-21 drinks/week 4%
Body weight (kg) 66 ± 6
BMI (kg/m2) 22.1 ± 1.7
Body fat percentage (%) 24.5 ± 5.5
Heart rate (beats/min) 66 ± 9
Systolic blood pressure (mmHg) 109 ± 9
Diastolic blood pressure (mmHg) 72 ± 8
a Data are expressed as median and [range] for age, percentage for alcohol consumption and means ± SD for the other 
variables. BMI: body mass index.
32
Chapter 2
Mood induction by ambiance
The study was designed to induce a positive and a negative mood by ambiance. The results 
of the questionnaires show that mood was influenced by ambiance, with a more positive 
mood in the pleasant ambiance than in the unpleasant ambiance. Scores on the subscales 
anger, tension and depression of the POMS were all higher in the unpleasant ambiance than 
in the pleasant ambiance (all P<0.05), with depression increasing over time in the unpleasant 
ambiance (P<0.05). The subscale happiness of the POMS and the items pleasantness, 
relaxation and mental alertness of the postprandial wellness questionnaire were all higher in 
the pleasant ambiance (P<0.05, P<0.001, P<0.01, P<0.05, respectively). There was no main 
effect of ambiance on the B-BAES subscales stimulation and sedation, although sedation 
scores were 10% lower in the pleasant ambiance (P=0.05). 
Effects of alcohol on mood
The hypothesis was that moderate alcohol consumption would amplify the ambiance-induced 
mood. 
Main effects of alcohol
Moderate alcohol consumption with a meal influenced mood, but these effects were different 
over time. Acute effects of alcohol (within 1 hour) were increased happiness and stimulation 
scores (Figure 2.3, P<0.001 and P<0.05) and reduced calmness and mental alertness scores 
(both P<0.001). Effects of alcohol consumption occurring or continuing after 1.5 hour were 
increased sleepiness (P<0.05) and sedation scores (Figure 2.4, P<0.01). These results show 
time-dependent effects of moderate alcohol consumption with a meal on mood, with a more 
positive and active mood state within 1 hour after alcohol and food consumption and a more 
sedated and inactive mood state occurring or continuing after 1.5 hour after alcohol and food 
consumption. The mean BAC was highest 30 min after alcohol consumption (0.53 ± 0.01‰). 
Compared to 30 min, BAC was decreased 60 min and 120 min after alcohol consumption 
(0.47± 0.01‰, 0.30 ± 0.01‰ and 0.24 ± 0.01‰ respectively). Thus, the positive and activation 
effects of alcohol on mood were more present during rising BACs, while the sedation and 
inactivation effects of alcohol on mood were more present during declining BACs. 
Interaction effects of ambiance and alcohol
The effect of ambiance on mood was influenced by the alcohol intervention for the POMS 
happiness subscale and the B-BAES stimulation subscale (Figure 2.3). Happiness scores 
were higher when alcohol was consumed in the unpleasant ambiance than when no alcohol 
was consumed in both the unpleasant and pleasant ambiance (16 vs. 13 and 14 respectively, 
both P<0.001). Stimulation scores were 14% higher when no alcohol was consumed in the 
pleasant ambiance than in the unpleasant ambiance (54 vs. 47, P=0.08). There were no 
interaction effects between ambiance, alcohol and time. 
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Figure 2.3. Influence of ambiance and alcohol on POMS happiness scores (A) and B-BAES 
stimulation scores (B). 
 –○–  Pleasant, alcohol-free;  –●–   Pleasant, alcohol;  –∆–   Unpleasant, alcohol-free;  –▲–   Unpleasant, alcohol; 
 – –  start alcohol consumption (t=0). (A) Happiness scores were higher 20 min and 50 min after alcohol consumption 
compared to no alcohol consumption (P<0.001 and P<0.05, respectively). Happiness scores were lower in the 
unpleasant ambiance without alcohol than in the pleasant and unpleasant ambiance with alcohol (P<0.001) and in 
the pleasant ambiance without alcohol (P<0.05). (B) Stimulation scores were decreased from 20 min until 50 min after 
alcohol consumption, which did not occur after consumption of alcohol-free drinks (P<0.05 vs. P=1.0). Stimulation scores 
tended to be higher in the pleasant ambiance without alcohol than in the unpleasant ambiance without alcohol (P=0.08).
Figure 2.4. Influence of ambiance and alcohol on B-BAES sedation scores. 
 –○–  Pleasant, alcohol-free;  –●–   Pleasant, alcohol;  –∆–   Unpleasant, alcohol-free;  –▲–   Unpleasant, alcohol;
 – –  start alcohol consumption (t=0). Sedation scores were higher after alcohol consumption compared to no alcohol 
consumption at 20 min, 50 min, 110 min (all P<0.001) and 140 min (P<0.01) after consumption. Sedation scores tended 
to be higher in the unpleasant ambiance (P=0.05).
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Autonomic nervous system measurements 
Skin conductance level
Skin conductance acutely increased 25 min after alcohol consumption (Figure 2.5). At this 
point skin conductance was 25% higher than after consumption of alcohol-free drinks (8.8 
µS vs. 7.0 µS respectively; P<0.001). In the pleasant ambiance skin conductance decreased 
more during the time interval from 25 min until 155 min after consumption than in the 
unpleasant ambiance (P<0.05). The increased skin conductance during the first hour after 
alcohol consumption suggests an increase in sympathetic nervous system activity, with a 
gradual decline afterwards that might be associated with our findings on the sedation and 
inactivation effects of alcohol. 
Heart rate variability parameters
Heart rate variability responses after consumption of alcohol or alcohol-free drinks with a meal 
are shown in Figure 2.6. After moderate alcohol consumption ln [HF power] was decreased 
during all time points (25 min until 115 min after consumption) compared to no alcohol 
consumption (P<0.001, P<0.01 and P<0.001, respectively). After 115 min, ln [HF power] 
was still 12% lower in the alcohol intervention group than in the alcohol-free intervention 
group. RMSSD was similarly influenced by alcohol as HF power and showed a very similar 
response, with lower RMSSD 25 min, 55 min and 115 min after alcohol consumption than 
after consumption of alcohol-free drinks (P<0.001, P<0.01 and P<0.001, respectively). The 
decrease in HF power and RMSSD after alcohol consumption suggests an alcohol induced 
parasympathetic suppression.
Figure 2.5. Influence of ambiance and alcohol on skin conductance.
 –○–  Pleasant, alcohol-free;  –●–   Pleasant, alcohol;  –∆–   Unpleasant, alcohol-free;  –▲–   Unpleasant, alcohol;
 – –  start alcohol consumption (t=0). Skin conductance was higher 25 min after alcohol consumption compared to no 
alcohol consumption (P<0.001). Skin conductance decreased more from 25 min until 155 in the pleasant ambiance than 
in the unpleasant ambiance (P=0.042). The values shown at time point -5, 25, 55 and 115 are averages of the mean skin 
conductance levels measured during three succeeding 2 min time frames.  
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The LF:HF ratio was higher when alcohol was consumed than when no alcohol was consumed 
(P<0.001).  HF power, RMSSD and LF:HF ratio were not influenced by ambiance. Heart rate 
was also increased by alcohol consumption, with higher values 25 min and 115 min after 
alcohol consumption than after consumption of alcohol-free drinks (P<0.001). The heart rate 
response was different in the pleasant ambiance than in the unpleasant ambiance (P<0.001). 
Until 55 min after consumption, heart rate was higher in the pleasant ambiance, but from 
110 min onwards heart rate was higher in in the unpleasant ambiance. However, differences 
were very small. The increased LF:HF ratio after alcohol consumption indicates a sympathetic 
overtone in the balance between sympathetic and parasympathetic activity that does not 
recover within 2 hours. 
Figure 2.6. Influence of alcohol on HF power (A), LF:HF ratio (B) and heart rate (C).
 –○–    Alcohol-free;   –●–    Alcohol;  – –  start alcohol consumption (t=0). (A) HF power was lower after alcohol 
consumption compared to no alcohol consumption (at 25 min and 115 min P<0.001, at 55 min P<0.01). (B) LF:HF 
ratio was higher after alcohol consumption (P<0.001). (C) Heart rate was higher 25 min and 115 min after alcohol 
consumption compared to no alcohol consumption (P<0.01 and P<0.001, respectively). The heart rate values shown at 
time point -5, 25, 55 and 115 are averages.
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Relation between autonomic nervous system parameters and subjective feelings 
Associations were calculated between changes in autonomic nervous system parameters and 
changes in subjective feelings to examine whether these were related. If correlations were 
higher than r=0.5 or lower than r=-0.5 and if r=0.0 was not part of the confidence interval than 
they were assumed significantly enough to describe (Table 2.2).
Skin conductance, the index for sympathetic activity, was positively related with the stimulation 
subscale and negatively related with calmness after alcohol consumption in both the pleasant 
and unpleasant ambiance. Skin conductance was positively related to happiness and 
experienced body temperature and negatively related to fatigue in the unpleasant ambiance 
with alcohol.  
Table 2.2. Correlations between autonomic nervous system parameters and subjective feelings 
(n=28)a.
Correlated variables Intervention Correlation 95% CI
SNS parameter – subjective feeling
SC – Stimulation (B-BAES) Alcohol, pleasant 0.60 (0.29, 0.79)
SC – Stimulation (B-BAES) Alcohol, unpleasant 0.63 (0.34, 0.81)
SC – Calmness (POMS) Alcohol, pleasant -0.51 (-0.74, -0.07)
SC – Calmness (POMS) Alcohol, unpleasant -0.66 (-0.83, -0.37)
SC – Happiness (POMS) Alcohol, unpleasant 0.75 (0.52, 0.87)
SC – Fatigue (POMS) Alcohol, unpleasant -0.51 (-0.74, 0.17)
SC – Anger (POMS) No alcohol, unpleasant 0.51 (0.16, 0.74)
SC – Pleasant (PPW) Alcohol, pleasant 0.54 (0.21, 0.76)
SC – Experienced BT (PPW) Alcohol, unpleasant 0.52 (0.19, 0.75)
PNS parameter – subjective feeling
HF power – Sedation (B-BAES) Alcohol, unpleasant -0.61 (-0.80, -0.31)
HF power – Mental alertness (PPW) Alcohol, unpleasant 0.62 (0.33, 0.81)
HF power – Experienced BT (PPW) Alcohol, pleasant -0.51 (-0.74, -0.17)
HF power – Experienced BT (PPW) Alcohol, unpleasant -0.58 (-0.78, -0.26)
HF power – Experienced BT (PPW) No alcohol, pleasant -0.52 (-0.75, -0.18)
HF power – Experienced BT (PPW) No alcohol, unpleasant -0.55 (-0.77, -0.22)
a All values are mean [correlation coefficient (r)] and 95% confidence interval after Fisher’s z transformation. Correlations 
are shown when r=0.0 is not part of the confidence interval and when r>0.5 or r<-0.5.
Abbreviations: SNS: sympathetic nervous system; PNS: parasympathetic nervous system; SC: skin conductance; 
HF power: high frequency power; B-BAES, brief biphasic alcohol effects scale; POMS, profile of mood states; PPW: 
postprandial wellness questionnaire; BT: body temperature.
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HF power and RMSSD are two heart rate variability parameters that are related to 
parasympathetic activity. In Table 2.2 only HF power is shown, but RMSSD showed similar 
correlations with the listed subjective items. In the unpleasant ambiance with alcohol, HF 
power and RMSSD were negatively related to the sedation subscale and positively related to 
mental alertness. HF power and RMSSD were associated with experienced body temperature 
in all conditions, except for the pleasant ambiance with alcohol. 
Discussion
The present study provided two major findings on the role of pre-drinking mood state in 
alcohol-induced mood changes and the possible involvement of the ANS. First, alcohol did 
not amplify ambiance-induced mood, but it improved mood in the unpleasant ambiance as 
shown by increased scores for feelings of happiness. Second, parameters for ANS activity 
were influenced by alcohol consumption, but not by ambiance-induced mood, except for 
some minor changes in skin conductance. Although no effects of pre-drinking mood state 
were found on ANS activity, ANS parameters were associated to subjective feelings of high 
or low arousal after alcohol consumption. This indicates that ANS parameters can be used as 
objective measures of the arousal dimension of mood.
We hypothesized that alcohol would amplify the ambiance-induced mood, but the opposite 
was found; in a more negative mood state, created by an unpleasant ambiance, moderate 
alcohol consumption with a meal increased self-reported happiness feelings. In the pleasant 
ambiance mood was not further improved by alcohol. Alcohol did not affect any other mood 
scales that were influenced by ambiance. With the exception of happiness, alcohol and 
ambiance influenced different mood scales. 
We successfully induced a positive and negative mood state by creating rooms with either 
a pleasant or an unpleasant ambiance.  In the pleasant ambiance, subjects scored higher 
on pleasantness and relaxation and lower on depression and tension than in the unpleasant 
ambiance. This indicates that subjects were indeed in a better mood in the pleasant ambiance 
than in the unpleasant ambiance. This is in accordance with previous research showing that 
mood declines when there is no color, and when light is too bright, similar to the conditions 
of the unpleasant ambiance in our study (36). The mood effects of ambiance were present 
as long as the subjects were in the rooms, which was almost 3 hours.  Other mood induction 
methods used previously, such as images, music, film clips and personalized recall, generally 
affect mood for a much shorter period (27, 37-39). Therefore, the mood induction by ambiance 
used in this study may be more useful for intervention studies in which a longer mood induction 
is preferred, such as experiments on food intake and eating behavior. Ambiance has been 
shown previously to influence eating behavior. This is probably caused by mood changes, 
although mood effects were not evaluated in these studies (40-42). 
Moderate alcohol consumption with a meal resulted in biphasic mood effects. During the first 
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hour after wine consumption subjects reported higher happiness and stimulation and lower 
calmness and mental alertness than after consumption of alcohol-free wine. During the first 
hour following alcohol consumption also sedative feelings were increased, but these effects 
remained elevated until the last measurement. This biphasic pattern differs from studies in 
which alcohol is consumed without food in the early-late afternoon. Those studies found that 
sedative effects arose on the descending limb of the BAC curve, while we observed sedative 
effects directly after consumption (31, 43, 44). However, Addicot et al. (2007) also observed 
sedative effects before BAC levels started to decline (45). The earlier onset of sedative feelings 
in the present study might be due to an increase in tiredness caused by the food intake. 
Indeed, in the alcohol-free condition, fatigue scores were increasing and vigor scores were 
decreasing after the meal. Lloyd & Rogers (1997) and Markus et al. (2004) also measured 
the influence of combined alcohol and food intake on mood (18, 19). Lloyd & Rogers (1997) 
observed no effects of moderate alcohol consumption on elation, energy and tiredness, which 
is in contrast to our findings. An explanation may be the lower number of subjects in the 
study of Lloyd & Rogers (1997) (18). Markus et al. (2004) did not find any mood effects of a 
moderate dose of alcohol (40 g) with an evening meal. However, they measured mood only 
once, 2 h after consumption (19). Therefore, the study designs of both studies may not have 
had enough power to detect differences.
Motives to drink a moderate amount of alcohol are mostly to enhance mood or for social 
reasons, but with heavy alcohol consumption motives as coping with stress or negative 
mood also occur frequently. Although in the present study mood effects of moderate alcohol 
consumption were measured, we realize that coping motives in heavy alcohol consumption 
are related to problem drinking and addiction (1, 2).
The second hypothesis was that alcohol consumption in a positive pre-drinking mood would 
cause higher heart rate variability and lower skin conductance than in a negative pre-drinking 
mood. This hypothesis, however, is not confirmed by our results, as we did not find interaction 
effects of alcohol and ambiance on ANS activity. 
Ambiance only had a small influence on ANS activity. Skin conductance was further declined 
2.5 h after consumption in the pleasant ambiance compared to the unpleasant ambiance, 
but heart rate variability parameters were not affected by ambiance. The small influence of 
ambiance on ANS activity may be due to the fact that varying ambiances resulted in mood 
changes. In contrast to emotional changes, mood changes are suggested to have no influence 
on ANS activity, because mood is not related to an object and no action from the body is 
required (25).
Moderate alcohol consumption influenced ANS activity. Compared to the situation in 
which no alcohol was consumed, alcohol increased skin conductance within the first hour, 
which indicates a short-term increase in sympathetic activity. On the other hand, alcohol 
consumption decreased heart rate variability (RMSSD and HF power), indicating a decrease 
in parasympathetic tone and vagal withdrawal. As a result, LF:HF ratio and heart rate, indices 
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of sympathovagal balance, were increased after alcohol consumption.  
These results are in accordance with previous research on the effect of alcohol on heart rate 
variability (10, 20-22). Skin conductance was also increased after alcohol consumption in a 
study by Levenson et al (1980) (10). However, Stritzke et al (1995) found an attenuated skin 
conductance response after alcohol consumption when subjects watched either pleasant or 
unpleasant pictures inducing arousal (46). In contrast to previous studies, in the present study 
alcohol was combined with food consumption. Autonomic activity plays an important role in 
energy balance and thermoregulation. Sympathetic stimulation increases energy metabolism 
and thermogenesis and reduces food intake (47, 48). In the present study, energy metabolism 
was not measured and food intake was standardized. However, the distinct short-term increase 
in sympathetic outflow could have caused an increase in energy metabolism and energy 
expenditure. This is in line with a study by Addicott et al. (2007), which showed that moderate 
alcohol consumption increases physical activity during rising BACs. Surprisingly, when 
sympathetic tone was returned to normal values, parasympathetic tone stayed decreased and 
sympathovagal balance was not restored 2 hours after consumption as shown by elevated 
levels of the LF:HF ratio an heart rate. However, heart rate was recorded until 2.5 hour after 
consumption and at this time its levels were recovered. Whether this 2 hours increase in 
sympathovagal balance is related to long-term effects is not known.  Epidemiological studies 
found inconsistent results on the association between chronic moderate alcohol consumption 
and heart rate variability (49-51). An acute increase in sympathovagal balance is also seen 
during physical activity and mental stress (52). Furthermore, previous studies showed that 
even a meal increased sympathovagal balance for 1 or 2 hours due to a continuous inhibition 
of parasympathetic activity (53, 54). Therefore, we suggest that the acute increase in 
sympathovagal balance after combined food and alcohol consumption indicates an activated 
physiological state of the body, which may be generated to restore homeostasis.
 ANS activity was found to be related to the arousal dimension of mood. The increased 
sympathetic tone was related to increased happiness and stimulation and decreased 
calmness and fatigue. This indicates that sympathetic activity was related to increased arousal 
and can be used as an objective measure of the arousal dimension of mood. The reduced 
parasympathetic tone was related to decreased mental alertness and increased sedation, 
suggesting this was caused by a central effect of alcohol. These associations are not in line 
with the idea that mood states, in contrast to emotions, are not related to ANS activity (25). 
However, Matthews et al. (1990) also found a relation between skin conductance and self-
report of the arousal dimension of mood in subjects measured prior to an intelligence test (55). 
Strengths of the study are the randomized crossover design and the controlled study 
conditions. However, the study design also has some limitations that warrant consideration. 
We did not measure the mood effects of a meal separately from the alcohol effects. Therefore 
we cannot disentangle the alcohol and meal effects on mood. Second, although the 
alcohol intervention was blinded, the subjects might have noticed the alcohol content of the 
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beverages. A confounding effect of expectancy in the observed mood effects can therefore 
not be excluded. Third, mood was measured in a laboratory setting and the physiological 
measurements may have influenced the mood of the subjects. However, we tried to interfere 
as little as possible with the physiological measurements. The subjects did not notice much 
of the autonomic nervous system measurements as they were carrying a small ambulatory 
device, which all electrodes from the ECG and skin conductance were connected to, so they 
could move freely in the rooms. 
The study was carried out in women and the generalizability of the results to men may not 
be directly possible because men and women showed different mood effects of a meal in a 
previous study (56). Furthermore, subjects were eating and drinking alone in this study. Social 
interaction has been shown to influence mood effects of alcohol and therefore the results may 
not be generalizable to food and alcohol consumption in a social setting (57, 58).
To conclude, mood inductions and autonomic nervous system parameters may be useful to 
evaluate mood changes by nutritional interventions. Moderate alcohol consumption elevates 
happiness in an unpleasant ambiance. However, drinking alcohol during a pleasant mood 
results in an equally positive mood state. Consuming alcohol with a meal does not result in 
different mood changes than alcohol consumption alone, although sedative feelings may have 
an earlier onset. 
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Abstract
Background: The endocannabinoid system is suggested to play a regulatory role in mood. 
However, the response of circulating endocannabinoids (ECs) to mood changes has never 
been tested in humans. In the present study, we examined the effects of mood changes induced 
by ambiance and moderate alcohol consumption on plasma ECs 2-arachidonoylglycerol (2-
AG), anandamide (AEA), and some N-acylethanolamine (NAE) congeners in humans. 
Methods: Healthy women (n=28) participated in a randomized cross-over study. They 
consumed sparkling white wine (340 mL; 30 g alcohol) or alcohol-free sparkling white wine 
(340 mL; <2 g alcohol) as part of a standard evening meal in a room with either a pleasant or 
an unpleasant ambiance. 
Results: Plasma concentrations of palmitoylethanolamide (PEA) and stearoylethanolamide 
(SEA) increased after 30 min in the unpleasant ambiance, while they decreased in the pleasant 
ambiance. Changes in ECs and their NAE congeners correlated with mood states, such as 
happiness and fatigue, but in the pleasant ambiance without alcohol only. ECs and their NAE 
congeners were correlated with serum free fatty acids and cortisol. 
Conclusions: This is the first human study to demonstrate that plasma NAEs are responsive 
to an unpleasant meal ambiance. Furthermore, associations between mood states and ECs 
and their NAE congeners were observed. 
Trial registration: Clinicaltrials.gov NCT01426022
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Introduction
The endocannabinoid system (ECS) has been suggested to play a role in the regulation of 
mood (1, 2). Endocannabinoids (ECs) are endogenous agonists of the cannabinoid receptors 
CB1 and CB2. The CB1 receptor is located primarily in the brain but has also been identified 
in peripheral tissues, such as the gastro-intestinal tract and adipose tissue (3). Anandamide 
(AEA) and 2-arachidonoylglycerol (2-AG) are the two most well-studied and described ECs. 
AEA belongs to the N-acylethanolamines (NAEs), a group of endogenous compounds that 
is assumed to share the same biosynthesis and degradation pathways. Unlike AEA, most 
other NAEs are not able to bind CB1 or CB2 receptors, but are suggested to be involved in 
physiological processes via their action on other receptors or via a potentiating (entourage) 
effect on AEA (4). NAEs are synthesized from the hydrolysis of their corresponding N- 
acylphosphatidylethanolamines (NAPEs), whereas 2-AG is produced from diacylglycerol after 
conversion by diacylglycerol lipase (DAGL). NAEs and 2-AG also have different degradation 
pathways; NAEs are hydrolysed by fatty acid amide hydrolase (FAAH), while 2-AG is degraded 
by monoacylglycerol lipase (MAGL) (5). 
The effects of AEA and 2-AG on anxiety and depression have been demonstrated in animals. 
Decreased anxiety and depression responses were demonstrated after inhibition of AEA and 
2-AG degradation (6-8) or by microinjection of an AEA analogue into the prefrontal cortex of 
rats (9). Human studies also indicate a role of ECs in mood regulation (10-13). Considerable 
insight has become available from the use of rimonabant, an inverse CB1 agonist. The drug 
was not approved by the FDA and taken from the market in Europe 1 year after its approval 
because of side-effects, including anxiety and a depressed mood (10). Further support for an 
involvement of AEA and 2-AG in mood comes from a study of Hill et al. (2009) who showed 
decreased AEA and 2-AG serum levels in individuals with major depression. However, in 
another study of Hill et al. (2008) individuals with minor depression displayed higher AEA 
and 2-AG serum levels. These findings suggest that progression of depression might be 
associated with a reduced ECS activity. Hill and Patel (2013) hypothesized that in healthy 
individuals the ECS acts as a buffer system that dampens negative emotions to regulate mood, 
while in individuals with major depression the ECS is hypoactive (11). This is supported by 
neuroimaging studies showing a reduced amygdala activity in response to aversive emotional 
stimuli after cannabinoid administration, or in regular marijuana users (12, 13). 
ECs have been demonstrated to have a regulatory role in the stress response as well (14-
17). Mood is negatively influenced by psychological stress, which increases tension and 
depression. In human interventions, an increase in circulating 2-AG and AEA was shown in 
response to psychological stress (18, 19). In the study of Dlugos et al. (2012) also the other 
NAEs oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) were increased by stress. 
Therefore, we suggest that NAEs other than AEA may also play a role in mood regulation. 
Taken together, these studies suggest that circulating ECs and their NAE congeners are 
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relevant to measure in relation to mood and psychological stress regulation. Circulating 
concentrations of ECs have been suggested to be a ‘spill-over’ of local production in tissues, 
as ECs are produced on demand and are thought to have mainly local effects (3, 20). In 
a previous study, we showed that plasma AEA and related NAEs strongly correlate with 
serum free fatty acid (FFA) levels after food intake, suggesting that changes in NAE and FFA 
concentrations may be induced via common mechanisms (21). 
However, to date, no study in humans has been done in which the response of ECs and their 
NAE congeners on mood changes were evaluated. Mood can be influenced by ambiance both 
positively and negatively. Ambiance consists of multiple environmental factors, such as lighting 
and music, which can each affect mood. For example, soft lighting and listening to preferred 
music makes people feel more comfortable compared to bright lighting and listening to non-
preferred music (22). In addition, mood can be influenced by moderate alcohol consumption. 
Well-known effects of alcohol on mood are stimulating effects, e.g. feelings of elation and 
happiness, and increased feelings of relaxation and sleepiness (23-26). 
The objective of this study was to examine the effects of mood induction on circulating 
concentrations of ECs and related NAEs in humans. It was hypothesized that a more negative 
mood would increase circulating ECs and NAE congeners, whereas a more positive mood 
would not influence circulating ECs and NAE congeners. Mood was induced by either a 
positive or negative meal ambiance and by moderate alcohol consumption or no alcohol 
consumption. Mood was evaluated by a short version of the ‘Profile of Mood States’ (POMS-
SF), a validated and widely used mood questionnaire (27). Plasma concentrations of the ECs 
2-AG and AEA and 4 related NAEs were analysed by a validated LC-MS/MS method (28). 
Materials and Methods
Ethics statement
The study was conducted at TNO (The Netherlands Organization for Applied Scientific 
Research) in Zeist, The Netherlands, and was performed according to the International 
Conference on Harmonisation Guidelines for Good Clinical Practice. The study also complied 
with the Declaration of Helsinki and was approved by an independent ethics committee 
(METOPP, Medisch-Ethische Toetsing Onderzoek Patiënten en Proefpersonen, Tilburg, 
The Netherlands). Written informed consent was obtained from all subjects. The study is 
registered at ClinicalTrials.gov (NCT): NCT01426022. The protocol for this trial and supporting 
CONSORT checklist are available as supporting information (S1 Protocol and S1 Checklist) 
(26).
Subjects
We recruited 28 non-smoking healthy women within the age of 18-45 years from a pool of 
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volunteers at TNO in Zeist, The Netherlands (Figure 3.1). Eligible subjects did not use any 
medication, habitually consumed alcohol (3-20 glasses/week), and had no (family) history of 
alcoholism. During the screening also the use of THC was excluded. We chose women who 
were taking oral contraceptives, thus expecting to reduce possible effects of the menstrual 
cycle on mood. They were not tested in the week they were not taking oral contraceptives. 
The calculated sample size was 24 subjects, where α was 0.05 (two-sided), β was 0.80, the 
effect size was 1.2 and the within-person SD was 2.0, based on a previous study with Profile 
of Mood States (POMS) as outcome measure (29). This was calculated for a within-subjects 
analysis of the differences of means in mood (POMS). Twenty-eight subjects were included 
to guarantee sufficient power, even in case drop out may occur. Furthermore, there were two 
backup subjects to replace potential early drop out. Subjects were recruited and enrolled in 
the trial between September and December 2011 (Figure 3.1). 
Experimental protocol
The study used a randomized, single-blind, crossover design. Subjects consumed three 
glasses of sparkling white wine (30 g alcohol) or alcohol-free sparkling white wine with a meal in 
either a pleasant or an unpleasant ambiance. Each subject participated in all four experimental 
Figure 3.1. Flow chart (CONSORT). 
Adapted from Schrieks et al. (2014) (26).
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conditions, which occurred at least one week apart. Subjects were equally divided in 4 groups 
with different intervention orders according to a Latin square design. Allocation to intervention 
order was randomized according to body fat percentage and age by a computer-generated 
randomization scheme. Randomization and intervention order allocation were performed by 
statisticians of TNO. Subjects were kept ignorant to the study aim; they were informed that the 
study aim was to investigate the effect of different meal settings and alcohol on hormones and 
satiety. In addition, they were informed the alcohol content of the beverages could vary per 
intervention day. Subjects were blinded to the alcohol intervention. 
An overview of the procedures during a study day is shown in Figure 3.2. Subjects were 
instructed to refrain from drinking alcohol on the preceding evening, to eat their normal 
breakfast and lunch on standard times, and to refrain from eating and drinking anything except 
water 2 h before testing. After a baseline blood collection at 16:30 h, subjects relaxed for 
at least 15 min in a room where soft music was playing. Afterwards, they went to the test 
rooms with either a pleasant or an unpleasant ambiance. In these rooms, subjects filled out 
a computer questionnaire on mood before they consumed their first glass of sparkling white 
wine or alcohol-free white wine at t=0 within 5 min. Immediately after they consumed their 
wine, the participants were served a meal consisting of a macaroni dish (2004 kJ, Apetito B.V., 
Denekamp, The Netherlands) with two more glasses of wine. The meal and 2 glasses of wine 
had to be finished in 15 min. Blood was drawn by venapuncture before the first drink and 30 
min and 120 min afterwards. BAC was measured with a breathalyzer (Alcotest 7410, Dräger 
Nederland, Zoetermeer, The Netherlands) at regular time points. The mood questionnaire was 
filled out before the first drink and at 20 min, 50 min and 110 min after. 
Minor changes were made in the study procedure after the second study day to reduce 
potential stress from e.g. number of blood collections. These changes were approved by the 
Medical Ethics Committee METOPP.
Figure 3.2. Overview of the experimental procedures during a study day. 
Time points are indicated within parentheses. BAC, Blood alcohol concentration; POMS, Profile of Mood 
States questionnaire.
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Mood induction by meal ambiance
Rooms with a pleasant or an unpleasant meal ambiance were created by environmental 
factors as lighting, music, cleanness, decoration and a film scene. In the pleasant meal 
ambiance room there was colourful decoration, softened lighting, and music. The unpleasant 
meal ambiance was created by having very bright lighting, no music, a filled dustbin next to the 
table, no decoration and plastic cutlery and serving dish. These ambiances were enhanced 
by showing the participants either a happy or sad film scene from the animation films ‘Bambi’ 
(Walt Disney, 1942) and ‘The Lion King’ (Walt Disney, 1994). The scenes were approximately 
2.5 min long and were shown during the first glass of wine or alcohol-free wine. The happy 
scenes were either the scene of ‘Bambi on the ice’ or the Lion King scene of ‘hakuna matata’. 
The sad scenes were the scene of ‘Bambi’s mother dying’ (30) or the ‘Lion Kings father dying’ 
(31). Subjects watched each film scene once. Subjects had dinner individually and stayed in 
the room all the time, except for blood collection. 
Mood induction by alcohol
The mood induction by alcohol consisted of either three glasses of sparkling white wine (30 
g alcohol; Prosecco Santa Chiara, Italy) or alcohol-free sparkling white wine (<2 g alcohol; 
Vita Nova Sparkling Secco, The Netherlands). As alcohol consumption is combined with food 
consumption, the blood alcohol concentration was expected not to exceed 0.5‰. Therefore, 
we considered consumption of 30 g alcohol together with a meal as a moderate dose.
 
Mood questionnaire
Changes in mood states were measured using the short version of the ‘Profile of Mood States’ 
(POMS) (27) questionnaire. The questionnaire was computer based and asked participants 
to answer questions on a five-point interval scale ranging from ‘strongly disagree’ to ‘strongly 
agree’. The POMS also comprises adjectives for five different subscales for mood. The 
subscale Anger (range 7-35), Depression (range 8-40), Fatigue (range 6-30) and Tension 
(range 6-30) refer to a negative mood state, whereas the subscale Vigour (range 5-25) refers 
to a positive mood state. We added two more positive mood subscales, Happiness (range 
4-20) and Calmness (range 4-20) from the Brunel mood scale (32) to make the questionnaire 
more balanced. Subjects practised the questionnaire once to familiarize. 
Biochemical analyses
Blood samples were collected in tubes containing clot activator for serum or in ice-chilled tubes 
containing EDTA for plasma. (Vacutainer Systems, Becton Dickinson, Plymouth, UK). For the 
analysis of ECs and related NAEs, phenylmethanesulfonyl fluoride and URB602 (biphenyl-
3-ylcarbamic acid, cyclohexyl ester) were added to the blood samples to inactivate the 
degradation enzymes fatty acid amide hydrolase and monoglycerol lipase immediately after 
blood collection. In addition, blood samples for plasma were handled at 4°C and centrifuged 
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within 30 min for 15 min (2000g, 4°C) after which they were stored immediately. Serum and 
plasma samples were stored at -20°C and -80°C respectively, until further analysis. Plasma 
levels of 2-AG, AEA and the related NAEs, OEA, PEA, stearoylethanolamide (SEA) and 
docosahexaenoylethanolamide (DHEA) were determined using an LC-MS/MS technique 
as previously described (28). Plasma levels of ECs and related NAEs were analysed in a 
subsample of the subjects (n=16) that had a complete dataset. Serum concentrations of FFAs 
and cortisol were determined using Olympus analytical equipment and reagents.
Data analysis
Statistical analyses were performed using the SAS statistical software package (SAS version 
8; SAS Institute, Cary, NC, USA).  Data were visually checked on normality and constant 
variance of residuals with histograms and plots of residuals vs. corresponding predicted 
values.
Intervention effects were analysed with a mixed analysis of variance model. Because of 
the crossover design, intervention effects within subjects were compared by including the 
random factors subject and subject by study day. Alcohol (alcohol vs. alcohol-free), ambiance 
(pleasant vs. unpleasant ambiance) and time were included as fixed factors. Since the design 
was a fully crossed design, the two-way interactions between alcohol and ambiance, time 
and alcohol and time and ambiance, and the three-way interaction between time, alcohol and 
ambiance were also included as fixed factors in the model. A post hoc test with Tukey-Kramer 
adjustment was used if an intervention effect occurred. 
To assess the correlation of mood changes with changes in plasma concentrations of ECs 
and NAE congeners, Spearman rank correlations were calculated. These correlations were 
calculated between changes in scores from pre-meal until 110 min after the meal and changes 
in ECs and NAEs from pre-meal until 120 min after the meal. A Spearman rank correlation was 
chosen because it is less sensitive to strong outliers than a Pearson correlation.
To assess the correlation of ECs and NAE congeners with FFAs and cortisol, Pearson 
correlations were calculated for each subject. On these individual correlations a Fisher’s 
z transformation was applied, to correct for deviations from the normal distribution and a 
95% confidence interval was calculated. We used this method, because the variation in 
concentrations was high enough to compute individual correlations, which results in a more 
powerful calculation of correlations than with Spearman rank correlations. 
P values <0.05 were considered statistically significant. The measurements on the first 
intervention day of the first 11 subjects were considered not valid because of logistic problems 
that occurred, and were therefore excluded from the analyses. Error bars in figures indicate 
standard errors of the mean.
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Results
Subject baseline characteristics
All 28 women completed the study (Figure 3.1). Subjects’ characteristics are shown in Table 
3.1. During the pre-study screening the Dutch Eating and Behaviour Questionnaire (DEBQ) 
and State-Trait Anxiety Inventory (STAI) were taken. Subjects had a mean DEBQ restraint 
score of 2.5 and were therefore interpreted as being non restraint eaters. Their mean score on 
the STAI trait scale was 33, which is an average score of trait anxiety for women. Highest BAC 
was observed 30 min after alcohol consumption and was on average (±SD) 0.53 ± 0.09‰. 
Table 3.1. Characteristics of 28 women before intervention.
Variable Mean ± SD Range
Age (y) 23 ± 5 18 - 43
Body weight (kg) 66 ± 6 58 - 79
BMI (kg/m2) 22.1 ± 1.7 19.9 - 26.6
Body fat percentage (%) 24.5 ± 5.5 12.8 - 33.7
STAI trait score 2.5 ± 0.7 1.1 - 3.7
DEBQ restrained score 33 ± 6 22 – 48
Alcohol consumption
   3-6 drinks/week 61%
   7-14 drinks/week 36%
   15-21 drinks/week 4%
Abbreviations: BMI, body mass index; DEBQ, Dutch Eating Behaviour Questionnaire; STAI, State-Trait Anxiety Inventory.
Characteristics of the induced mood changes 
The mood induction by ambiance influenced tension and depression scores. Tension scores 
were overall higher in the unpleasant ambiance than in the pleasant ambiance (main effect 
of ambiance: P=0.018). Depression scores increased in the unpleasant ambiance until 110 
min after baseline (post hoc tests 110 min vs. -10 min and 20 min: P=0.010 and P=0.008, 
respectively). The mood induction by alcohol affected calmness and happiness scores. 
Calmness scores were lower immediately after alcohol consumption as compared to after 
consumption of alcohol-free drinks (post hoc test at 20 min: P<0.001). Happiness scores 
were higher 20 min and 50 min after alcohol consumption than after consumption of alcohol-
free drinks (post hoc tests: P<0.001 and P=0.029, respectively). However, there was also an 
interaction effect of ambiance and alcohol on happiness scores. The scores were higher in the 
unpleasant ambiance with alcohol consumption than without alcohol consumption (P<0.001). 
Happiness scores were not influenced by moderate alcohol consumption in the pleasant 
ambiance.
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Postprandial responses of ECs and NAE congeners
AEA and related NAEs, with the exception of SEA, changed after a meal (main time effect: 
all P<0.05). Post hoc tests showed that OEA and DHEA levels increased 30 min after food 
intake compared to before the meal (P=0.033 and P<0.001, respectively). Additionally, AEA, 
OEA and PEA concentrations were decreased 120 min after food intake compared to before 
the meal (P<0.001, P<0.001, P=0.012, respectively). Furthermore, AEA, OEA and DHEA 
concentrations were decreased 120 min after food intake compared to 30 min after food 
intake (all P<0.001).  Plasma 2-AG concentrations were not influenced by the meal.
Effects of induced mood changes on ECs and NAE congeners
The effects of the interventions on the changes in ECs and NAE congeners from baseline 
were calculated to adjust for baseline differences. In Figure 3.3 the effect of ambiance on 
plasma concentrations of ECs and NAE congeners is shown. PEA and SEA concentrations 
were influenced by ambiance over time (interaction effect of time*ambiance: P=0.041 and 
P=0.050, respectively). PEA and SEA levels were increased in the unpleasant ambiance but 
decreased in the pleasant ambiance 30 min after consumption (post hoc tests at 30 min: 
P=0.073 and P=0.036). The ambiance mood induction had no effect on 2-AG, AEA or other 
NAEs. Furthermore, moderate alcohol consumption did not influence plasma concentrations 
of 2-AG, AEA or related NAEs.
Relation with mood states
Changes in EC and NAE concentrations from baseline until 120 min after the meal correlated 
with changes in mood states in the pleasant ambiance without alcohol only (Figure 3.4). 
Happiness scores were negatively correlated with 2-AG and PEA levels (rs=−0.52  and 
rs=−0.60, respectively). Furthermore,  changes in fatigue scores correlated positively with 
changes in AEA (rs=0.53) and DHEA (rs=0.76), whereas changes in vigour scores correlated 
negatively with changes in OEA levels (rs=−0.66). Finally, changes in calmness scores 
correlated positively with SEA levels (rs=0.56). 
Relation with free fatty acids and cortisol
The postprandial responses of ECs and NAE congeners correlated positively with the 
postprandial responses of FFAs in all intervention combinations (Table 3.2). The correlations 
were not significantly different between the interventions. For SEA, the correlations with FFA 
change were lower for all interventions as compared with the other NAEs. 
The correlations between EC and NAE responses and cortisol responses differed per 
intervention combination. Plasma concentrations in 2-AG and AEA were positively correlated 
with serum cortisol concentrations in every intervention combination, except in the unpleasant 
ambiance with alcohol. OEA and DHEA were also positively correlated with cortisol in the 
unpleasant ambiance without alcohol (r=0.82 and r=0.60, respectively). SEA showed a strong 
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negative correlation with cortisol in the unpleasant ambiance with alcohol (r=-0.87).
The effect of meal ambiance and moderate alcohol consumption on the postprandial responses 
of FFAs and cortisol are shown in Figure 3.5. The FFA response was not influenced by the 
mood inductions. Cortisol was more decreased 120 min after moderate alcohol consumption 
as compared to after consumption of alcohol-free drinks (post hoc test at 120 min: P=0.001). 
Figure 3.3. Changes in endocannabinoids and N-acylethanolamines after mood inductions by 
ambiance and moderate alcohol consumption1. 
(A) 2-arachidonoylglycerol (2-AG), (B) anandamide (AEA) and related compounds (C) palmitoylethanolamide (PEA) and 
(D) stearoylethanolamide (SEA). Black bars represent pleasant ambiance with alcohol; white bars represent pleasant 
ambiance without alcohol; dark grey bars represent unpleasant ambiance with alcohol; light grey bars represent 
unpleasant ambiance without alcohol. PEA and SEA concentrations are increased 30 min after a meal in the unpleasant 
ambiance, but decreased after a meal in the unpleasant ambiance (*P=0.073; ** P=0.036). 
1 n=16.
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Figure 3.4. Correlations between changes in mood and endocannabinoids and N-acylethanolamines 
in a pleasant ambiance without alcohol1. 
(A) 2-arachidonoylglycerol (2-AG), (B) anandamide (AEA), (C) palmitoylethanolamide (PEA), (D) docosahexaenoyl-
ethanolamide (DHEA), (E) oleoylethanolamide (OEA), and (F) stearoylethanolamide (SEA). The figure shows spearman 
rank correlations with ranked values on both axes of the panels.
1 n=16.
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Table 3.2. Correlations between endocannabinoid and N-acylethanolamines responses and FFA 
and cortisol responses1.
Variable Intervention FFA Cortisol
r (95% CI) r 95% CI
2-AG Pleasant, no alcohol 0.47 (-0.04 to 0.78) 0.62 (0.19 to 0.86)
Pleasant, alcohol 0.72 (0.34 to 0.89) 0.54 (0.06 to 0.82)
Unpleasant, no alcohol 0.82 (0.55 to 0.94) 0.86 (0.64 to 0.95)
Unpleasant, alcohol 0.49 (-0.01 to 0.79) 0.45 (-0.06 to 0.77)
AEA Pleasant, no alcohol 0.71 (0.34 to 0.89) 0.53 (0.05 to 0.81)
Pleasant, alcohol 0.73 (0.37 to 0.90) 0.68 (0.27 to 0.88)
Unpleasant, no alcohol 0.93 (0.82 to 0.98) 0.78 (0.47 to 0.92)
Unpleasant, alcohol 0.92 (0.77 to 0.97) 0.36 (-0.17 to 0.73)
OEA Pleasant, no alcohol 0.81 (0.53 to 0.93) 0.38 (-0.14 to 0.74)
Pleasant, alcohol 0.95 (0.87 to 0.98) 0.79 (0.49 to 0.92)
Unpleasant, no alcohol 0.95 (0.85 to 0.98) 0.82 (0.54 to 0.93)
Unpleasant, alcohol 0.91 (0.77 to 0.97) -0.14 (-0.60 to 0.38)
PEA Pleasant, no alcohol 0.74 0.39 to 0.91) -0.38 (-0.74 to 0.14)
Pleasant, alcohol 0.72 (0.34 to 0.90) 0.55 (0.07 to 0.82)
Unpleasant, no alcohol 0.44 (-0.07 to 0.77) 0.31 (-0.22 to 0.70)
Unpleasant, alcohol 0.82 (0.56 to 0.94) 0.62 (0.18 to 0.85)
SEA Pleasant, no alcohol 0.48 (-0.02 to 0.79) -0.87 (-0.95 to -0.65)
Pleasant, alcohol 0.58 (0.12 to 0.84) 0.09 (-0.43 to 0.56)
Unpleasant, no alcohol 0.47 (-0.03 to 0.79) 0.02 (-0.48 to 0.51)
Unpleasant, alcohol -0.23 (-0.65 to 0.30) -0.51 (-0.80 to -0.01)
DHEA Pleasant, no alcohol 0.84 (0.58 to 0.94) 0.33 (-0.19 to 0.71)
Pleasant, alcohol 0.76 (0.42 to 0.91) 0.23 (-0.30 to 0.65)
Unpleasant, no alcohol 0.88 (0.69 to 0.96) 0.60 (0.15 to 0.85)
Unpleasant, alcohol 0.80 (0.50 to 0.93) 0.18 (-0.35 to 0.62)
1 All values are mean [pearson’s correlation coefficient (r)] and 95% confidence interval after Fisher’s z transformation 
(n=16). Interventions are alcohol (sparkling white wine vs. alcohol-free sparkling white wine) and ambiance (pleasant 
vs. unpleasant). 
Abbreviations: FFA, free fatty acid; NAE, N-acylethanolamine; 2-AG, 2-arachidonoylglycerol; AEA, anandamide; OEA, 
oleoylethanolamide; PEA, palmitoylethanolamide; SEA, stearoylethanolamide; DHEA, docosahexaenoylethanolamide; 
DLE, dihomo-γ-linolenoylethanolamide.
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Discussion
The primary outcomes of this study are that 1) PEA and SEA were increased in an unpleasant 
meal ambiance where tension and depression scores were higher; 2) ECs and NAE 
congeners correlated with mood states in the pleasant ambiance without alcohol only; 3) 2-AG 
and AEA were not influenced by the mood inductions but were related to FFA and cortisol 
concentrations. 
This study showed that two NAEs, PEA and SEA, were responsive to the mood induction by 
meal ambiance. In the unpleasant ambiance, PEA and SEA concentrations were elevated 
after 30 min, while they were decreased in the pleasant ambiance. Possibly, these NAEs can 
become elevated in a tension and depression increasing ambiance, as scores for tension 
and depression were higher in the unpleasant ambiance. This concords with animal studies 
indicating a regulatory role for ECs and related NAEs in emotion and stress (16, 33). In 
addition, this would be in line with human studies showing elevated circulating PEA during 
psychological stress and elevated PEA and SEA in patients with posttraumatic stress disorder 
(19, 34). Little is known about the role of PEA and SEA in mood, although PEA has been 
investigated for its anti-inflammatory, neuroprotective and analgesic properties (35-37). 
We investigated whether patterns of correlations existed between postprandial mood 
responses and circulating ECs and their NAE congeners. In the pleasant ambiance without 
alcohol we found negative correlations with happiness (2-AG and PEA) and vigour (OEA) 
and positive correlations with fatigue (AEA and DHEA). These findings might suggest that 
increasing ECs and NAE congeners are related to decreasing mood states as we hypothesized. 
Figure 3.5. Postprandial changes in (A) serum free fatty acid and (B) cortisol after mood inductions1.
White bars represent pleasant ambiance with alcohol; dark grey bars represent unpleasant ambaince with alcohol; 
black bars represent pleasant ambiance without alcohol; light grey bars represent unpleasant ambiance without alcohol. 
Cortisol concentration is more decreased 120 min after a meal with alcohol than without alcohol (*P=0.001).
1 n=28.
59
Alcohol, ambiance and endocannabinoid system
However, calmness was positively related to SEA concentrations and no correlations were not 
found in the other experimental conditions. Therefore, we conclude that we did not observe a 
consistent pattern of correlations. 
The biological relevance of plasma concentrations of ECs and NAE congeners remains 
speculative because plasma levels are likely to reflect a ‘spill over’ of 2-AG and NAE synthesis 
in tissues, such as adipose tissue, liver and perhaps brain. Joosten et al. (2010) observed that 
circulating FFAs and NAEs are highly correlated. Here, correlations were calculated between 
NAEs and FFA levels similarly as in Joosten et al. (2010) and similar correlations were found 
between postprandial responses of FFAs and AEA, OEA and PEA. Therefore, this study 
confirms that plasma NAE patterns may reflect fatty acids patterns and that their short-term 
release from N-acylphosphatidylethanolamine (NAPE) is triggered by similar mechanisms as 
are involved in the release of FFA. However, in this study, plasma ECs and related NAEs were 
also positively related to serum cortisol concentrations, especially in the unpleasant ambiance 
without alcohol. This finding together with the results from previous human studies where ECs 
and NAE congeners are shown to be responsive to stress (18, 19, 38), supports a role for 
plasma ECs and NAE congeners as indicators of stress. 
Strengths of the study are the randomized crossover design and the controlled study 
conditions. Furthermore, the mood induction method by meal ambiance was completely 
standardized and induced a positive and negative mood for a relative long time of three hours. 
This was shown by higher depression and tension scores in the unpleasant ambiance and 
higher happiness scores in the pleasant ambiance. In comparison with the mood induction by 
ambiance, moderate alcohol consumption influenced different mood states and effects were 
more acute. We also showed an interaction effect of alcohol and ambiance on happiness, 
which was not shown before. Moderate alcohol consumption in an unpleasant ambiance 
increased happiness, but drinking alcohol during a pleasant mood results in an equally positive 
mood state. This indicates that the mood induction methods used were complementary and 
interacting, thereby providing the ability to study the response of ECs and NAE congeners on 
a variety of mood changes. 
This study also has some important limitations. The experimental design of this study may 
not have provided the appropriate conditions to examine the relation between changes in 
mood and changes in ECs and related NAEs. A further limitation of the study is that ECs 
and their NAE congeners were measured at three time points and the effects of ambiance 
on NAEs may have been missed. Additionally, mood was induced by rooms with a pleasant 
or an unpleasant ambiance. Perhaps, these ambiances did not influence mood to such an 
extent that correlations between mood scores and plasma ECs and NAE congeners could be 
observed. Therefore, further research may focus on mood induction by ambiance using more 
extreme conditions. The role of ECs and NAE congeners may also be better detectable when 
no food is consumed during mood induction, and consequently exclusively focusing on the 
association of mood with ECs and NAE congeners. 
60
Chapter 3
This study was carried out in women, and generalizability of the results to men may therefore 
not be directly possible, because men and women showed different mood effects of a meal in 
a previous study (39).
We conclude that this is the first human study to demonstrate that plasma NAEs are responsive 
to an unpleasant meal ambiance. Furthermore, associations between mood states and ECs 
and related NAEs were observed, but not in all intervention combinations. This study provides 
additional insight in the response of plasma ECs and NAE congeners on mood changing 
conditions in humans. 
The findings are in line with animal and human studies suggesting a role of endocannabinoids 
in mood and stress regulation. However, for a better translation between animal and human 
studies, animal studies should also measure circulating levels of ECs and NAE congeners 
and study their response on mood inductions. This would provide more information on the 
clinical relevance of changes in circulating ECs and NAEs. For clinical implications on the use 
of plasma ECs and NAE congeners as diagnostic agents for mood disorders, more research 
is necessary. Future human studies may focus on mood induction by ambiance using more 
extreme conditions. Associations may also be better detectable when no food is consumed 
during mood induction, and consequently exclusively focusing on the association of mood 
with endocannabinoids and NAEs.  
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Abstract
The aim of this study was to investigate whether food reward plays a role in the stimulating 
effect of moderate alcohol consumption on subsequent food intake. In addition, we explored 
the role of oral and gut sensory pathways in alcohol’s effect on food reward by modified sham 
feeding (MSF) or consumption of a preload after alcohol intake. 
In a single-blind crossover design 24 healthy men were randomly assigned to either 
consumption of vodka/orange juice (20 g alcohol) or orange juice only, followed by consumption 
of cake, MSF of cake or no cake. Food reward was evaluated by actual food intake measured 
by an ad libitum lunch 45 min after alcohol ingestion and by behavioural indices of wanting 
and liking of four food categories (high fat, low fat, sweet and savoury). 
Moderate alcohol consumption increased food intake during the ad libitum lunch by 11% 
(+338 kJ, P=0.004). Alcohol specifically increased intake (+127 kJ, P<0.001) and explicit liking 
(P=0.019) of high-fat savoury foods. Moreover, moderate alcohol consumption increased 
implicit wanting for savoury (P=0.013) and decreased implicit wanting for sweet (P=0.017) 
before the meal. Explicit wanting of low-fat savoury foods only was higher after alcohol 
followed by no cake as compared to after alcohol followed by cake MSF (P=0.009), but not 
as compared to alcohol followed by cake consumption (P=0.082). Both cake MSF and cake 
consumption had no overall effect on behavioural indices of food reward. 
To conclude, moderate alcohol consumption increased subsequent food intake, specifically 
of high-fat savoury foods. This effect was related to the higher food reward experienced for 
savoury foods. The importance of oral and gut sensory signalling in alcohol’s effect on food 
reward remains largely unclear.
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Introduction
Consistent evidence shows that alcohol stimulates short-term food intake when it is 
consumed before or with the meal (1-3). This effect may relate to reduced satiety signalling 
after alcohol consumption. However, there is only limited evidence in humans to support 
such a hypothesis (4, 5). Another potential mechanism through which alcohol may stimulate 
food intake is by increasing the rewarding value of food via its effects on reward systems. 
Food reward comprises of two components: ‘liking’ and ‘wanting’, which can be divided both 
psychologically and neurologically (6). Psychologically, liking refers to the pleasantness of 
food and the pleasure derived from tasting the food, and wanting to the intrinsic motivation 
to eat. Neurologically, liking has been shown to be influenced by opioid, endocannabinoid 
and GABA neurotransmission, whereas wanting appears to mainly depend on dopaminergic 
neurotransmission (6-8). Alcohol may stimulate both liking and wanting as it has been shown 
to enhance opioid release, and stimulate GABA and dopaminergic neurotransmission (9-11). 
However, previous studies observing an increased food intake showed no influence of alcohol 
on the pleasantness nor on pleasure of eating either a savoury or a mixed (savoury and 
sweet) meal (12, 13). The effect of alcohol on food wanting has not been measured previously. 
Oral nutrient sensing plays an important role in food reward. Orosensory stimulation by food 
may induce a cephalic phase response but it may also increase the hedonic and rewarding 
value of food  (14, 15). Gut nutrient sensing may also increase the rewarding value of food, 
although evidence is less strong as compared to oral nutrient sensing (16, 17). Recently, the 
effects of oral and gut sensory stimulation on brain reward systems were compared in a study 
performed in pigs, showing that oral and gut stimulation influenced diverse reward regions 
(18). 
To our best knowledge, no studies have been conducted on the effect of moderate alcohol 
consumption on the satiety or reward response of orally sensed food. A method to study 
orosensory stimulation is the modified sham feeding (MSF) technique, in which food is 
smelled, chewed and tasted, but not swallowed (19-21). By the use of MSF after alcohol 
consumption the role of orosensory stimulation in alcohol’s effect on food intake and food 
reward can be investigated. Typically, the rewarding value of food decreases with food 
intake, ultimately causing the person to stop eating. Therefore, we predicted that orosensory 
stimulation only and oral plus gut sensory stimulation would reduce food intake of the next 
meal, since both conditions will initiate a reward response. The role of oral and gut stimulation 
could be explored by comparing food intake after alcohol consumption in combination with 
cake MSF and in combination with cake consumption. 
Rewarding food is often highly palatable food, such as sweet and high-fat food, although 
savoury food, such as pizza, may also be rewarding (22, 23). Finlayson et al. (2012) studied the 
effect of equi-palatable savoury and sweet drinks on food reward and observed no difference 
in liking and wanting between the drinks (24). However, exposure to savoury taste has a 
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stronger modulating effect on subsequent food preferences as compared with exposure to 
sweet taste (25). In addition, sweet and savoury intake may activate different reward-related 
brain systems (26). Therefore, we hypothesized that alcohol could differentially influence the 
rewarding value of specific food categories based on taste or fat content. Previous studies, 
however, do not show a difference in taste preference after alcohol intake. Studies showing an 
increased food intake after alcohol consumption mainly used mixed meals and observed no 
difference in food preferences (13, 27), though, Caton et al. (2004) showed an elevated intake 
of high-fat savoury food (crisps) after 4 glasses of alcohol. 
The primary aim of this study was to investigate if moderate alcohol consumption stimulates 
subsequent food intake via an increased food reward. Food reward was evaluated by explicit 
ratings of wanting and liking and an implicit measure of wanting. Second, we investigated 
the role of oral and gut sensory stimulation in alcohol’s effect on food reward. This was 
evaluated by comparing food reward after only alcohol consumption with food reward after 
alcohol consumption followed by oral stimulation or followed by both oral and gut stimulation 
(normal consumption). We hypothesized that alcohol increases food intake via an increased 
food reward (both explicit and implicit measures of wanting and liking) of high-fat and sweet 
foods and that alcohol mediates food reward mainly via orosensory pathways. Both oral 
stimulation and oral plus gut stimulation were predicted to induce a reward response and 
thereby decrease food intake of the next meal. The combined oral and gut stimulation was 
expected to have a larger effect. 
Method
Participants
Healthy men (n=24, age 25-50 y, BMI 20-25 kg/m2) participated in the study. The participants 
were recruited from a pool of volunteers at CHDR (Centre for Human Drug Research) in 
Leiden, The Netherlands and by advertising in newspapers. Eligible participants did not 
use any medication, habitually consumed alcohol (5-20 glasses/week, equal to ± 50-200 g 
alcohol/week (28)) and had no (family) history of alcoholism. Additionally, participants had to 
like all the food products used in the study. They were excluded if they scored above average 
(>2.26) on the restraint eating scale of the Dutch Eating Behaviour Questionnaire (DEBQ). 
The reasons for including only male participants were the stronger association of moderate 
alcohol consumption with body weight in men than in women and the possible influence of 
hormonal fluctuations in women on food intake and reward (29, 30).   
The study was conducted at CHDR in Leiden, The Netherlands, and was performed according 
to the International Conference on Harmonisation Guidelines for Good Clinical Practice. The 
study also complied with the Declaration of Helsinki and was approved by an independent 
Medical Ethics Committee (The Medical Ethics Committee of the University Medical Centre of 
Leiden). Written informed consent was obtained from all participants. The study is registered 
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at ClinicalTrials.gov (NCT): NCT01738906. 
Study design
The study used a single-blind randomized crossover design, with the intervention factors 
alcohol (alcohol vs. alcohol-free) and food exposure (no cake vs. cake MSF vs. cake 
consumption). Participants came 6 times to CHDR to have all intervention combinations. 
Each participant participated in all 6 experimental conditions, which occurred at least 2 days 
apart. Participants were randomly allocated to one of the 6 groups with different intervention 
orders according to a 6x6 Williams square design. Randomized allocation was performed by 
statisticians of CHDR by the use of a computer-generated randomization scheme. 
Interventions
Alcohol intervention 
The alcohol intervention consisted of either 200 mL vodka orange juice (20 g alcohol) or 
200 mL orange juice with 31 g maltodextrin (Nutricia Fantomalt, Nutricia Cuick, Cuijk, The 
Netherlands) which they had to consume within 5 min. The beverages were matched for 
calories by adding maltodextrin, a nonsweet carbohydrate, to the orange juice beverage 
(Table 4.1). The dosage of 20 g alcohol was considered to be moderate for men (28). 
Participants were blinded to the alcohol intervention. Beverages were served in a closed 
cup and at a serving temperature of ca. 5°C. In addition, a little sterilium (an alcohol based 
disinfection lotion) was placed at the opposite side of the drinking opening of the lid on only 
the alcohol-free beverage to make it smell like alcohol. 
Food exposure intervention 
The food exposure intervention consisted of either MSF of 40 g cake or consumption of 40 g 
cake or a control condition with no cake. The cake was a commercially available plain butter 
cake (Table 4.1; Albert Heijn, The Netherlands). The MSF procedure consisted of 3 min oral 
processing of half of the amount of cake administered (part I), two minutes break for data 
collection, and again 3 min oral processing of the final half of the amount of cake (part II). 
During MSF the cake was not swallowed, but spit out in a paper cup together with the water 
used to rinse their mouth. The weight of this cup was measured to calculate MSF production 
and to assess whether no cake was swallowed and whether the participant successfully 
performed the procedure. During consumption of the cake, the procedure was similar to the 
MSF of cake (e.g. equal oral processing time), except that the cake was swallowed and not 
spit out. In the control condition, participants received no cake and were inactive during this 
6 minute period.
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Table 4.1. Energy content and nutritional value of the test foods per served quantitya.
 
65 mL Vodka +
135 mL orange juice
175 mL Orange juice + 
31 g maltodextrin
40 g Cake
Energy (kJ) 804 800 630
Protein (g) 0.9 1.2 2.2
Carbohydrates (g) 12 45 18
   Of which sugars (g) 12 17 11
Fat (g) - - 8
Alcohol (g) 20 - -
a Values derived from the package labels.
Experimental procedures 
Participants were instructed to refrain from alcohol 24 hours before each test day, to eat their 
usual breakfast and lunch on standard times on each test day and to refrain from eating and 
drinking anything except water 3 hours before testing. Compliance to these instructions was 
checked by nurses before baseline. At baseline (t0) participants received the beverage with 
either vodka orange juice or orange juice only, and after 20 min the participants received cake 
for MSF, for consumption or they received no cake. During the day blood and saliva samples 
were also collected regularly. In between the measurements and interventions participants 
were inactive. However, after the last questionnaire, participants went to the waiting room 
where they could watch television or read while they waited for the final blood alcohol 
concentration measurement.
Food reward
Food reward was evaluated in the following ways: first, actual intake was measured by an ad 
libitum lunch, which was served 45 min after participants started drinking. Second, on regular 
times behavioural indices of food liking and wanting were measured (Figure 4.1).  
Figure 4.1. Schematic overview of the experimental procedures.
Number in brackets represent the time points (min) at which measurements were performed or food or beverages were 
administered. BAC, blood alcohol concentration; LFPQ, Leeds Food Preference Questionnaire; A, appetite ratings.
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Food intake 
Actual intake was measured by an ad libitum lunch that was composed of water, bread, 
diet margarine and several toppings. The exact composition of the lunch is shown in Table 
4.2. Participants could choose from 8 toppings, comprising 2 toppings from each of the 
following food categories: high-fat savoury, low-fat savoury, high-fat sweet, and low-fat sweet. 
Participants were in separate rooms and had 30 min to eat an ad libitum lunch. They could 
choose and prepare their lunch themselves with the foods supplied. Bread was cut in to 
quarters, so that cues for amount to consume were lessened.
Behavioural indices of food liking and wanting 
The Leeds Food Preference Questionnaire (LFPQ) is a tool to measure various aspects of 
reward. It is a validated tool developed and extensively described by Finlayson et al. (2007, 
2008) (31, 32). We used a Dutch version including 16 photographs of snacks from the food 
categories high-fat savoury, high-fat sweet, low-fat savoury, and low-fat sweet developed and 
described by Griffioen-Roose et al. (2010) (25). Explicit wanting and liking was measured on 
a VAS (100-unit). Participants had to rate their liking (‘‘how pleasant do you find the taste of 
this food right now?’’) and wanting (‘‘how much do you want to eat this food right now?’’) for 
the presented snack products. In addition, implicit wanting was measured by a task where two 
snack products were shown and participants had to select their most wanted food (‘‘select the 
food which you most want to eat right now’’) as quickly and accurately as possible. During this 
task the reaction time (RT) was measured and transformed to a standardized ‘d-score’ (D-RT) 
according to the algorithm of Greenwald et al. (2003) (33). Smaller D-RT indicates higher 
implicit wanting for that food category in relation to the other categories.  
Appetite
Appetite was evaluated with visual analogue scales (range 0-100) for hunger, desire to eat, 
prospective food consumption and fullness. Appetite ratings were measured on regular times 
(Figure 4.1).  
Blood alcohol concentration 
Blood alcohol concentration (BAC) was measured repeatedly by a breath analyser (Alco-Sensor 
IV, Honac Nederland B.V., Apeldoorn, The Netherlands). An overview of the measurement 
time points and food and alcohol administration are shown in Figure 4.1. Participants were not 
allowed to leave premises until their BAC was below 0.20‰ w/v.
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Table 4.2. Energy content and nutritional valuea of the products offered during the ad libitum lunch 
(per 100 g).
 Servingb Energy (kJ) Protein (g) CHO (g) Fat (g)
General
Wholemeal bread 15 slices 930 10 38 2
Diet margarine 1 jar 1200 1 3 30
Water 500 mL 0 0 0 0
High-fat savoury 
Paté 1 piece 1610 8 4 38
Salami 10 slices 1632 17 2 35
Average 1621 13 3 37
Low-fat savoury
Lean ham 10 slices 397 16 3 2
Smoked beef 10 slices 502 24 1 3
Average 450 20 2 2
High-fat sweet
Hazelnut spread 1 jar 2273 6 57 32
Coconut slices 6 slices 1730 3 67 14
Average 2002 4 62 23
Low-fat sweet
Jam 1 jar 1033 0 59 0
Apple syrup 1 jar 1161 1 66 0
Average 1097 1 63 0
Total averages
High-fat 1811 8 33 30
Low-fat 773 10 32 1
Savoury 1035 16 2 19
Sweet 1549 3 62 11
a Values derived from the package labels. CHO, carbohydrate.
b Equal servings were supplied to the participants and new jars were provided on every occasion.
Data analysis
Intervention effects on energy intake and choice of the food products from the different 
categories were analysed within participants with a mixed model analysis of variance including 
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the fixed factors alcohol (alcohol vs. alcohol-free), food exposure (no cake vs. cake MSF vs. 
cake consumption), time, and the interaction between alcohol and food exposure. The factors 
participant and participant by period were added to the model as random factors. 
Intervention effects on food reward and appetite before the meal were analysed within 
participants with a mixed model analysis of variance including the fixed factors alcohol and 
food exposure, and the 2-way interaction between alcohol and food exposure. The factors 
participant and participant by period were added to the model as random factors. The 
interaction effect compared the alcohol effect on food reward and appetite between the food 
exposure conditions, namely no cake, cake MSF and cake consumption.  
Post hoc comparisons were made using Tukey-Kramer adjustment, to correct for multiple 
testing. Results were considered significantly different at a P-value of <0.05. All analyses were 
performed using SAS version 8 (SAS Institute, Cary, NC, USA) and all data are presented as 
mean with standard error unless otherwise specified. 
Results
Participants
Participants had an average age of 32 ± 0.8 y (median 27.5, range 25-50) and a BMI of 23 
± 0.1 kg/m2. Their fat percentage, measured by bio-impedance (InBody 720, Biospace Inc, 
Cerritos, CA, USA), was 14 ± 0.4% and their DEBQ restrained score was 1.63 ± 0.03. The 
average alcohol consumption was 11 ± 0.3 (range 6-20) glasses per week. Highest mean BAC 
was measured at 10 min after alcohol ingestion and was on average 0.52‰ w/v.  
One participant dropped out for study unrelated reasons; data of this participant’s first 3 study 
days were included in the analysis. One participant was excluded from the analysis because 
of non-compliance. 
Five participants may have swallowed a small portion of the cake during the MSF condition, 
as the cake weight was lower after MSF than before; data of these occasions were excluded 
from the analysis. Finally, 130 occasions (of the original 144 occasions) were included in the 
analysis. The average increase in cake weight after MSF was 13.4 ± 1.2 g (33%).
Energy intake during lunch
Energy intake during lunch is shown in Table 4.3 for all experimental conditions.
Alcohol consumption increased subsequent energy intake during lunch by 11% as compared 
to no alcohol intake (P=0.004), regardless of the food exposure after the beverage. 
Cake MSF before lunch did not decrease lunch intake as compared to the control condition 
without cake. Cake consumption before lunch decreased energy intake during lunch as 
compared to control (P=0.011), regardless of alcohol consumption. Energy intake during 
lunch was not different after cake MSF and cake consumption. 
A trend was observed for an interaction effect of alcohol and food exposure on energy intake 
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during the lunch (P=0.094). Since this was a non-significant trend, post hoc comparisons were 
not conducted. However, for comparability with previous studies we analysed the difference 
in food intake after alcohol consumption compared to no alcohol consumption in the control 
condition without cake. Alcohol consumption increased food intake by 19% in the control 
condition (P=0.031). 
Table 4.3. Energy intake during lunch (MJ)a.
Mean ± SE Mean ± SE Mean difference ± SE P-value
Alcohol effect
Alcohol-free 3.02 ± 0.21 Alcohol 3.36 ± 0.21 -0.34 ± 0.11 0.004
Food exposure effect 0.015
MSF 3.20 ± 0.22 Control 3.39 ± 0.21 -0.19 ± 0.14 0.365
Consumption 2.99 ± 0.21 MSF 3.20 ± 0.22 -0.21 ± 0.14 0.294
Consumption 2.99 ± 0.21 Control 3.39 ± 0.21 -0.40 ± 0.14 0.011
Interaction effect 0.094
Alcohol-free, control 3.10 ± 0.23
Alcohol-free, MSF 3.21 ± 0.24
Alcohol-free, consumption 2.77 ± 0.23
Alcohol, control 3.68 ± 0.23
Alcohol, MSF 3.19 ± 0.24
Alcohol, consumption 3.21 ± 0.24
a Least squared means and differences of least squared means are shown as calculated from the mixed model with 
Tukey-Kramer adjustment for post hoc comparisons.
Energy intake from food categories
The influence of alcohol on energy intake from food categories is shown in Figure 4.2A. Overall, 
participants consumed 24% more high-fat savoury lunch toppings after alcohol consumption 
as compared to no alcohol consumption (+127 kJ, P<0.001). A trend was observed for a 
higher intake of low-fat savoury toppings after alcohol vs. alcohol-free (+21 kJ, P=0.076). 
Also, more bread was consumed in the alcohol condition (+124 kJ, P=0.004). Together, these 
elevated intakes of bread and savoury toppings accounted for 35% and 52%, respectively, of 
the total increase in lunch intake by alcohol. 
In Figure 4.2B the influence of the food exposure intervention on the energy intake from 
different food categories is shown. The intake of high-fat sweet toppings was 31% lower when 
cake was consumed as compared to when no cake was received (P=0.009). Food exposure 
did not influence the intake of other food categories. 
The effect of alcohol on food intake of different food categories was not influenced by the 
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exposure to cake or not.
Behavioural indices of wanting and liking
The effect of alcohol and food exposure on the wanting and liking of food categories before 
the meal (30 min after baseline) was studied. Results on implicit wanting are shown in Figure 
4.3.  
Explicit liking of savoury food was higher after alcohol consumption than after consumption 
of alcohol-free drinks (high-fat savoury P=0.019; low-fat savoury P=0.055). Explicit liking of 
sweet food was not influenced by alcohol. After alcohol consumption implicit wanting was 
higher for savoury (lower D-RT, P=0.013) and lower for sweet (higher D-RT, P=0.017) in the 
alcohol condition as compared to the alcohol-free condition (Figure 4.3). 
Food exposure to any of the cake conditions had no overall effect on wanting nor on liking of 
savoury and sweet food. However, there was an interaction effect of alcohol and food exposure 
on wanting of low-fat savoury food (P=0.018). This was caused by a higher wanting of low-fat 
savoury food in the condition where alcohol was consumed without cake as compared to the 
alcohol-free condition without cake consumption (P=0.015) and as compared to the alcohol 
condition with cake MSF (P=0.009).
Rated appetite
Overall, hunger and desire to eat ratings were lower during alcohol consumption followed by 
cake MSF as compared to alcohol consumption only (P =0.04, P=0.003, respectively). 
The different food exposures influenced the time course of hunger (P=0.019), desire to eat 
(P=0.002) and fullness (P=0.011) ratings. Post hoc comparisons showed that desire to eat 
was lower during cake consumption (in between food exposure part I and II) as compared to 
Figure 4.2. The effect of (A) alcohol and (B) food exposure on energy intake of high-fat and low-fat 
savoury and sweet lunch toppings during the ad libitum lunch. 
HFSA, high-fat savoury; HFSW, high-fat sweet; LFSA, low-fat savoury; LFSW, low-fat sweet. **P<0.001 for alcohol vs. 
alcohol-free; #P=0.076 trend for alcohol vs. alcohol-free; *P=0.009 cake consumption vs. control. 
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the control condition. Additionally, hunger and desire to eat ratings increased from 10 min after 
the drink until the meal when no cake was consumed (P=0.007 and P=0.009, respectively). 
This rise in hunger and desire to eat was not observed after cake consumption or cake 
MSF. Fullness ratings were higher during and after cake consumption compared to baseline 
measures (both P<0.001).
Discussion
The role of food reward in the stimulatory effect of moderate alcohol consumption on 
subsequent food intake was studied. We showed that alcohol increased subsequent food 
intake, especially of high-fat savoury food, which concurred with an increased food reward for 
savoury foods. We also explored if moderate alcohol consumption increases food reward via 
oral or gut sensory pathways, by the use of cake MSF or cake consumption. However, this 
study showed no modulation of alcohol’s influence on food reward by oral stimulation only 
(cake MSF) or oral and gut stimulation (cake consumption).  
The finding that consumption of a moderate amount (20 g) of alcohol stimulated subsequent 
food intake confirms findings from previous studies. In the present study, a 19% increased 
energy intake was observed after 20 g alcohol consumption in the control condition, which 
is comparable to observed increases of 26-30% in energy intake in previous studies using 
dosages of 15-30 g alcohol (3, 12, 34). This is the first study, however, that measured the 
effect of moderate alcohol consumption on food intake in combination with behavioural indices 
of reward, liking and wanting. Liking and wanting of different food categories was measured 
in order to discriminate reward of sweet and savoury foods and of high-fat and low-fat foods. 
Figure 4.3. Implicit wanting of savoury and sweet food before the meal in the conditions with or 
without alcohol and after no cake, cake modified sham feeding (MSF) or cake consumption. 
* P=0.013 alcohol vs. alcohol-free. $ P=0.017 alcohol vs. alcohol-free.
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Moderate alcohol consumption increased the intake of savoury food, and liking and wanting of 
savoury food as compared to no alcohol consumption. More specifically, alcohol consumption 
increased the intake and explicit liking of high-fat savoury food and increased the explicit 
wanting of low-fat savoury food. Also implicit wanting of savoury food was increased after 
alcohol consumption. These effects were not shown by previous studies, although Caton et 
al. (2004) showed an increased intake of crisps after 4 glasses of alcohol as compared to 1 
glass of alcohol, suggesting a higher preference of high-fat savoury by alcohol consumption 
(13, 27). Yeomans and Phillips (2002) showed that alcohol acutely increased the saltiness 
perception and intake of a savoury test meal, which suggests that altered taste perception 
may play a role (35). The higher savoury food intake and reward after alcohol consumption 
could also be a learned effect, because in Western societies alcohol consumption is often 
combined with the consumption of savoury foods. 
To study the role of oral and gut sensory signalling in alcohol’s effect on food intake and 
reward, we compared food intake after alcohol consumption in combination with cake MSF 
and in combination with cake consumption. Oral stimulation by MSF has been shown to 
induce a cephalic phase response via oral sensory signalling, which in turn activates different 
physiological processes, such as a satiation and a reward response (14, 21). In our study, 
cake consumption reduced subsequent food intake compared to control. After cake MSF, 
subsequent food intake was not reduced. Moreover, only in the cake consumption condition, 
a decreased intake of high-fat sweet food was observed. This reduction in high-fat sweet 
after cake consumption may have been due to sensory specific satiation, since the cake was 
high-fat sweet too. Furthermore, we observed an increased appetite over time in the control 
condition, but not in the MSF and consumption condition, suggesting a reduced appetite by 
MSF and consumption relative to the control. However, fullness was only increased over 
time by consumption of cake but not by cake MSF. In contrast to our hypotheses, no main 
effects of cake MSF and consumption were found on wanting and liking of the food categories. 
These results suggest that the reduction of overall food intake during lunch and high-fat sweet 
food after cake consumption appear more related to a reduction in general appetite feelings 
than to a reduced food reward for specific food categories. Other studies have shown an 
effect of MSF on subsequent food intake and sensory specific satiation (21, 36, 37). However, 
similar to our findings, they also found a non-significant decrease in appetite after MSF. It 
could be that the sham feeding time was too short or the volume was too small to influence 
subsequent food intake and reward (21). It should be noted that the MSF procedure may 
have been experienced as unpleasant for some of the participants. It is possible that the 
combination with alcohol consumption made the experience even more unpleasant, resulting 
in reduced appetite. However, none of the participants reported feeling nauseous after alcohol 
consumption and MSF.  
We observed one interaction effect between alcohol and food exposure: wanting of low-
fat savoury was lower after cake MSF compared to control when preceded by alcohol 
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consumption. Since this was the only interaction effect observed, the role of oral and gut 
sensory stimulation in alcohol’s appetizing effect remains unclear. Therefore, further research 
on the role of oral and gut sensory signalling in alcohol’s effect on food reward is needed.
A strength of this study is the randomized crossover design. Therefore, effects could be studied 
within participants and without influence of between-person variance, which may be large for 
behavioural indices of reward. Moreover, this is the first study that measured the effect of 
alcohol on both intake and food reward of different food categories. Therefore, the increased 
intake of savoury foods during the lunch could be linked to the increased explicit liking and 
wanting and implicit wanting of savoury food measured by the LFPQ. This consistency 
between the outcomes also strengthens our findings.
However, the study design also had limitations that warrant consideration. First, blinding of 
the alcohol treatment might not have been complete due to physiological and behavioural 
effects of alcohol.  Most participants guessed correctly whether the beverage contained 
alcohol. Therefore, learned associations may have influenced the increased consumption 
of savoury food with alcohol. However, Yeomans et al. (2010) showed that when alcohol is 
provided in a non-alcohol context, such as orange juice, learned associations with increased 
food intake have a lower impact than when it is provided in an alcohol-context (38). Yet, it 
would be interesting to study this effect on savoury in cultures where alcohol consumption is 
not associated with savoury food intake. Second, the type and taste of alcohol used in this 
study may have influenced the rewarding value and intake of savoury food. In the present 
study vodka orange juice was used as alcoholic beverage, which has a sweet and bitter 
taste. It could be hypothesized that effects on savoury intake and reward would have been 
different with other alcoholic beverages. Third, the beverages could not be fully matched on 
taste and smell, although we tried to make them as equal as possible. The vodka orange 
juice had a more bitter taste than the orange juice due to the alcohol content. This may have 
influenced subsequent food choice and food reward of the different food categories and may 
also have decreased the effectiveness of the blinding. Also, the palatability of the beverages 
has not been measured. Therefore, a difference in palatability between the alcoholic and 
non-alcohol drink may also have influenced subsequent food reward of the different food 
categories. Fourth, the study design was single-blind. The experimenter was not blinded to 
the treatment and may therefore have influenced the participant. A final limitation is the strong 
association between the measurement of explicit liking and wanting indices by the LFPQ, 
also shown previously (25). This strong association made it difficult to differentiate these two 
components of reward. 
To conclude, moderate alcohol consumption increased subsequent food intake, specifically 
of high-fat savoury foods. This effect was related to the higher food reward experienced for 
savoury foods. The importance of oral and gut sensory signalling in alcohol’s effect on food 
reward remains largely unclear.
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Abstract 
Aims: Alcohol is often consumed to reduce tension and improve mood when exposed to 
stressful situations. Previous studies showed that moderate alcohol consumption may 
reduce stress when alcohol is consumed prior to a stressor, but data on the effect of alcohol 
consumption after a mental stressor is limited. Therefore, our objective was to study whether 
moderate alcohol consumption immediately after a mental stressor attenuates the stress 
response.
Methods: Twenty-four healthy men (age 21-40 y, BMI 18-27 kg/m2) participated in a placebo-
controlled trial. They randomly consumed 2 cans (660 mL, ~26 g alcohol) of beer or alcohol-
free beer immediately after a mental stressor (Stroop task and Trier Social Stress Test). 
Physiological and immunological stress response was measured by monitoring heart rate and 
repeated measures of the hypothalamic-pituitary-adrenal axis (HPA-axis), white blood cells 
and a set of cytokines.   
Results: After a mental stressor, cortisol and adrenocorticotropic hormone (ACTH) 
concentrations were 100% and 176% more reduced at 60 min (P=0.012 and P=0.001, 
respectively) and 92% and 60% more reduced at 90 min (P<0.001 and P=0.056, respectively) 
after beer consumption as compared to alcohol-free beer consumption. Heart rate and 
dehydroepiandrosterone (DHEA) were not influenced by alcohol consumption. Plasma IL-8 
concentrations remained lower during the stress recovery period after beer consumption than 
after alcohol-free beer consumption (P<0.001). 
Conclusions: Consumption of a moderate dose of alcohol after a mental stressor may 
facilitate stress response recovery as reflected by decreasing plasma ACTH and cortisol.  
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Introduction
Humans have to respond adequately to physiological and behavioral challenges occurring 
in a dynamically changing environment in order to survive. Physiological reactions to stress 
generally comprise changes in neuroendocrine, hormonal and immune functions (1).
Several studies have shown that alcohol consumption shortly before a mental stressor blunts 
the stress response (2-4). Such a stress-response dampening effect of alcohol has first 
been proposed by Levenson et al. (1980) (5). They showed in male students that alcohol 
consumption prior to a stressor (either speech or electric shock) reduced anxiety and heart 
rate during the stress response as compared to the placebo condition. Similarly, a reduced 
hypothalamic-pituitary-adrenal axis (HPA axis) activity, evaluated as adrenocorticotropic 
hormone (ACTH) and cortisol has been reported (2, 3). However, an increased activity of 
the HPA axis by alcohol consumption has also been reported (6). This difference in hormonal 
responses may be related to the dosage used in the studies. Although there is some evidence 
for a stress-response dampening effect of alcohol, when consumed before a stressor, data 
on the effect of alcohol during stress response recovery is scarce. This is surprising, because 
alcohol is frequently used to reduce the stress after a working day or stressful event. Childs 
et al. (2011) compared the influence of an intravenous alcohol infusion immediately or 30 
min after a mental stressor on the stress response (7). They showed that infusion of alcohol 
immediately after the stressor blocked the cortisol response. Another study by de Wit et al. 
(2003) showed no effect of moderate alcohol consumption on cortisol levels immediately after 
mental stress. However, they measured cortisol only once after the stressor, possibly leaving 
an effect of alcohol consumption on cortisol recovery undetected (8). Moderate alcohol 
consumption may also shortly induce arousal and increase heart rate (9). This might interfere 
with the stress-response dampening effects of alcohol when consumed after the stressor. 
The neuroendocrine and immune systems are highly interrelated (10). The acute immune 
response after a mental stressor has been well described. A meta-analysis has shown robust 
effects, such as increased levels of circulating IL-6 and IL-1β, and marginal effects on CRP 
(11). Additionally, Kimura et al. (2007) have documented changes in the number circulating 
T and B cells and natural killer cells following acute mental stress (12). Moderate alcohol 
consumption has been suggested to have immuno-modulatory and anti-inflammatory effects 
(13). For example, Mandrekar et al. (2006) observed an attenuated monocyte inflammatory 
response and an augmented response of anti-inflammatory cytokine IL-10 after alcohol 
consumption (14). However, the influence of moderate alcohol consumption on the immune 
response to a mental stressor has not been investigated.
Therefore, our primary aim was to investigate whether moderate alcohol consumption 
immediately after a mental stressor attenuates the stress response. Our secondary aim was 
to investigate whether the stress-induced immune response was also affected by moderate 
alcohol consumption.
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Materials and methods
Participants
Twenty-four healthy men (age 21-40 years, BMI 18-27 kg/m2) participated in the study. The 
participants were recruited from a pool of volunteers at TNO (The Netherlands Organization 
for Applied Scientific Research) in Zeist. Eligible participants did not use any medication, 
habitually consumed alcohol (5-27 standard units/week), were non-smokers and had 
no (family) history of alcoholism. The study was performed according to the International 
Conference on Harmonisation Guidelines for Good Clinical Practice. The study also complied 
with the Declaration of Helsinki and was approved by an independent Medical Ethics 
Committee (METOPP, Tilburg, The Netherlands). Written informed consent was obtained from 
all participants. 
Experimental protocol
The study was originally set up as a randomized, open-label, crossover design. Participants 
consumed either 2 cans of beer (660 mL, ~26 g alcohol) or alcohol-free beer (<0.5 g alcohol) 
in a randomized order shortly after they performed a mental stress test. Because of a strongly 
attenuated cortisol and ACTH stress response after the second mental stress test, indicating 
a strong learning effect, we decided to use data from the first mental stress test only. 
Participants were instructed to refrain from eating or drinking anything except water 2.5 hours 
before testing (participants arrived at 11:30 h). The mental stress test was performed after 
initial blood samples were taken and heart rate had been recorded. Immediately after the 
stress test, 2 cans of beer (either beer or alcohol-free beer) were consumed within 30 min. 
Participants were instructed to drink the first can during the first 15 min, and the second can 
during the remaining 15 min. During the following 3 hours subjects were kept in a fasted 
state. During this period blood samples were obtained at regular intervals and heart rate was 
continuously monitored (Table 5.1). 
Table 5.1. Overview of experimental protocol.
-45 
min
-30 min 
stressor
0 min 
1st can
15 min 
2nd can
30 
min
60 
min
90 
min
150 
min
210 
min
Heart rate a x x x
HPA-axis response b x x x x x x x
Immune response c x x x x x x x
a heart rate was continuously monitored and afterwards the average heart rate was calculated at baseline (-45 min till -30 
min), during the stress period (-20 min till 0 min), and during the stress recovery period (10 min till 210 min). These time 
points will be referred to as t=-30 min, t=0 min and t=60 min, respectively.
b measurement of adrenocorticotropic hormone (ACTH), cortisol and dehydroepiandrosterone (DHEA)
c measurement of IL-1β, IL-6, IL-8, TNF-α, number of white blood cells
HPA-axis, hypothalamic-pituitary-adrenal axis.
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Mental stress test
The mental stress test comprised of two stress protocols: the Stroop task and the Trier Social 
Stress Test (TSST). These tests were performed in approximately 30 min. Both the Stroop 
task and the TSST have been shown to induce a physiological stress-response (15).  
The Stroop task is a computerized color-word interference task, involving the successive 
presentation of target color words printed in an incongruous color. Participants had to press 
the computer key that corresponded to the name of the color in which the word was printed. 
The TSST is a standardized laboratory stress test that was performed following the procedure 
of Kirschbaum et al. (1993) (16). The TSST consists of two tasks: a mental arithmetic task 
(10 min) and a public speaking exercise (10 min). In the mental arithmetic task participants 
had to serially subtract the number 13 from 1022 as fast and accurate as possible. In case 
of miscalculation they had to start over. For the public speaking exercise, participants got 
5 minutes to prepare a talk about their personal characteristics, e.g. their strengths and 
weaknesses. Afterwards, they went to a room where they had 5 min to present their talk in 
front two actors, who criticized their talk non-verbally. 
Physiological measures
Blood samples were collected at 7 time points for the measurement of ACTH, cortisol and 
dehydroepiandrosterone (DHEA) and at 8 time points for the measurement of cytokines 
and total and differential white blood cell count (i.e. leucocytes, lymphocytes, neutrophils, 
monocytes, eosinophils and basophils) (Table 5.1). Blood was obtained from the antecubital 
vein of the forearm and collected in pre-chilled tubes containing EDTA for plasma (Vacutainer 
Systems, Becton Dickinson, Plymouth, UK). After the tubes had been centrifuged, the plasma 
samples were stored at -80°C until assayed. 
Plasma ACTH concentrations were measured by an enzyme-linked immunosorbent assay 
(ELISA) (AlpcoDiagnostics, Salem, NH). The intra-assay coefficient of variation was 6.7%. 
Plasma cortisol concentrations were determined using Olympus analytical equipment and 
reagents. Plasma DHEA concentrations were measured with an ELISA (Enzo Life Sciences, 
Lausen, Switzerland) with an intra-assay coefficient of variation of 4.8%.
The plasma concentration of the cytokines IL-1β, IL-6, IL-8, TNF-α were analyzed with a 
multi-spot assay (Meso Scale Diagnostics, Rockville, MD). For total and differential white 
blood cell count, blood was collected at room temperature in tubes containing EDTA. After 
collection, the tubes were stored at room temperature and analysed within 6 h using an Advia 
120 hematology system. 
Data analysis
Repeated measures of changes in physiological responses (ACTH, cortisol, DHEA, heart rate, 
total white blood cells and differential white blood cells) were compared between beer and 
alcohol-free beer consumers, using mixed model analyses. Time, treatment (beer vs. alcohol-
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free beer) and the interaction of time and treatment were added as fixed factors to the model. 
Post hoc comparisons were made using Tukey-Kramer adjustment, to correct for multiple 
testing. Statistical analyses were performed using the SAS statistical software package (SAS 
version 8; SAS Institute, Cary, NC, USA). Error bars in figures express standard errors of the 
mean. Results were considered significantly different at a P-value of <0.05.
Results
Subjects
The baseline characteristics are shown in Table 5.2. Participants in the beer group and the 
alcohol-free beer group did not differ in their baseline values of stress hormones, heart rate 
and immune function. Although age, body weight and BMI were slightly higher in the alcohol-
free beer group, the difference did not reach significance.
Table 5.2. Baseline characteristics of 24 mena 
Beer (n=12) Alcohol-free beer (n=12) P-value
Age (years) 24.8 (4.6) 27.4 (6.2) 0.245
Body weight (kg) 78.6 (7.2) 81.1 (11.3) 0.533
BMI (kg/m2) 22.2 (1.3) 23.4 (2.0) 0.091
Heart rate (beats/min) 73.9 (8.7) 73.3 (10.9) 0.872
Cortisol (nmol/L) 353 (124) 343 (102) 0.832
Log ACTH (pg/mL) 2.68 (0.57) 2.51 (0.39) 0.402
DHEA (ng/mL) 4.37 (3.01) 4.66 (4.57) 0.870
Leucocytes (giga/L) 6.85 (1.53) 6.71 (1.19) 0.802
- Lymphocytes (%) 35.03 (9.36) 33.20 (6.18) 0.578
- Neutrophils (%) 56.63 (9.83) 57.85 (5.46) 0.710
- Monocytes (%) 5.53 (1.38) 5.18 (0.90) 0.481
- Eosinophils (%) 2.33 (0.98) 3.21 (2.96) 0.348
- Basophils (%) 0.49 (0.12) 0.53 (0.20) 0.625
IL-1β (pg/ml) 0.59 (0.41) 0.37 (0.14) 0.105
IL-6 (pg/ml) 4.25 (2.34) 3.62 (1.44) 0.438
IL-8 (pg/ml) 2.81 (1.08) 3.35 (1.15) 0.247
TNF-α (pg/ml) 2.38 (0.74) 2.34 (0.69) 0.878
STAI trait score 31.3 (6.1) 30.3 (5.9) 0.689
a All characteristics are mean (SD) and were measured on the treatment day, except for age, body weight, BMI and STAI 
that were measured during the screening.
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Physiological response to the mental stress test
Physiological responses to the mental stress test are shown in Figure 5.1 for the alcohol-
free condition. Cortisol increased immediately after the stress test (+28%, P=0.044) and 
decreased again at 90 min (P=0.002). A similar pattern was observed for ACTH and DHEA, 
although the rise and fall in ACTH and DHEA did not reach significance. ACTH tended to 
increase immediately after the stressor (+13%, P=0.070) and decreased again at 90 min 
(P<0.001). DHEA did not increase (P=0.71), but showed a significant decrease from 0 min to 
90 min (P=0.013). Heart rate increased by the mental stress test from 73.3 to 89.1 beats/min 
(P=0.024). 
Stress response recovery
Recovery of cortisol and ACTH after the mental stress test is shown in Figure 5.2. Overall, 
plasma cortisol and ACTH were more decreased during the stress recovery period after 
beer consumption than after alcohol-free beer consumption (P<0.001). However, there was 
an alcohol x time interaction effect. Plasma cortisol concentrations decreased 100% and 
90% more at 60 and 90 min after beer consumption as compared to after alcohol-free beer 
consumption (P=0.012 and P<0.001, respectively). A similar pattern was observed for ACTH; 
concentrations decreased 176% more at 60 min after beer consumption vs. alcohol-free beer 
consumption (P=0.001) and tended to decrease more after beer consumption at 90 min after 
the stress test (P=0.056). Heart rate and DHEA were not influenced by alcohol consumption 
(P=0.659 and P=0.882, respectively).
Figure 5.1. The response in cortisol, ACTH (A), DHEA and heart rate (B) before and after the mental 
stress test in the alcohol-free beer condition. 
The grey area represents the period of mental stress.
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Immune response
The influence of beer or alcohol-free beer consumption on the immune response is shown in 
Figure 5.3. IL-8 response was overall lower when beer was consumed than when alcohol-free 
beer was consumed after the mental stressor  (P<0.001). No influence of alcohol consumption 
was observed on the change in cytokines IL-1β, IL-6, and TNF-α. Of the white blood cells, 
only the percentage of monocytes were affected by alcohol. Monocytes were more decreased 
at 150 min after beer consumption (P<0.001) but not after alcohol-free beer consumption 
(P=0.81). This resulted in a lower monocyte level after beer vs. alcohol-free beer consumption 
(P=0.009).    
Discussion
The study showed that moderate alcohol consumption immediately after a mental stressor 
increases the decline of plasma cortisol and ACTH concentrations during stress recovery. 
Additionally, moderate alcohol consumption decreased plasma concentrations of IL-8 during 
stress recovery.
The finding of a more pronounced decrease in HPA-axis hormones, cortisol and ACTH, is 
in accordance with previous studies showing a reduced HPA-axis response when alcohol 
was consumed before stress or was intravenously administered immediately after stress 
induction (2, 3, 7). De Wit et al. (2003) observed no difference in cortisol concentration after 
stress when this was followed by moderate alcohol consumption or placebo. However, in 
this study cortisol was measured at 10 min after the stressor only (8). In the present study, 
the difference in cortisol and ACTH response was not observed until 60 min after alcohol 
consumption. This is in agreement with a previous study in which we observed a reduction in 
Figure 5.2. Changes in cortisol and ACTH response after consumption of beer (n=12) or alcohol-
free beer (n=12) after a mental stress test. 
* P<0.05 beer vs. alcohol-free beer; ** P<0.01 beer vs. alcohol-free beer.
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cortisol 2 h after alcohol consumption (unpublished data). To our knowledge, this is the first 
study measuring the effect of alcohol on the DHEA response to mental stress. DHEA is, like 
cortisol, secreted by the adrenal cortex in response to ACTH. It is a hormone with anabolic 
Figure 5.3. Changes in selected cytokines, monocytes and lymphocytes after a psychological 
stressor during beer consumption  (-○-) (n=12) or alcohol-free beer consumption (-■-) (n=12). 
# IL-8 concentrations were overall lower after beer vs. alcohol-free beer consumption (P<0.001). * Percentage monocytes 
were lower at 150 min after beer consumption vs. alcohol-free beer consumption (P=0.009). 
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properties and has been related to anti-inflammatory and anti-glucocorticoid effects (17). 
Sierksma et al. (2004) showed that 6 weeks of moderate alcohol (beer) consumption resulted 
in 16.5% higher DHEA sulphate concentrations compared to alcohol-free beer consumption 
(18). Previous studies showed an increase in DHEA in response to acute stress (19, 20). In 
our study, however, DHEA was not significantly increased by stress, but showed a reduction 
during stress recovery. We did not observe any indication for even a slight effect of alcohol on 
DHEA. We observed a large inter-individual variation, however, which was also observed by 
Lennartsson et al. (2012) (19). 
In contrast to the studies of Levenson et al. (1980) and Sher et al. (1986), we did not observe 
an effect of alcohol consumption on heart rate (5, 21). This might be due the limited time 
frames at which average heart rate was calculated in our study (i.e. baseline, stress, and 
recovery period). However, Sher et al. (2007) did also not observe an effect of alcohol on heart 
rate response during stress, while they analyzed heart rate during a larger number of time 
frames around the mental stressor (4). 
We also observed small effects of alcohol consumption on the immune response during the 
stress recovery period. However, the interpretation of some of the cytokines, especially IL-
1β, was difficult due to values measured below the detection limit. We observed a lower IL-8 
concentration throughout the stress recovery period and a lower percentage of monocytes 
150 min after alcohol consumption than after consumption of alcohol-free drinks. Both IL-8 
and monocytes have an important function in the pathology of atherosclerosis. The chemokine 
IL-8 has been shown to trigger the firm adhesion of monocytes to vascular endothelium (22). In 
addition, IL-8 has been suggested to stimulate plaque formation via its angiogenic properties 
(23). This would be in line with previous studies showing the beneficial effects of alcohol 
on vascular health (24-26). However, other cytokines and white blood cells, which are also 
important immune factors in atherosclerosis development (27), were not affected by alcohol 
consumption in the current study.
The current study is limited by several factors. First, it was not possible to have a within-subjects 
design because of the large learning effect which resulted in an attenuated stress response 
on the second mental stress test. This limited our power to detect differences, because of 
the inter-individual differences in the effect of alcohol on stress-response dampening (21). 
Nevertheless, we observed effects of alcohol on the stress response and some factors of the 
immune system. Second, the effects of alcohol on the physiological stress response could 
not be compared to perceived stress responses as we did not included subjective measures 
on anxiety or tension. Therefore, the interpretation that alcohol reduces feelings of stress 
cannot be made. Third, the study was an open-label study, and therefore expectancy effects 
may have influenced the results (3). This should be taken into account when interpreting the 
results. Finally, the response of ACTH and cortisol may not have been measured long enough 
to measure the complete period during which alcohol influences these hormones, because 
the effect of alcohol was still increasing at the last measurement at 90 min after consumption.
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This study was performed in young men, who were not very anxious before they started 
the stress test as indicated by STAI state scores. Anxiety before the stress test may have 
influenced both the cortisol response to stress as well as the effects of alcohol on stress (20, 
28). Therefore, the effects are not directly generalizable to more anxious men and women. 
In conclusion, consumption of a moderate dose of alcohol after a mental stressor may facilitate a 
reduction in stress by decreasing ACTH and cortisol. Additionally, the lower levels of monocytes 
and IL-8 after alcohol consumption, suggest a modest attenuation of the immune response 
during the stress recovery period by alcohol consumption. The high incidence of stress-related 
disorders underlines the relevance of further exploring the influence of moderate alcohol 
consumption on mental stress and stress disorders. The influence of alcohol consumption on 
the stress-induced immune response needs further research and may include nuclear factor-
κB (NF-κB) and anti-inflammatory cytokine IL-10. In previous studies we showed  that NF-κB 
may play a pivotal role in the effect of alcohol consumption on immune function (29, 30), and 
Mandrekar et al. (2006) showed an increased IL-10 response after alcohol consumption (14). 
Additionally, the influence of long-term moderate alcohol consumption on stress-response 
dampening and stress habituation to repeated stress would improve our understanding of the 
influence of alcohol on stress-related disorders. 
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Abstract
Aims: To evaluate the effect of acute and chronic consumption of red wine or de-alcoholized 
red wine with a similar antioxidant capacity on plasma total antioxidant capacity (TEAC), 
nuclear factor-κB (NF-κB) activity and F2-isoprostanes (8-iso-PGF2α) in healthy men. 
Methods: Nineteen healthy men with an increased waist circumference (≥94 cm) and a BMI 
above 25 kg/m2 participated in a randomized, controlled cross-over design trial. They daily 
consumed 450 mL of red wine (4 drinks; 41.4 gram alcohol) or 450 mL de-alcoholized red 
wine during dinner for 4 weeks each. On the last day of every treatment period, blood was 
collected before and 1 h after a standardized dinner with red wine or de-alcoholized red wine 
and also 24 hour urine was collected. 
Results: Absolute TEAC levels were higher 1 h after dinner with red wine compared with 
dinner with de-alcoholized red wine (1.3 mmol versus 1.1 mmol Trolox equivalents/L; P=0.03). 
Consumption of dinner together with de-alcoholized red wine acutely stimulated NF-κB 
activity in peripheral blood mononuclear cells (0.4 to 0.7 HeLa equivalents/2.5 µg protein; 
P=0.006), whereas this increase was completely suppressed when the dinner was combined 
with red wine. A chronic increase in urinary 8-iso-PGF2α after 4 weeks of red wine consumption 
compared with de-alcoholized red wine consumption (157 pg/mg creatinine and 141 pg/mg 
creatinine, respectively, P=0.006) was also observed.
Conclusions: Consumption of a moderate dose of red wine can acutely increase plasma 
TEAC and suppress NF-κB activation induced by a meal. Controversially, 4 weeks of red wine 
consumption compared with de-alcoholized red wine consumption increases the oxidative 
lipid damage marker 8-iso-PGF2α.
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Introduction
Epidemiological studies have provided abundant evidence that moderate alcohol consumption 
is associated with a lower risk for cardiovascular disease (CVD) (1-3). Atherosclerosis, the 
underlying cause of CVD, is a process in which lipoproteins, fibrinolytic and inflammatory 
factors are involved. 
The formation of reactive oxygen species (ROS) and an enhanced oxidative stress status 
is associated with CVD and CVD risk factors, such as obesity, diabetes type II and smoking 
(4, 5). It has been shown that red wine consumption can increase plasma antioxidant 
capacity (6-9) demonstrated that this was probably caused by the polyphenolic content of 
the wine. However, Arendt et al. (2005) found no increase in antioxidant capacity after red 
wine consumption, while the polyphenolic plasma content was increased (10). It has been 
suggested that ethanol in wine is capable of increasing plasma antioxidant capacity in an 
indirect way, because the absorption of polyphenols is insufficient to explain the total increase 
of antioxidant capacity (8, 11). 
Nuclear factor-κB (NF-κB) is an oxidative stress related transcription factor involved in the 
regulation of inflammatory responses. Oxidative stress, for example induced by cigarette 
smoke (12) activates NF-κB whereas antioxidants may inhibit this activation (13-15). In vitro 
studies have shown that exposure to moderate doses of alcohol can inhibit NF-κB activation in 
human monocytes (16-18). Furthermore, Joosten et al. (2011) demonstrated that four weeks 
of moderate alcohol consumption resulted in a decreased NF-κB gene expression compared 
to abstention (19). This suggests that down-regulation of NF-κB may be a mechanism involved 
in the alcohol-induced suppression of inflammatory processes.
Excessive intake of alcohol, however, is associated with increased inflammation (20-22).  
To our knowledge, only two human intervention studies have examined the effect of alcohol 
consumption on NF-κB activation. Dhindsa et al. (2004) showed that consumption of 300 
kcal from alcohol did not have acute effects on NF-κB activation, while 300 kcal from glucose 
increased NF-κB activation (23). In a study from Blanco-Colio et al. (2000) it was demonstrated 
that the antioxidants in red wine rather than moderate alcohol consumption prevented NF-
κB activation induced by a fat-enriched breakfast, however an alcohol free control condition 
was not included (24). In contrast, previous studies (25-27) showed that alcohol consumption 
may increase oxidative damage markers (F2-isoprostanes), while red wine consumption may 
protect against low-density lipoprotein lipid oxidation (28). Therefore, we performed a human 
intervention study to investigate the effect of moderate alcohol consumption on NF-κB activity 
and other biomarkers of oxidative stress. In a randomized crossover design healthy men 
consumed a moderate dose of red wine or de-alcoholized red wine with similar antioxidant 
capacity.
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Subjects and Methods
Subjects
The study was conducted at TNO (a Dutch acronym for the Netherlands Organization for 
Applied Scientific Research), in Zeist, The Netherlands. TNO is an independent research 
organization which collaborates with universities and companies, and has the facilities to carry 
out clinical studies. The study was performed according to the ICH Guideline for Good Clinical 
Practice, complied with the Declaration of Helsinki and approved by the independent Medical 
Ethics Committee of TNO (authorization no 01/22). Nineteen subjects, all non-smoking, were 
recruited from the pool of volunteers of TNO. The volunteers received complete information 
about the study by verbal briefing and in writing and subsequently signed for informed consent. 
A questionnaire (self-report) was used for information on alcohol intake, medical history and 
(family) history of alcoholism. Subjects were considered healthy, based on the values of the 
pre-study laboratory tests (haematology, clinical chemistry and safety parameters), their 
medical history, and the physical examination. Subjects fulfilled the following inclusion criteria: 
consumption between 10 and 28 alcohol-containing beverages weekly, waist circumference 
≥94 cm and no (family) history of alcoholism, diabetes mellitus type 2 or CVD. Subjects were 
selected for having an increased waist circumference as this represents the growing group 
of obese subjects in the western world. Obesity has been associated with an increased state 
of oxidative stress (Vincent et al., 2007), therefore we hypothesize that moderate alcohol 
consumption improves oxidative stress in this population.  
Study design
The subjects entered a randomized crossover trial consisting of 2 periods of 4 weeks in which 
they consumed red wine or de-alcoholized red wine.
The red wine and the de-alcoholized red wine were specially bottled for this study (Carl Jung 
GmbH, Rüdesheim am Rhein, Germany). The red wine had an alcohol content of 11.5 vol%. 
The de-alcoholized wine (alcohol content of 0.13 vol%) was made from exactly the same base 
wine, however it was sweetened with sugar (4%). The alcohol was extracted from the wine 
by vacuum distillation at low temperature (<30°C) to maintain the taste and characteristics of 
the wine.
Half of the subjects were randomly allocated to the treatment order red wine followed by de-
alcoholized red wine. The other half of the subjects consumed de-alcoholized red wine first 
followed by red wine. In this way, any bias due to the beverage order and a possible drift of 
variables over time was eliminated. 
Subjects were instructed to drink 450 mL (4 glasses) of red wine (41.4 g alcohol) or de-
alcoholized red wine (control) with dinner, representing the habitual pattern of alcohol intake in 
The Netherlands. Beverages were provided in bottles at the start and halfway each treatment 
period together with a measuring cup marked at 450 mL. Subjects were asked to maintain 
101
Alcohol and oxidative stress
their normal dietary habits and exercise patterns and not to consume any (additional) alcoholic 
beverages throughout the study. Each day, the subjects completed a questionnaire detailing 
beverage intake, dietary habits, exercise performed, medications taken and illnesses incurred. 
The questionnaires were routinely reviewed by the medical investigator and all problems 
identified were discussed with the subjects during the next visit or by telephone call. In 
addition, compliance was checked by counting the number of bottles returned and measuring 
the left-over. Body weight was determined halfway and at the end of each treatment period, 
with the subjects wearing indoor clothing, without shoes, wallet and keys. 
On the last day of every treatment period subjects collected 24 h urine and had a standardized 
dinner together with red wine or de-alcoholized red wine at TNO. They were requested not to eat 
or drink anything starting at 3 h before this standard dinner, which consisted of approximately 
19% energy from protein, 31% energy from fat, and 50% energy from carbohydrate. 
Analysis of total antioxidant capacity and flavonoid content of the beverages
The antioxidant capacity was measured using the Trolox equivalent antioxidant capacity 
(TEAC) assay as described by Van den Berg et al. (1999) (29). This method was used to 
relate total antioxidant capacity to oxidative stress markers (NF-κB, F2-isoprostanes) by all 
compounds present with an antioxidant potential. Briefly, the beverages were diluted using 
ethanol, added to an 2,2’-azinobis-(3-ethylbenzothiazoline-6-sulphonate) (ABTS) radical 
solution and the decrease in radical concentration was monitored spectrophotometrically at 
734 nm.
Quantitative flavonoid analysis of the major flavonoids myricitin, quercetin and isoramnetin was 
performed using high-performance liquid chromatography (HPLC) equipped with photodiode 
array detection according to a method described by Hertog et al. (1992) (30). Sample 
preparation to analyze for free flavonoids consisted of diluting the sample with ethanol (50%, 
V/V) containing 1% ascorbate, and subsequent filtration, after which the filtrate was analyzed 
directly. Glycosilated flavonoids were analyzed as their corresponding deglycosilated analogs. 
For this, samples were treated as described above. The resulting filtrate was diluted 5 fold with 
water and cleaned using a C18 SPE cartridge. After elution of the glycosilated flavonoids with 
50/50 water/methanol, the eluate was hydrolyzed for 2 h at 1.5 M HCl under reflux conditions. 
The resulting hydrolysate was analyzed using an Alliance 2690 HPLC system, equipped with 
a Hypersil BDS column (4.6 x 250 mm) and photodiode array detection. Compounds were 
quantified at their compound-specific absorption maxima. 
Biological sample collection and analysis
In vitro studies have shown that ethanol can affect NF-κB as early as after 1 h (16, 18) and 
therefore blood was collected before and 1 h after the standardized dinner at TNO on the last 
day of each treatment period. The following morning a fasting blood sample was collected 
to determine serum HDL-cholesterol and plasma adiponectin levels. Staff members who 
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conducted the laboratory analysis were blind to the treatment assignments.
Isolation of peripheral blood mononuclear cells
For determination of NF-κB activity, peripheral blood mononuclear cells (PBMCs) were 
isolated immediately after blood collection. Heparinized blood (20 mL) was transferred into 
LeucoSep tubes (Greiner-Bio One GmbH, Frickenhausen, Germany) containing Ficoll Paque 
(Amersham Biosciences, Piscataway, New Jersey, USA) and diluted with a balanced salt 
solution. Samples were centrifuged for 30 min at 800 x g at room temperature and subsequently 
PBMCs were collected, washed twice and divided over 2 aliquots containing approximately 1 
x 107 cells. These samples were stored at -80°C until preparation of nuclear extracts.
Preparation of nuclear extracts
Nuclear extracts were prepared using a nuclear extraction kit (Active Motif Europe, Rixensart, 
Belgium) by using approximately 1 x 107 PBMCs. Briefly, PBMCs were washed with ice-cold 
phosphate-buffered saline containing phosphatase inhibitors. Cytoplasmic fractions were 
collected by incubating the cells in a hypotonic buffer for 15 min at 4°C. After addition of 
detergent, cell suspensions were thoroughly mixed, centrifuged for 30 seconds at 14,000 x g 
and 4°C, supernatants were transferred into pre-cooled tubes. Finally, nuclear fractions were 
collected by addition of complete lysis buffer, incubated for 30 min on ice and centrifuged for 
10 min at 14,000 g and 4ºC. The supernatants (nuclear fractions) were transferred into pre-
cooled tubes and stored at -80ºC until analysis.
NF-κB activity
For detection and quantification NF-κB activation a TransAM™ NF-κB p65 Kit (Active 
Motif Europe) containing a 96-well plate to which oligonucleotides with NF-κB consensus 
binding sites has been immobilized was used. Nuclear extracts were added to the 96-well 
plate and analysed using an antibody directed against the NF-κB p65 subunit from the 
NF-κB complex which is bound to the oligonucleotides. Addition of a secondary antibody 
conjugated to horseradish peroxidase provided a colorimetric readout that was quantified 
spectrophotometrically at 450 nm.
Plasma total antioxidant capacity
For determination of plasma total antioxidant capacity, blood was collected in tubes containing 
ethylenediaminetetraacetic acid. Blood was centrifuged for 10 min at 2000g and 4°C. Plasma 
samples were stored at -80°C until analysis. Plasma total antioxidant capacity as measured 
by the TEAC assay was determined according to the method described by Van den Berg et 
al. (1999) (29). Briefly, plasma samples were deproteinized by adding an equal volume of 
ethanol. After centrifugation the supernatant was added to an ABTS radical solution. The 
decrease in radical concentration was monitored and related to the decrease obtained with 
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Trolox. 
Serum HDL-cholesterol and plasma adiponectin
Serum HDL-cholesterol levels were determined using fasting blood samples which were 
collected in tubes containing cloth activator. Between 15 and 30 min after collection blood 
was centrifuged for 15 min at 2000g and 4°C. Serum samples were stored at −80°C until 
analysis. HDL-cholesterol was determined enzymatically with a commercially available kit 
(Roche Diagnostics, Mannheim, Germany). 
For plasma adiponectin determination, blood was collected in tubes containing citrate-
theophylline-adenosine-dipyridamole and centrifuged for 15 min at 2000g and 4°C. Plasma 
samples were stored at −80°C until analysis. Fasting plasma adiponectin concentrations were 
determined using a validated sandwich enzyme-linked immunosorbent assay employing an 
adiponectin-specific antibody (ANOC9108), as described by Arita et al. (1999) (31). 
Urinary F2-isoprostane (8-iso PGF2α) analysis
Twenty-four hours urine samples were stored in 10 mL aliquots containing 100 μg butylated 
hydroxytoluene at −80°C until analysis. Measurement of 8-iso PGF2α was performed using 
gas chromatography mass spectrometry using negative chemical ionization using a method 
described by Morrow et al. (1999) with some minor modifications (32).
Statistical analysis
Statistical analyses were performed with SAS statistical software package (SAS/STAT Version 
8.02, SAS Institute, Cary, NC, USA). Differences in the characteristics (TEAC and flavonoid 
concentrations) of the wines were assessed by an independent sample t-test. Treatment 
effects on F2-isoprostanes and fasting clinical parameters at the end of each treatment period 
were assessed by the mixed model procedure with period as random term and treatment and 
treatment order as fixed terms. Treatment effects on NF-κB activity and TEAC before and 1 
h after dinner were assessed by the mixed model procedure that included a random term 
for period and fixed terms for treatment (red wine and de-alcoholized red wine) and moment 
(before and 1 h after dinner) and an interaction term of treatment and moment. Treatment 
order was added to the model as fixed factor to correct for possible carry-over effects. 
Model terms were considered significant at P≤0.05. Data are presented as means and SEs.
Results
The characteristics of the 19 subjects are provided in Table 6.1. The total antioxidant capacity 
and the major glycosylated flavonoids concentrations were similar for red wine and de-
alcoholized red wine (Table 6.2).
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Table 6.1 Characteristics of the subjects at baselinea.
Mean (range)
Age (y) 55 (35-68)
Height (cm) 180.8 (169.2-196.0)
Weight (kg) 95.5 (82.5-154.5)
BMI (kg/m2) 29.2 (25.0-45.2)
Waist circumference (cm) 109.5 (95.0-151.0)
Hip circumference (cm) 106.6 (99.5-137.0)
Waist-hip ratio 1.03 (0.93-1.12)
Hemoglobin (mmol/L) 9.4 (8.4-10.2)
Triacylglycerol (mmol/L) 1.84 (1.12-4.07)
Total cholesterol (mmol/L) 5.90 (4.54-7.77)
HDL cholesterol (mmol/L) 1.28 (0.97-1.69)
Low-density lipoprotein (LDL) cholesterol (mmol/L) 3.77 (2.23-5.23)
Aspartate aminotransferase (ASAT) (U/L) 25 (12-43)
Alanine aminotransferase (ALAT) (U/L) 34 (9-74)
γ-glutamyl transpeptidase (GGT) (U/L) 38 (11-79)
Glucose (mmol/L) 5.7 (4.7-6.4)
Insulin (mU/L) 10.9 (4.7-19.3)
a n=19.
Table 6.2. Flavonoids content and antioxidant capacity of red wine and de-alcoholized red wine.
Red wine De-alcoholized red wine
TEAC (mmol TE/La) 24.5 24.3
Free flavonoids
    Myricitin (mg/L) 3.0 2.8
    Quercetin (mg/L) 3.2 3.1
    Isoramnetin (mg/L) 0.4 0.2
Glycosylated flavonoids
    Myricitin (mg/L) 5.1 6.2
    Quercetin (mg/L) 4.6 4.5
    Isoramnetin (mg/L) 1.3 1.6
a mmol Trolox equivalents/L. 
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Compliance with the beverage intake was good, as judged from the daily questionnaire and 
the return of the empty bottles. Another indication that the subjects were compliant with the 
beverage intake was their fasting serum HDL-cholesterol which increased approximately 8.5% 
after 4 weeks red wine consumption compared with de-alcoholized red wine consumption (1.15 
mmol/L and 1.06 mmol/L, respectively; P<0.01). Additionally, fasting adiponectin levels was 
approximately 8.6% higher after 4 weeks red wine consumption compared to de-alcoholized 
red wine consumption (6.3 μg/mL and 5.8 μg/mL, respectively; P=0.02).  The effects of 4 
weeks red wine or de-alcoholized red wine consumption on clinical fasting parameters and 
body weight are shown in Table 6.3. Average body weight did not differ between red wine and 
de-alcoholized red wine treatments, suggesting that the dietary habits and exercise patterns 
did not materially change. 
Plasma TEAC before dinner did not differ after four weeks daily consumption of red wine or 
de-alcoholized red wine (P=0.87) (Figure 6.1). Postprandial TEAC was influenced differently 
by red wine and de-alcoholized red wine consumption. Plasma TEAC was 17% higher 1 h 
after dinner with red wine compared with the plasma TEAC 1 h after dinner with de-alcoholized 
red wine (P=0.03) (Figure 6.1). 
Figure 6.1. Plasma total antioxidant capacity (TEAC) was increased 1 h after dinner with red wine 
compared with the plasma TEAC 1 h after dinner with de-alcoholized red wine (P=0.03).
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Figure 6.2. Intake of dinner with de-alcoholized red wine significantly increased NF-κB activity 
(P=0.006) while this effect was absent (P=0.99) when dinner was consumed with red wine. NF-κB 
activity was higher 1 h after dinner with de-alcoholized red compared with NF-κB activity 1 h after 
a dinner with red wine (P=0.05).
Figure 6.3. Four weeks red wine consumption compared with de-alcoholized red wine consumption 
significantly increased the oxidative damage marker isoprostane (8-iso-PGF2α; P=0.006).
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Four weeks daily consumption of red wine did not influence the basal NF-κB activity differently 
than daily consumption de-alcoholized red wine (P=0.44), although NF-κB activity before 
dinner was on average 19% higher after 4 weeks red wine consumption. Postprandial NF-
κB activity was influenced differently by dinner with de-alcoholized red wine compared to 
dinner with red wine. Intake of dinner with de-alcoholized red wine increased NF-κB activity 
with 65% after 1h (P=0.006) while this effect was absent (+0.3%, P=0.99) when dinner was 
consumed with red wine. This resulted in an absolute difference in NF-κB activity 1 h after 
dinner between the red wine and the de-alcoholized red wine condition, with the first being 
38% higher (P=0.05) (Figure 6.2). 
Four weeks red wine consumption compared with de-alcoholized red wine consumption 
significantly increased the oxidative damage marker isoprostanes (8-iso-PGF2α; 157 pg/mg 
creatinine and 141 pg/mg creatinine, respectively, P=0.006, Figure 6.3).
Table 6.3. Fasting blood parameters (mean ± SE) at the end of each treatment period
De-alcoholized red wine     Red wine P-value
Body weight (kg)              95.3 ± 4.1   95.8 ± 4.1    0.06
Glucose (mmol/L)              5.44 ± 0.12     5.55 ± 0.12 0.12
Insulin (mU/L)            10.60 ± 1.21     9.95 ± 0.86 0.44
Triacylglycerol (mmol/L)              1.66 ± 0.10     1.63 ± 0.11 0.78
Total cholesterol (mmol/L)              5.59 ± 0.19     5.76 ± 0.19 0.08
HDL cholesterol (mmol/L)              1.06 ± 0.04     1.15 ± 0.04 <0.01
LDL cholesterol (mmol/L)              3.76 ± 0.17     3.86 ± 0.16 0.30
Adiponectin (μg/mL)                5.8 ± 0.4     6.3 ± 0.6 0.02
Leukocytes (109/L)                5.6 ± 0.2     5.5 ± 0.2 0.79
Platelets (109/L               205 ± 9  200 ± 9  0.24
Creatinine (μmol/L)              77.7 ± 1.9    78.9 ± 2.1 0.30
Alkaline phosphatase (U/L)              64.7 ± 3.8    64.4 ± 4.1 0.72
ASAT (U/L)              22.4 ± 1.2    23.3 ± 1.2 0.36
ALAT (U/L)              25.2 ± 2.6    24.6 ± 2.3 0.54
GGT (U/L)              27.4 ± 2.3    32.2 ± 3.0 <0.01
Discussion
The results of our study show that red wine or de-alcoholized red wine consumption with 
dinner differently affected biomarkers of oxidative stress. 
Plasma total antioxidant capacity increased approximately 17% 1 h after red wine consumption 
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compared with de-alcoholized red wine consumption, despite similar total antioxidant capacity 
of both beverages. Since plasma total antioxidant capacity reflects the absorption of all 
compounds with antioxidant capacity this may suggest that alcohol improves the short-term 
uptake of these compounds. 
These results suggest that consumption of a dinner decreases plasma total antioxidant 
capacity. Post-prandial oxidative stress has been described to occur after ingestion of high-
fat or high-carbohydrate meals (33). Hyperlipidemia and hyperglycemia are both associated 
with an increased ROS production. A meal high in oxidized and oxidizable lipids can increase 
plasma levels of lipid hydroperoxides, which is associated with a higher susceptibility to low-
density lipoprotein oxidation (34). High plasma glucose levels may induce labile nonenzymatic 
glycation and increase the intracellular NADH/NAD+ ratio, which are both accompanied with 
ROS production (35). 
We observed no effect on plasma antioxidant capacity before dinner between the red wine 
and de-alcoholized red wine period. This indicates that long-term alcohol consumption does 
not affect plasma antioxidant capacity. 
The results of our study show that the intake of a dinner with de-alcoholized red wine acutely 
(1 h) stimulated NF-κB activation. Dinner with red wine attenuated this food-induced NF-κB 
activation. Both red wine and de-alcoholized red wine had similar total antioxidant capacity, 
suggesting that the food-induced NF-κB activation is suppressed by alcohol itself or that 
alcohol possibly facilitates the action of antioxidants present in red wine. The last may be 
supported by the increased plasma antioxidant capacity measured 1h after wine consumption 
compared with de-alcoholized wine consumption. 
Since NF-κB plays an important role in the coordinated expression of inflammatory genes, 
the prevention of diet-induced NF-κB activation suggests a mechanism for cellular regulation 
of the anti-inflammatory effects of moderate alcohol consumption. This is in agreement with 
the findings of Joosten et al. (2011) indicating a central role for transcription factor NF-κB 
in altered gene expression profiles in immune response after four weeks moderate alcohol 
consumption (19).  
The prevention of diet-induced NF-κB activation after moderate alcohol consumption is in 
agreement with in vitro observations (16-18), but does not correspond with findings of (24). 
In their intervention study an increased NF-κB activity was observed after a fat-enriched 
breakfast with vodka, whereas a fat-enriched breakfast with red wine prevented NF-κB 
activation. The authors concluded that not alcohol but antioxidants in red wine caused this 
effect. Unfortunately they did not include an alcohol-free control condition. A combined effect 
of alcohol and compounds with antioxidant capacity can therefore not be excluded. The 
acute reduction of postprandial oxidation of a meal by antioxidants and wine has been very 
well described (34, 36, 37). These observations are in line with our study showing the acute 
suppression of NF-κB induced by the dinner.
The prevention of food-induced NF-κB activation with moderate red wine consumption was 
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acute and transient, because NF-κB activity did not differ before dinner between the red wine 
and the de-alcoholized red wine period. Similarly, Van den Berg et al. (2001) did not observe 
a chronic effect on NF-κB activation in smokers after 3 weeks high antioxidant intake (38). 
These two studies suggest that the effect of nutritional compounds on NF-κB activation in 
healthy subjects can only be measured acutely after activation of NF-κB. The induced NF-κB 
activation after consumption of a meal or single foods was also shown in previous studies 
(39-41).
In our study sugar was added to the de-alcoholized red wine to improve taste and to 
compensate for caloric loss due to the de-alcoholization process (4%). The de-alcoholized 
red wine still had a lower caloric content than the red wine, while the sugar content was 
somewhat higher (18 grams, equal to 72 kcal per 450 ml). The study of Dhindsa et al. (2004) 
reported an increased NF-κB activity 1 h after intake of 300 kcal from glucose compared to 
intake of 300 kcal from alcohol (23). However, the amount of sugar used by Dhindsa et al. 
(2004) was 4 times higher than the amount of sugar added to the de-alcoholized red wine in 
our study. Therefore, we do not expect that the difference in NF-κB activation between the two 
conditions caused by alcohol may be confounded by the difference in sugar content. 
Coinciding with the acute suppressive effect on NF-κB activity there was an increase in urinary 
excretion of 8-iso-PGF2α after 4 weeks daily consumption of 450 mL red wine consumption 
compared to the de-alcoholized red wine period. F2-isoprostanes are oxidative products 
of arachidonic acid and are regarded as a reliable and specific measure of in vivo lipid 
peroxidation. Our results show that (4 weeks) consumption of 450 mL (41.4 g alcohol) of 
red wine chronically increases the lipid oxidation marker F2-isoprostanes in comparison with 
de-alcoholized red wine. This effect is independent of the acute dinner effects and the acute 
suppression of postprandial oxidative stress by alcohol consumption. Chronic increases in 
F2-isoprostanes can therefore only be attributed to the difference in alcohol content of the 
beverages. This is in line with the observations of Caccetta et al. (2001) and Hartman et al. 
(2005) (25, 26). They showed that chronic consumption of alcohol compared with no alcohol 
resulted in increased F2-isoprostane levels. Beulens et al. (2008) also reported increased 
urinary F2-isoprostane levels after chronic alcohol consumption, although this did not reach 
significance (P=0.09) (27). Rifici et al. (2002) showed that polyphenols in red wine did 
decrease lipoprotein oxidation in vitro, while alcohol did not (42). Wine polyphenols have also 
been shown to reduce the release of nitric oxide and to scavenge ROS in vitro (43). However, 
the absorption of polyphenols from wine is very low and after entering plasma, they are 
quickly metabolized and excreted. The effect of plasma polyphenols after wine consumption 
on oxidative capacity is therefore negligible when compared to endogenous antioxidants (44). 
More research is required to establish whether a chronic increase in isoprostanes caused 
by oxidative stress induced-lipid peroxidation is physiologically relevant. Additional research 
is also needed to establish whether other nutritional compounds can attenuate NF-κB 
activation. The relation between NF-κB and inflammation should be further investigated as 
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well as the effect on other transcription and inflammation related factors, in order to explain 
the physiological relevance of both contradictory effects.
In conclusion, red wine consumption can acutely increase plasma total antioxidant capacity 
and suppress NF-κB activation induced by a meal. However, chronic red wine consumption 
compared to de-alcoholized red wine consumption may increase the oxidative lipid damage 
marker 8-iso-PGF2α.
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Abstract
Background: Fetuin-A, a liver-derived glycoprotein that impairs insulin-signalling, has 
emerged as a biomarker for diabetes risk. Although moderate alcohol consumption has been 
inversely associated with fetuin-A, data from clinical trials are lacking. Thus, we evaluated 
whether moderate alcohol consumption decreases circulating levels of fetuin-A.
Methods: We analyzed data of three separate open-label, randomized, crossover trials: 1) 
36 postmenopausal women consuming 250 mL white wine (25 g alcohol) or white grape 
juice daily for 6 weeks, 2) 24 premenopausal women consuming 660 mL beer (26 g alcohol) 
or alcohol-free beer daily for 3 weeks, and 3) 24 young men consuming 100 mL vodka (30 
g alcohol) orange juice or only orange juice daily for 4 weeks. After each treatment period 
fasting blood samples were collected.
Results: Circulating fetuin-A concentrations decreased in men after vodka consumption 
(Mean ± SEM: 441 ± 11 to 426 ± 11 μg/mL, P=0.02), but not in women after wine (448 ± 
17 to 437 ± 17 μg/mL, P=0.16) or beer consumption (498 ± 15 to 492 ± 15 μg/mL, P=0.48) 
compared to levels after each corresponding alcohol-free treatment. Post-hoc power analyses 
indicated that the statistical power to detect a similar effect as observed in men was 30% 
among the postmenopausal women and 31% among the premenopausal women.
Conclusions: In these randomized crossover trials, moderate alcohol consumption decreased 
fetuin-A in men but not in women. This sex-specific effect may be explained by the relatively 
short intervention periods or the low statistical power in the trials among women.
Trials registration: ClinicalTrials.gov ID no’s: NCT00285909, NCT00524550, NCT00918918. 
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Introduction
Fetuin-A (α-Heremans-Schmid glycoprotein) is an abundant hepatokine that impairs insulin 
signalling by inhibiting tyrosine kinase activity (1, 2). Several prospective studies have 
reported positive associations between circulating fetuin-A and type 2 diabetes risk and, 
concomitantly, observed inverse relations between alcohol consumption and fetuin-A (3-5). 
More importantly, a recent case-control study suggested that fetuin-A may partially explain 
the reduced risk of type 2 diabetes (6) that has consistently been observed with moderate 
alcohol consumption (7-9). However, the cross-sectional and observational nature of these 
alcohol-fetuin-A associations may raise concern about potential confounding. Thus, to 
comprehensively investigate the effect of moderate alcohol consumption on fetuin-A levels, 
we performed post-hoc analyses of three randomized crossover interventions with different 
alcohol-containing beverages in men and women.
Materials and methods 
The rationale of the three trials was to study the effect of moderate alcohol consumption on 
markers of insulin sensitivity and/or inflammation. Each trial is registered at ClinicalTrials.
gov: NCT00285909, NCT00524550, and NCT00918918. Independent medical ethics 
committees approved the research protocols (The Medical Ethics Committee of the University 
Medical Centre Utrecht; Utrecht, the Netherlands [NCT00285909] and METOPP; Tilburg, the 
Netherlands [NCT00524550, and NCT00918918]) and all participants gave written informed 
consent. Eligible subjects were apparently healthy, were habitual alcohol consumers, 
refrained from smoking, and had no family history of alcoholism. The design of each individual 
intervention has been described in more detail elsewhere (10-12). In short, the three studies 
were open-label, randomized, crossover intervention trials and were all conducted at TNO 
(a Dutch acronym for Netherlands Organisation of Applied Scientific Research) in Zeist, the 
Netherlands. The trials consisted of 1) 36 postmenopausal women consuming 250 mL white 
wine (25 g alcohol; Chardonnay; Jean d’Alibert, Rieux, France) or whitegrape juice (Albert 
Heijn, Zaandam, the Netherlands) daily for 6 weeks between March and June 2006, 2) 24 
premenopausal women consuming 660 mL beer (26 g alcohol) or alcohol-free beer daily 
(both Amstel, Amsterdam, the Netherlands) for 3 weeks between August and November 2007, 
and 3) 24 young men consuming 100 mL vodka (30 g alcohol; Smirnoff, Diageo, London, 
UK) and 200 mL orange juice (Appelsientje, Riedel, Ede, The Netherlands) or only orange 
juice daily for 4 weeks between August and November 2009. Postmenopausal women had 
an absence of menses for at least two years. Premenopausal women used phase I or II 
oral contraceptives. Allocation to treatment order (alcohol-containing vs. alcohol-free period) 
was randomized according to age and body mass index (BMI). After each treatment period, 
fasting blood samples were obtained. Plasma samples were stored at −80°C (beer and vodka 
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trials) and serum samples at −20°C (wine trial) until analysis. Fetuin-A concentrations were 
determined by a sandwich enzyme-linked immunosorbent assay (ELISA) (R&D Systems, 
Minneapolis, MN) with a mean intra-assay coefficient of variation of 6.8%. 
Data were analyzed using SAS statistical software (version 8.2; SAS Institute, Cary, NC, 
USA). Variables were compared between treatments with a mixed analysis of variation 
(ANOVA) model that included terms for treatment, period and the interaction between period 
and treatment (indicating possible carryover effects). Correlation coefficients were computed 
according to Spearman rank order to assess associations between intervention- induced 
changes in fetuin-A and other biochemical variables. Data are presented as mean ± standard 
error of the mean (SEM). All tests were two-sided. Statistical significance was defined as 
P<0.05.
Results 
All subjects completed both arms of their intervention. No notable adverse effects were 
reported. Age and BMI were 56.5 ± 4.2 y and 25.4 ± 3.3 kg/m2 in postmenopausal women, 
23.9 ± 4.3 y and 22.2 ± 1.6 kg/m2 in the premenopausal women, and 25.5 ± 4.3 y and 22.2 
± 1.6 kg/m2 in the men, respectively. Indicators of compliance were the increased high-
density lipoprotein (HDL)-cholesterol and adiponectin levels after each of the three alcohol 
consumption periods compared with after the alcohol-free consumption periods (Table 7.1). 
No carry-over effects were found in fetuin-A, indicating that a possible effect on fetuin-A 
levels due to a treatment given in the first time period of the crossover trial did not persist 
into the second period and influence the effect of the second treatment. Fetuin-A levels 
decreased in men after vodka juice consumption (441 ± 11 to 426 ± 11 μg/mL, P=0.02) but not 
significantly in postmenopausal women after wine (448 ± 17 to 437 ± 17 μg/ mL, P=0.16) or in 
premenopausal women after beer consumption (498 ± 15 to 492 ± 15 μg/mL, P=0.48) (Figure 
7.1) as compared to levels after each corresponding alcohol- free beverage consumption. 
No correlations were observed between alcohol-induced changes in fetuin-A and corresponding 
changes in the homeostasis model assessment of insulin resistance (HOMA-IR) (ρ=0.01, 
P=0.95; ρ=0.25, P=0.26; ρ=0.20, P=0.24) or changes in adiponectin (ρ=0.22, P=0.31; ρ=0.17, 
P=0.44; ρ=0.25, P=0.15) among young men, pre- or postmenopausal women, respectively. 
Changes in HOMA-IR and adiponectin were also not correlated among men (ρ=0.14, P=0.51), 
premenopausal women (ρ=0.01, P=0.96), or postmenopausal women (ρ=0.27, P=0.11). Also, 
no consistent correlations were observed between alcohol-induced changes in fetuin-A and 
analogous changes in fasting blood lipids including HDL-cholesterol and free fatty acids (FFA), 
or liver function parameters across the three trials.
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Conclusions 
In post-hoc analyses of three separate open-label randomized crossover intervention studies, 
we found that moderate alcohol consumption reduced fetuin-A levels in men but not in women. 
This decrease was apparent after four weeks of moderate vodka consumption. No consistent 
correlations between intervention-induced changes in fetuin-A and other biochemical markers 
were observed across the three studies.
To our knowledge, these are the first intervention studies investigating the effect of different 
alcohol-containing beverages on circulating fetuin-A. The lowered fetuin-A levels in men 
after moderate alcohol consumption partially confirm cross-sectional observations in several 
epidemiological studies (3-6, 13, 14) and may provide some physiological support for the 
protective effect of moderate alcohol consumption on the risk of developing type 2 diabetes (6, 
8) besides adiponectin (15). Furthermore, these findings extend prior evidence of short-term 
clinical trials that noted favourable changes in selected biological markers associated with 
diabetes and cardiovascular risk after moderate alcohol consumption (16). The underlying 
physiological explanation how alcohol consumption may lower fetuin-A is not clear. Also, 
the sex-specific alcohol-fetuin-A effect was unexpected, particularly since all women were 
either on oral contraceptives or postmenopausal, which limits potential influences of hormonal 
fluctuations or menstrual cycles. The null finding in our trials among pre- and postmenopausal 
women do not seem to correspond with a previous observational study among 1331 middle-
Figure 7.1. Individual changes of circulating fetuin-A levels at the end of the alcohol or alcohol-
free treatment periods after an overnight fast for three open-label randomized crossover trials. 
121
Alcohol and fetuin-A
aged and older US female nurses, where moderate alcohol consumption was inversely 
associated with plasma fetuin-A even after adjustment for several lifestyle variables, 
demographic information, and medical history (6). Perhaps this discrepancy can be explained 
by the low statistical power in the two trials among women. Post-hoc power analyses 
indicated that the power to detect a similar effect as observed in men was only 30% among 
the postmenopausal women and 31% among the premenopausal women. Circulating fetuin-A 
was strongly and negatively associated with the insulin-sensitizing adipokine adiponectin in 
humans (17) and treatment of human adipocytes with fetuin-A repressed ADIPOQ mRNA 
levels (17). Furthermore, given the prior associations between fetuin-A and insulin resistance 
(18) and insulin sensitivity (19), we hypothesized that reductions in fetuin-A may play a role in 
the increased adiponectin levels or improved insulin sensitivity after alcohol consumption (10). 
Therefore, we analyzed correlations between intervention-induced changes in fetuin-A and 
adiponectin levels and other markers of insulin sensitivity, such as HOMA-IR. We, however, 
did not find such inverse correlations despite the fact that moderate alcohol consumption 
increased both ADIPOQ expression (10) and corresponding circulating adiponectin levels 
(10-12), suggesting that fetuin-A and adiponectin levels may be independently affected by 
alcohol. Also, it is important to note that the HOMA-IR index is a weak estimate of insulin 
resistance, particularly in a small study. The absence of a correlation between alcohol-induced 
changes in fetuin-A and HOMA-IR may partially be explained by the relatively low FFA levels 
of the studied participants. In a study among 347 healthy subjects at increased risk of type 2 
diabetes, fetuin-A was only inversely associated with insulin sensitivity among individuals with 
high FFA levels (~ >0.65 mmol/l) (20). 
Strengths of the study are the randomized crossover design (considered the ‘gold standard’ 
for evidence-based research), the assessment of compliance markers (i.e. HDL-cholesterol 
and adiponectin) to the study treatments, the inclusion of both sexes, and the broad range of 
biochemical variables. Some limitations warrant consideration. The trials consisted of alcohol-
administration periods of 3 to 6 weeks and were performed among fairly insulin-sensitive 
subjects. Maybe more profound effects on fetuin-A levels would have been observed if the 
interventions lasted longer and/or were executed in subjects with glucose levels in the (pre)
diabetic range. For example, three months of moderate alcohol consumption decreased 
fasting glucose levels among subjects with impaired glucose metabolism (21) and fetuin-A 
levels were particularly associated with an increased diabetes risk among subjects with higher 
fasting glucose (3, 5). Regardless, the duration of the present interventions were long enough 
to detect alcohol-induced changes in other biochemical markers such as adiponectin and 
HDL-cholesterol. Also, the association between moderate alcohol consumption and lower risk 
of type 2 diabetes mellitus is not limited to subjects with impaired glucose metabolism but 
also exists for subjects already at low risk for diabetes on the basis of multiple combined low-
risk lifestyle behaviours (22). Nevertheless, the subjects studied were rather lean (mean BMI 
values 22-26), had no fatty liver (low liver enzyme levels) and were rather insulin sensitive (low 
122
Chapter 7
HOMA-IR). Also, all premenopausal women used oestrogen-containing oral contraceptives, 
which may explain their somewhat higher fetuin-A levels given the positive associations 
between oestrogen and fetuin-A (23, 24). Thus, the data are not representative for a typical 
at-risk population for metabolic diseases. Second, the daily amounts of alcohol consumed 
by women (~25 g alcohol) were higher than what is considered ‘moderate’ according to most 
guidelines (i.e. max. ~15 g alcohol). However, the nadir of the alcohol-diabetes association 
for women appeared to be at 24 g of alcohol/day in a meta-analysis of 20 prospective studies 
(8) while alcohol consumption became harmful above 50 g/day (and above 60 g/day for 
men). Third, post-hoc power analyses showed that there was low statistical power in the two 
trials among women to detect a similar effect as observed in the trial among men. Fourth, 
although unlikely since vodka is basically an ethanol-water mixture, we cannot fully exclude 
a potential beverage specific effect. Finally, the alcohol-induced reductions in fetuin-A were 
comparable to associations reported in epidemiological studies (3, 5, 6), but were relatively 
small as compared to alcohol’s effect on HDL-cholesterol and adiponectin. It is possible that 
the findings, including the sex differences, were due to chance. 
In conclusion, the results of these three randomized clinical trials with different alcohol-
containing beverages demonstrated that short-term moderate alcohol consumption decreases 
fetuin-A levels in men but not in women. Further research is needed to determine whether 
long-term moderate alcohol consumption de creases fetuin-A levels. If so, these findings may 
add to the current knowledge of possible metabolic benefits of moderate alcohol consumption.
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Abstract
Objective: Moderate alcohol consumption is associated with a reduced risk of type 2 diabetes. 
This reduced risk might be explained by improved insulin sensitivity or improved glycemic 
status, but results of intervention studies on this relation are inconsistent. The purpose of 
this study was to conduct a systematic review and meta-analysis of intervention studies 
investigating the effect of alcohol consumption on insulin sensitivity and glycemic status.
Research design and methods: PubMed and Embase were searched until August 2014. 
Intervention studies on the effect of alcohol consumption on biological markers of insulin 
sensitivity or glycemic status of at least 2 weeks duration were included. Investigators 
extracted data on study characteristics, outcome measures and methodological quality. 
Results: We included 14 intervention studies in a meta-analysis of 6 glycemic endpoints. 
Alcohol consumption did not influence estimated insulin sensitivity (standardized mean 
difference [SMD] 0.08 [-0.09 to 0.24]) or fasting glucose (SMD 0.07 [-0.11 to 0.24]) but 
reduced HbA1c (SMD -0.62 [-1.01 to -0.23]) and fasting insulin concentrations (SMD -0.19 
[-0.35 to -0.02]) compared with the control condition. Alcohol consumption among women 
reduced fasting insulin (SMD -0.23 [-0.41 to -0.04]) and tended to improve insulin sensitivity 
(SMD 0.16 [-0.04 to 0.37]) but not among men. Results were similar after excluding studies 
with high alcohol dosages (>40 g/day) and were not influenced by dosage and duration of the 
intervention. 
Conclusions: Although the studies had small sample sizes and were of short duration, the 
current evidence suggests that moderate alcohol consumption may decrease fasting insulin 
and HbA1c concentrations among nondiabetics. Alcohol consumption might improve insulin 
sensitivity among women but did not do so overall. 
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Introduction
Moderate alcohol consumption, compared to abstaining and heavy drinking, is related to a 
reduced risk of type 2 diabetes (1, 2). Although the risk is reduced with moderate alcohol 
consumption in both men and women, the association may differ for men and women. In a 
meta-analysis, consumption of 24 g alcohol/day reduced the risk of type 2 diabetes by 40% 
among women, while consumption of 22 g alcohol/day reduced the risk by 13% among men 
(1). 
The association of alcohol consumption with type 2 diabetes may be explained by increased 
insulin sensitivity, anti-inflammatory effects, or effects of adiponectin (3). Several intervention 
studies have examined the effect of moderate alcohol consumption on these potential 
underlying pathways. Recently, a meta-analysis of intervention studies by Brien et al. (2011) 
showed that alcohol consumption significantly increased adiponectin levels but did not affect 
inflammatory factors (4). Unfortunately, the effect of alcohol consumption on insulin sensitivity 
has not been summarized quantitatively. A review of cross-sectional studies by Hulthe and 
Fagerberg (2005) suggested a positive association between moderate alcohol consumption 
and insulin sensitivity (5), although the three intervention studies included in that review did 
not show an effect (6-8). Several other intervention studies also reported inconsistent results 
(9, 10). Consequently, consensus is lacking about the effect of moderate alcohol consumption 
on insulin sensitivity. Therefore, we aimed to conduct a systematic review and meta-analysis 
of intervention studies investigating the effect of alcohol consumption on insulin sensitivity and 
other relevant glycemic measures.
Research design and methods
This study was performed according to the PRISMA (Preferred Reporting Items for Systematic 
Reviews) Statement guidelines for the reporting of systematic reviews and meta-analysis of 
intervention studies. The PRISMA checklist and the protocol for this study are provided in the 
Supplementary Data. 
Data sources and searches 
A literature search was conducted in PubMed MEDLINE and Embase for relevant intervention 
studies published up to August 2014. A prespecified search-string including search terms 
on alcohol, consumption, and glycemic measures was used for PubMed and Embase 
(Supplementary Data). References and related citations of articles were screened to identify 
other relevant papers. The exposure of interest was (moderate) alcohol consumption and the 
primary outcome measure insulin sensitivity. All estimates of insulin sensitivity were included. 
This includes indices from direct measures (e.g., hyperinsulinemic euglycemic glucose clamp 
[HEGC]), and indirect measures of insulin sensitivity (e.g. the frequently sampled intravenous 
128
Chapter 8
glucose tolerance test [FSIVGTT] and oral glucose tolerance test [OGTT]). HOMA of insulin 
resistance (HOMA-IR) was also included, which is based on fasting insulin and glucose 
levels and therefore primarily reflects hepatic insulin resistance (11). Other relevant outcome 
measures that were taken into account were fasting insulin, fasting glucose and hemoglobin 
A1c (HbA1c). HbA1c reflects average plasma glucose levels over the past 8-12 weeks and is 
therefore used as a measure of glycemic status (12).
Study selection
Relevant studies were selected by two researchers (A.L.J.H., J.W.J.B.) during a multi-phase 
process based on the following inclusion criteria: trials with an alcohol intervention, relevant 
outcome measures as previously described, intervention period of at least 2 weeks, and written 
in English or Dutch. We excluded studies including individuals with (a history of) alcoholism or 
heavy drinkers (individuals consuming ≥60 g alcohol for at least 1 day per week) and animal 
studies. No publication date or status restrictions were imposed. In the first phase, titles of 
all retrieved studies were screened to select papers with a relevant subject; the abstracts of 
these articles were judged on relevance in the next phase. If judged relevant, the full text was 
studied in the third phase to determine whether the article was eligible for inclusion. When 
discrepancies occurred about the inclusion of a particular article, a third author (K.J.M. or 
I.C.S.) was consulted. 
Data extraction and quality assessment
From the included studies, sample size, participant characteristics, inclusion and exclusion 
criteria, study design, duration of intervention and specific outcome measures were extracted 
on a prespecified form. Detailed information about the alcohol intervention (e.g. dosage, type, 
frequency, duration) was described. If a study did not report the grams of alcohol per unit, 
this was calculated based on the amount in millimeters given to the subjects and the alcohol 
volume of the beverage (g alcohol = (mL X %v/v) X 0.8, where %v/v is the percentage of 
alcohol volume per total volume). Authors were contacted if further information was required 
(13-15).
To assess the quality of the studies, aspects such as randomization procedures, compliance 
with the intervention, and dropout rates were extracted. Randomization and the inclusion of 
an alcohol-free control group were regarded as the most important criteria to decide whether 
a study had sufficient quality. If these criteria were not met, the studies were excluded from 
further meta-analyses. Because randomization of crossover studies may be less important 
than randomization of parallel studies, we also conducted a sensitivity analysis including 
nonrandomized crossover studies. Because blinding of participants to the alcohol intervention 
is of uncertain effectiveness, this criterion was not regarded as essential for inclusion. To 
assess the quality of the included studies, the 5-point Jadad scale was used (16).
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Data synthesis and analysis
The mean and SD of the outcome variables at the end of the alcohol intervention period and 
control period were extracted from the articles. If SEs were reported, we used the equation: 
SD = SE X square root of number of subjects. The mean effects of the different studies 
measuring insulin sensitivity index (ISI), HOMA-IR, insulin, glucose, or HbA1c were pooled in a 
meta-analysis and shown in a forest plot. To combine the studies measuring ISI and HOMA-
IR in one meta-analysis, the inverted HOMA-IR (1/HOMA-IR) was calculated using the delta 
method. 
Heterogeneity between studies was investigated through calculation of the χ2 and I2 statistics. 
If the χ2 and I2 showed no evidence for heterogeneity (I2<30%) (17), analyses were conducted 
using the inverse variance fixed-effects model for pooling the studies. Otherwise, the 
DerSimonian and Laird random-effects model was used. The mean outcomes for insulin, 
glucose and insulin sensitivity were assessed using different methods and needed to 
be standardized. Therefore, the Cohen’s d was used to calculate the standardized mean 
difference (SMD), which is the mean difference between the intervention and control group 
divided by the pooled SD. 
In sensitivity analyses, the effect of moderate alcohol consumption on the reported outcomes 
was determined by excluding studies with high alcohol dosages (>40 g/day). Furthermore, 
if more than one intervention arm was tested in a study, we combined the outcomes (17). 
Additionally, analyses were performed excluding studies potentially causing heterogeneity to 
determine their effect on the results. 
In a meta-regression, the influences of alcohol dosage and duration of the intervention on the 
results were tested. The influence of type of alcoholic beverage was not assessed due to too 
few studies to stratify by alcoholic beverage. Because only two studies used the gold standard 
HEGC to estimate insulin sensitivity (11), we tested with a meta-regression whether the effect 
of alcohol on insulin sensitivity differed between these studies. 
Because the association of alcohol consumption with type 2 diabetes differs for men and 
women, we conducted sex-stratified analyses. Effect modification by sex was tested in a 
meta-regression for insulin sensitivity.
Potential publication bias was examined by visual inspection of the funnel plot and by the 
Egger’s and Begg’s statistical tests. In case evidence for publication bias was found, we used 
the trim and fill method by Duval and Tweedie to calculate a pooled SMD based on filled data 
to adjust for publication bias (18). The level of significance was set at P<0.05. Analyses were 
performed with the STATA meta-procedure (STATA 10.0).
Results
In total, 4,991 titles were found through database searching and 24 through additional 
methods (Supplementary Figure 8.1). After screening of titles and abstracts, 46 papers 
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remained eligible and the full-text assessed. Finally, 22 articles met criteria for inclusion in the 
qualitative synthesis.
Study characteristics
Descriptive data of the included studies are summarized in Table 8.1. Of the 22 studies, 15 
used a crossover design and 7 a parallel design. The intervention duration of the studies 
ranged from 2 to 12 weeks, with an average duration of 5.6 weeks for ISI, 4.2 weeks for 
HOMA-IR, 7.2 weeks for insulin, 5.9 weeks for glucose, and 4.3 weeks for HbA1c. Two studies 
did not use an alcohol-free control (14, 19). The dosage of alcohol varied from 10 to 70 g/
day of which one study used >40 g/day (20). ISI was measured by six studies, of which two 
used the gold standard HEGC (10, 21) and four used indirect measures of insulin sensitivity 
(based on OGTT, FSIVGTT or fasting levels) (8, 9, 22, 23) . HOMA-IR was measured by four 
studies (15, 24-26). Seven studies were performed by the same institute (10, 21-26). They 
were treated as independent because they included different subjects.
Quality assessment
The results of the quality assessment are shown in Supplementary Table 8.1. Of the 22 studies 
included in the qualitative synthesis, 4 did not report the measurement of compliance to the 
intervention (9, 14, 20, 27). Blinding of the researcher was not reported or not conducted in 
any of the studies. Drop-out rates were described in 18 studies. The studies scored between 
1 and 3 points on the Jadad scale (range 0–5). Of the 22 studies, 2 were excluded from 
the meta-analysis because they did not include an alcohol-free control group (14, 19) and 4 
were excluded because they did not have a randomized design (13, 28-30). Because only 
two studies included subjects with type 2 diabetes, these studies were excluded as well (31, 
32). One study included both healthy and type 2 diabetes subjects and from this study only 
data from healthy subjects was included (15). Overall, 14 studies were included in the meta-
analysis (Table 8.1 and Supplementary Table 8.1). 
Meta-analysis 
The number of included studies in the analysis was 7 for ISI, 5 for HOMA-IR, 9 for insulin, 
10 for glucose and 3 for HbA1c. The forest plots on insulin sensitivity and glycemic status are 
shown in Figure 8.1–8.3. 
Pooled analysis showed no difference in ISI after a period of alcohol consumption compared 
to no alcohol consumption (SMD 0.06, [-0.13 to 0.26]; P=0.53, test for heterogeneity P=0.76, 
I2=0%. For HOMA-IR, both the χ2 (P<0.01) and I2 statistic (I2= 97%) demonstrated heterogeneity. 
In a random-effects model, the pooled SMD was 0.35 [-0.90 to 1.59], indicating no effect 
of alcohol consumption on HOMA-IR (P=0.59). Similar results were observed when studies 
measuring ISI and HOMA-IR were combined (SMD -0.12, [-0.61 to 0.39], P=0.65). A random-
effects model was used because heterogeneity was present (P<0.01, I2=91%). The funnel 
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plot indicated that the results of the intervention arms (i.e. red wine, gin) of Chiva-Blanch et 
al. (2013) were largely responsible for this heterogeneity. Exclusion of this study resulted in 
an SMD of 0.08 [-0.09 to 0.24] (P=0.35), with no evidence of heterogeneity (P=0.90, I2=0%). 
Sex-stratified analysis showed different effects in men and women (Psex=0.018) (Figure 8.1). 
Alcohol consumption tended to increase insulin sensitivity in women (SMD 0.16 [-0.04 to 
0.37], P=0.12), but not in men (SMD -0.30 [-1.23 to 0.64], P=0.54). In men, heterogeneity 
was present (P<0.01, I2=95%) and exclusion of the study of Chiva-Blanch et al. resulted in a 
pooled SMD of -0.07 [-0.34 to 0.20], P=0.61. However, after exclusion of Chiva-Blanch et al., 
the pooled SMDs in men and women were no longer significantly different (P=0.18).
Fasting insulin concentrations were lower after alcohol consumption compared to abstaining, 
as shown by a pooled SMD of -0.19 [-0.35 to -0.02], (P=0.03), test for heterogeneity 
P=0.92, I2=0%. Sex-stratified analysis showed that alcohol consumption decreased insulin 
concentrations in women (SMD -0.23, [-0.41 to -0.04], P=0.02). Only two studies measured 
insulin concentrations in men, showing a decrease in insulin levels (SMD -0.13 [-0.62 to 0.36], 
P=0.59 (Figure 8.2A). 
For fasting glucose concentrations, the pooled SMD was 0.07 [-0.11 to 0.24], indicating no 
effect of alcohol consumption on glucose concentration among individuals without diabetes 
(P=0.45; Pheterogeneity=0.94, I
2=0%). Similar results were observed when men and women were 
analyzed separately (Figure 8.2B). In women the SMD was 0.01 [-0.20 to 0.21] (P=0.94), in 
men the SMD was 0.14 [-0.24 to 0.53] (P=0.48).
For HbA1c, a random-effects model was used, as the I
2 statistic indicated evidence for some 
heterogeneity (I2=30%). The pooled SMD was -0.62 [-1.01 to -0.23], showing lower HbA1c 
concentrations after alcohol consumption compared to no alcohol consumption (Figure 8.3; 
P<0.01).
Sensitivity analyses and meta-regression
Only the study of Contaldo et al. (20) used a high alcohol dosage (70 g/day) and measured 
insulin and glucose. Exclusion of this study from the meta-analysis resulted in generally 
similar results for insulin (SMD -0.18 [-0.36 to -0.01]) and glucose (SMD 0.06 [-0.12 to 0.23]). 
Combining the 2 intervention arms of the studies of Davies et al. (9) with 15 and 30 g alcohol 
per day and of Queipo-Ortuño et al. (35) with red wine and gin resulted in generally similar 
outcomes. The pooled SMD for insulin sensitivity (ISI & HOMA-IR) was SMD 0.06 [-0.11 to 
0.24] overall and 0.15 [-0.08 to 0.38] in women. For insulin, SMD -0.18 [-0.38 to -0.01] overall 
and SMD -0.22 [-0.43 to -0.02] in women. 
Including the non-randomized crossover study by Cordain et al. (13) resulted in generally 
similar results for insulin (SMD -0.17 [-0.33 to 0.00] and glucose (SMD 0.08 [-0.09 to 0.25]. 
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The meta-regression showed no influence of duration (all Ptrend>0.60) and/or alcohol dosage 
(all Ptrend>0.67) on the pooled SMD of ISI and HOMA-IR, insulin and glucose. Additionally, the 
meta-regression showed no differences between results from the studies using the HEGC to 
measured insulin sensitivity and the other studies (SMD -0.03 for HEGC studies vs. 0.09 for 
other studies, P=0.64).
Publication bias
Results of the Egger’s and Begg’s tests showed publication bias for the outcomes of ISI, ISI 
and HOMA-IR, and glucose (Supplementary Table 8.2). Visual inspection of the funnel plots 
showed some asymmetry, which was due to missing results in favor of alcohol treatment from 
smaller studies (Supplementary Figure 8.2). For ISI and HOMA-IR, we calculated an adjusted 
pooled SMD by using the trim and fill approach by Duval and Tweedie. This resulted in four 
extra study estimates (linear method used) and an adjusted pooled SMD of 0.17 [0.02 to 
Figure 8.1. Forest plot of meta-analysis of the effect of alcohol consumption on insulin sensitivity. 
Data are pooled SMDs with 95% CIs and are calculated with exclusion of the results of the two study arms of Chiva-
Blanch et al. (2013) (15), because they induced heterogeneity. 
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0.31], P=0.03. The trim and fill method shows that without publication bias, the pooled SMD 
would probably indicate a positive effect of alcohol consumption on insulin sensitivity, while 
the unadjusted SMD did not show an effect (SMD 0.08 [-0.09 to 0.24], P=0.35). Adjusted 
results and funnel plot are shown in Table 8.2 and Supplementary Figure 8.2. 
Discussion
This meta-analysis shows that moderate alcohol consumption did not affect estimates of 
insulin sensitivity or fasting glucose levels, but it decreased fasting insulin concentrations and 
HbA1c. Sex-stratified analysis suggested that moderate alcohol consumption may improve 
insulin sensitivity and decreased fasting insulin concentrations in women but not in men. The 
meta-regression suggested no influence of dosage and duration on the results. However, the 
number of studies may have been too low to detect influences by dosage and duration. 
Comparison with other studies
The primary finding that alcohol consumption does not influence insulin sensitivity concords 
with the intervention studies included in the review of Hulthe and Fagerberg (5). This is in 
contrast with observational studies suggesting a significant association between moderate 
Figure 8.3. Forest plot of meta-analysis of the effect of alcohol consumption on HbA1c. 
Data are pooled SMDs with 95% CIs.
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alcohol consumption and improved insulin sensitivity (36, 37). However, the results of these 
studies might be biased through residual confounding because of their observational nature. 
Moreover, in contrast to intervention studies, observational studies are not designed to detect 
a causal relationship. On the other hand, we cannot exclude the possibility that the intervention 
studies in this review may have had an insufficient sample size or too short a duration to 
detect an effect of alcohol consumption on insulin sensitivity (10, 21, 23, 24). 
We found lower fasting insulin levels after alcohol consumption. This finding agrees with the 
inverse relation between alcohol consumption and insulin levels observed in observational 
studies (38-41). However, in the DESIR (Data from an Epidemiological Study on the Insulin 
Resistance Syndrome) cohort, a longitudinal study, no relation between average or a change in 
alcohol consumption and fasting insulin levels was found, but this may be due to the inclusion 
of subjects with type 2 diabetes (42). Fasting insulin level is a surrogate marker of insulin 
sensitivity in healthy subjects, with lower insulin levels indicating higher insulin sensitivity 
(11, 43). Conversely, low insulin levels are a common phenomenon in subjects with type 2 
diabetes due to impaired insulin secretion by β-cells. Because we excluded studies in subjects 
with type 2 diabetes, the results of lower fasting insulin levels may indicate higher insulin 
sensitivity. Additionally, we observed no change in glucose levels by alcohol consumption, 
and lower insulin levels coinciding with unchanged glucose levels suggest an improved insulin 
sensitivity.  
The current meta-analysis suggests that men and women might respond differently to a period 
of alcohol consumption with regard to insulin sensitivity. Subgroup analysis showed that the 
effect of alcohol consumption on insulin sensitivity was only present among women, but the 
pooled effects in men and women were not significantly different. These results generally 
concord with observational studies showing a larger risk reduction of moderate alcohol 
consumption on risk of type 2 diabetes in women than in men (40% vs. 13%) (1) and with the 
study by Beulens et al. (44). The studies included in the review by Hulthe and Fagerberg (5), 
which were mainly cross-sectional, did not find sex differences in alcohol effects. 
We observed lower levels of HbA1c in subjects consuming moderate amounts of alcohol 
compared to abstainers. This has also been shown in several observational studies (41, 
45, 46). Alcohol may decrease HbA1c by suppressing the acute rise in blood glucose after 
a meal and increasing the early insulin response (47). This would result in lower glucose 
concentrations over time and, thus, lower HbA1c concentrations. Unfortunately, the underlying 
mechanism of glycemic control by alcohol is not clearly understood. 
Strengths and weaknesses of the study
A major strength of this meta-analysis is the inclusion of studies with a randomized controlled 
design and the inclusion of several complementary end points, providing a comprehensive 
overview of the evidence on this topic. There are also limitations that warrant consideration. 
As in any meta-analysis, the strength of our study is largely determined by the quality and 
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number of the included studies. The results of the quality assessment show that the larger 
part of the included studies did not report or did not take into account some important aspects, 
such as blinding. Nevertheless, randomization and the inclusion of an alcohol-free control 
group were the most important quality factors for this review and only six studies did not 
satisfy those criteria. Compliance was measured in most studies (17 of 22), but only reported 
in 13. However, of these 13 studies, 11 reported good or excellent compliance, suggesting that 
low compliance did not influence the results of the studies. Second, the analysis of several 
different outcomes resulted in inclusion of a small number of studies for certain end points, 
such as HbA1c. Third, only two studies used the gold standard HEGC to estimate insulin 
sensitivity (11). Because this may lead to inconsistency in the results, we standardized the 
results of the different studies using Cohen’s d. However, the results from the studies using 
HEGC were similar to the other intervention studies and no significant heterogeneity was 
present except for the combined meta-analysis of ISI and HOMA-IR. This was due to the study 
of Chiva-Blanch et al. (15), who reported a relatively small variation in HOMA-IR causing a 
relatively large SMD. Exclusion of this study removed heterogeneity without changing the 
effect. Fourth, because most studies used a crossover design, a carryover effect might have 
influenced the outcomes. Another limitation was the short duration and small sample sizes of 
the included studies. The average duration of 5.4 weeks may not have been long enough to 
show detectable differences in insulin sensitivity or glucose status. In addition, effects may 
change after longer-term intake of alcohol. Therefore, the short-term nature of the included 
studies does not allow us to draw conclusions on longer-term alcohol consumption. 
It is important to note evidence for publication bias for certain outcomes in the current study. 
The publication bias unexpectedly suggested that smaller studies with positive results are 
missing. After adjustment for publication bias using the trim and fill method, even a significant 
increase in insulin sensitivity by alcohol consumption was shown. However, statistical tests 
for publication bias may yield biased results with small numbers of studies and are prone to 
heterogeneity (17). 
Finally, the results of this research may not be generalizable to all healthy subjects because 
the selected studies included mainly light to moderate alcohol consumers. Therefore, the 
period of abstaining from alcohol might also be seen as an intervention, and subjects might 
have responded differently than alcohol abstainers.
Implications
To draw implications from the current research, the findings need to be placed in a clinical 
context. In this meta-analysis, we observed that alcohol consumption decreased fasting 
insulin levels by 0.19, which translates to an ~11% decrease in insulin (-20 pmol/L) in 
people with impaired glucose tolerance, as calculated from data of the Diabetes Prevention 
Program study (48), and a 13% decrease in insulin (-5.2 pmol/L) in normoglycemic people, as 
calculated from data of the Multiethnic Study of Atherosclerosis (MESA) (49). For comparison, 
139
Alcohol, insulin sensitivity and glycemic status
metformin treatment results in a 14% decrease in fasting insulin levels and a 40% lower risk 
of diabetes versus a control group (50). An 11% reduction of fasting insulin levels after alcohol 
consumption would result in an ~30% reduced risk of diabetes, which is in line with the 40% 
risk reduction observed among women. 
The reduced HbA1c concentration found in the current study by alcohol consumption (SMD 
-0.62) is equal to a 5% reduction in HbA1c concentration in both the MESA and the Diabetes 
Prevention Program study (from 5.4% [36 mmol/mol] to 5.1% [33 mmol/mol] and from 5.9% 
[41 mmol/mol] to 5.6% [38 mmol/mol], respectively (48, 51). The Diabetes Prevention Program 
study showed that 4 years of metformin medication and a lifestyle intervention both resulted in 
a reduction in HbA1c of ~3% (52). Because type 2 diabetes is characterized by hyperglycemia, 
HbA1c could be seen as a surrogate end point of the disease rather than an intermediate 
factor in the pathway toward type 2 diabetes. The World Health Organization indeed suggests 
that a level >6.5% (48 mmol/mol) be used as a cutoff point for diagnosing diabetes (53). 
In this respect, the current results for HbA1c match with the reduced risk of type 2 diabetes 
with moderate alcohol consumption. Results of alcohol intake on HbA1c should be carefully 
interpreted because we included only three intervention studies in the analysis. However, the 
results suggest that drinking a moderate amount of alcohol is not harmful with regard to insulin 
sensitivity and glycemic status in healthy adults without type 2 diabetes.  
Conclusion
This systematic review and meta-analysis showed that moderate alcohol consumption 
decreased fasting insulin and HbA1c concentrations among nondiabetics. Alcohol consumption 
might improve insulin sensitivity among women but did not do so overall. These results may 
partly explain the lower risk of type 2 diabetes with moderate alcohol consumption found in 
observational studies. However, more intervention studies with a longer intervention period 
are necessary to confirm the results.
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Supplemental Data
Supplementary Text 8.1. Pre-specified search string. 
Pubmed Medline
“((alcohol [Title/Abstract] OR ethanol [Title/Abstract]) 
AND 
(intake [Title/Abstract] OR consumption [Title/Abstract])) OR (alcoholic [Title/Abstract] AND 
(beverage [Title/Abstract] OR beverages [Title/Abstract] OR drink [Title/Abstract] OR drinks 
[Title/Abstract])) 
AND  
(Insulin [Title/Abstract] OR glycemic control [Title/Abstract] OR glycaemic control [Title/
Abstract] OR glycemic response [Title/Abstract] OR glycaemic response [Title/Abstract] OR 
glucose [Title/Abstract] OR HbA1c [Title/Abstract] OR Hb A1c [Title/Abstract] OR HbA1 [Title/
Abstract] OR HB A1 [Title/Abstract] OR Glycemic [Title/Abstract] OR Glycemia [Title/Abstract] 
OR Hemoglobin [Title/Abstract] OR Haemoglobin [Title/Abstract]) 
NOT (Animals [Mesh] NOT Humans [Mesh]))”
Embase
alcohol:ti:ab OR ethanol:ti:ab 
AND 
intake:ti:ab OR consumption:ti:ab OR alcoholic:ti:ab AND beverage:ti:ab OR beverages:ti:ab 
OR drink:ti:ab OR drinks:ti:ab
AND 
Insulin:ti:ab OR ‘glycemic control’:ti:ab OR ‘glycaemic control’:ti:ab OR ‘glycemic response’:ti:ab 
OR ‘glycaemic response’:ti:ab OR glucose:ti:ab OR HbA1c:ti:ab OR ‘Hb A1c’:ti:ab OR 
HbA1:ti:ab OR ‘HB A1’:ti:ab OR Glycemic:ti:ab OR Glycemia:ti:ab OR Hemoglobin:ti:ab OR 
Haemoglobin:ti:ab 
AND 
[embase]/lim NOT [medline]/lim NOT ([animals]/lim NOT [humans]/lim)
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Supplemental Figure 8.1. Flow chart of the multi-phase process for study selection.
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Supplemental Table 8.2. Publication bias calculated by Egger’s and Begg’s test.
Egger’s test Begg’s test
Begg test 
(continuity corrected)
ISI 0.01* 0.02* 0.04*
HOMA-IR 0.29 0.33 0.46
ISI & HOMA-IR 0.26 0.02* 0.02*
   - Women 0.13 0.33 0.46
   - Men 0.47 0.29 0.37
Insulin 0.18 0.30 0.35
   - Women 0.17 0.85 1.00
   - Men NA NA NA
Glucose 0.01* 0.01* 0.01*
   - Women 0.03* 0.05 0.09
   - Men 0.05* 0.04 0.09
HbA1c 0.28 0.12 0.30
* P<0.05 indicates evidence for publication bias.
Supplemental Figure 8.2. Funnel plots of all endpoints for identification of publication bias.
ISI & HOMA-IR (all) ISI & HOMA-IR (women)
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* The data from the study arms of Chiva-Blanch et al. (2013) were excluded, as they induced heterogeneity.
ISI & HOMA-IR (men) 
ISI & HOMA-IR (trim and fill method 
to adjust for publication bias)*
ISI (all) HOMA-IR (all)
Insulin (all) Insulin (women)
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Glucose (all) Glucose (women)
Glucose (men) HbA1c (all)
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Abstract
Background: Cross-sectional studies have suggested a positive association between 
moderate alcohol consumption and health-related quality of life, but prospective data remain 
scarce. We examined the bidirectional relationships between alcohol consumption and health-
related quality of life in women using a longitudinal design.
Methods: A total of 92,448 participants of the Nurses’ Health Study II (mean age 42.8 years) 
reported their alcohol consumption 4 times (1991, 1995, 1999, 2003) and health-related quality 
of life 3 times (1993, 1997, 2001) on biennial questionnaires. Using generalized estimating 
equations, we modeled the physical and mental component summary (PCS and MCS) scores 
(means ~50, SDs ~9) as a function of alcohol consumption 2 years earlier, and vice versa. 
Models were also adjusted for demographic and clinical covariates. 
Results: Greater alcohol consumption was associated with better PCS scores 2 years later 
in a dose-response relationship up to ~1 serving daily (mean difference (β)=0.67 ± 0.06 units 
of PCS; P<0.001, for moderate vs. infrequent drinkers). After adjustment for previous PCS, 
the association demonstrated a similar but attenuated pattern (β=0.33 ± 0.07; P<0.001). Daily 
moderate alcohol consumption was not related to MCS, although moderate to heavy drinkers 
had a lower MCS score than infrequent drinkers (β=−0.34 ± 0.15; P=0.027). When modelling 
the prospective association between HRQOL and alcohol consumption, higher PCS scores 
were associated with greater alcohol consumption 2 years later (β=0.58 ± 0.06 g/d; P<0.001), 
which was again attenuated after adjustment for previous alcohol consumption (β=0.53 ± 0.05 
g/d; P<0.001). MCS was not related to alcohol consumption 2 years later.
Conclusions: Among young and middle-aged women, greater alcohol intake (up to ~1 
serving daily) was associated with a small improvement in physical health-related quality of 
life two years later, and vice versa. No significant relation was observed between moderate 
alcohol consumption and mental health-related quality of life in either direction. 
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Introduction
Cross-sectional studies suggest an association between moderate alcohol consumption and 
higher health-related quality of life (HRQOL) (1-6). However, excessive alcohol consumption 
and binge-drinking have been associated with poorer subjective health (7, 8). Indeed, 
moderate alcohol consumption has been associated with physical and mental health benefits 
in longitudinal studies, such as a reduced risk of type 2 diabetes, rheumatoid arthritis and 
incident depression (9-11). Moreover, moderate alcohol consumption has been related to 
lower psychological distress, increased sociability and mood enhancement (12). However, 
these associations may be biased by reverse causation. For example, moderate drinkers may 
also engage in more social activities (13). A few small longitudinal studies have examined the 
associations between alcohol consumption and HRQOL prospectively. Kaplan et al. (2012) and 
Byles et al. (2006) found that persistent moderate alcohol consumption was related to a higher 
mental and physical HRQOL compared to abstaining or decreasing alcohol consumption (14, 
15). This suggests that alcohol consumption may influence subsequent quality of life. However, 
the reverse association, in which HRQOL influences subsequent alcohol consumption, may 
also be true. Bell & Britton (2014) suggested that the relationship between mental health 
and alcohol consumption is driven by mental health, meaning that mental health influences 
change in alcohol but not vice versa. Specifically, they showed that people with better mental 
HRQOL and high alcohol consumption showed a larger decrease in alcohol consumption in 
the next 5 years (16). Furthermore, people with poorer self-perceived health status tend to be 
more likely to reduce or stop drinking alcohol than people with excellent health status (17). 
These studies provide evidence for a more complex, bidirectional relationship between 
alcohol consumption and the physical and mental components of HRQOL. However, to our 
knowledge, these relationships have not been investigated in any large-scale prospective 
studies with repeated measures of both alcohol consumption and HRQOL. Therefore, the aim 
of this study was to examine these bidirectional relations in young and middle-aged women 
who were followed for 12 years in the Nurses’ Health Study II.
Methods
Study population
The Nurses’ Health Study II (NHS II) was established in 1989, when 116,430 U.S. female 
nurses aged 25-42 years responded to a mailed questionnaire regarding their diet and 
medical history. The participants have been followed every 2 years with mailed questionnaires 
that collect diet, lifestyle and medical information. We excluded women with missing data on 
alcohol consumption or HRQOL on every questionnaire throughout the study. Furthermore, 
we excluded women who were diagnosed with multiple sclerosis or cancer (except for those 
with nonmelanoma skin cancer) before 1991, when follow-up for these analyses started, 
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because these diseases have a large negative impact on health-related quality of life (18, 19). 
Additionally, in each cycle, we excluded women who were pregnant in the period from 2 years 
before exposure until the outcome measurement time, as pregnancy causes most women to 
stop drinking and reduces quality of life (20). After these exclusions, 186,845 observations 
(from 88,363 participants) remained for the analysis of the association between alcohol 
consumption and subsequent HRQOL and 178,849 observations (from 84,621 participants) 
remained for the analysis of the reverse association. The study flow is shown in Supplemental 
Figure 9.1. The study protocol was approved by the institutional review board of Partners 
Health Care System. The completion and return of the self-administered questionnaires was 
considered to represent informed consent.
Assessment of alcohol consumption
Alcohol consumption was assessed by a semi-quantitative food frequency questionnaire 
(FFQ) in 1991 and every 4 years subsequently. The FFQ included separate items for regular 
beer, light beer, white wine, red wine, and liquor with 9 frequency responses ranging from 
never or less than 1/month up to 6+ times/day over the previous year. We calculated total 
alcohol intake by multiplying the average consumption of each beverage by the published 
alcohol content of the specified portion size based on periodically updated U.S. Department 
of Agriculture food consumption tables and then summing across beverages (21). We 
previously assessed the reproducibility and validity of the self-reported alcohol intake with 
the FFQ against one-week dietary records completed every three months for a year among 
173 Boston-area participants of Nurses’ Health Study, a similar cohort of female nurses. The 
spearman correlation coefficient between these two measures of alcohol intake was 0.90 (22).
Assessment of HRQOL
Health-related quality of life was measured using the Medical Outcomes Study 36-Item 
Short-Form Health Survey (SF-36) in 1993, 1997 and 2001. The SF-36 is a self-administered 
questionnaire that comprises 8 scales of HRQOL: 1) physical functioning, 2) role limitations 
due to physical health problems (role physical), 3) bodily pain, 4) general health perceptions, 
5) vitality, 6) social functioning, 7) role limitations due to emotional problems (role emotional), 
and 8) mental health. Each scale was scored separately from 0 to 100, with higher scores 
reflecting better HRQOL (Ware et al. 1992). There were two primary outcomes of this study: 
the physical component summary (PCS) and the mental component summary (MCS) scores. 
These component summary scores reflect overall physical and mental HRQOL. By design, 
the PCS and MCS scales represent orthogonal (i.e., uncorrelated) constructs (23). Summary 
scores were standardized by using the mean, standard deviation and factor score coefficients 
for the SF-36 scales in the US general population, so that a mean PCS and MCS score of 50 
(standard deviation = 10) reflects the mean in the general US population (24). The instrument 
has been extensively validated, has good construct validity, and high test-retest ability and 
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internal consistency (25-27).  
Covariates
In follow-up biennial questionnaires, we obtained self-reported information on demographics, 
lifestyle factors (28), social integration (29), diseases, medication and other characteristics that 
were included as covariates in multivariable analyses: age (years), race (white or non-white), 
region of residence (Northeast, Midwest, South, West, Non-US), body mass index (<18.5 kg/
m2 ,18.5-22.9 kg/m2, 23-24.9 kg/m2, 25-29.9 kg/m2, 30-34.9 kg/m2, ≥35 kg/m2), smoking status 
(never, past and current smokers), physical activity (MET-h/week), energy intake (kcal/d), 
marital status (married or not married), living arrangement (alone or with others), parity, 
employment status (employed or not employed), night shift work, (30) arthritis (i.e. osteoarthritis 
and rheumatoid arthritis), diabetes mellitus, hypertension, hypercholesterolemia, asthma, 
premenstrual syndrome, regular use (during the past 2 years) of antidepressants (selective 
serotonin reuptake inhibitors, tricyclic antidepressants or other), anxiolytics, analgesics 
(acetaminophen, aspirin, or non-steroidal anti-inflammatory drugs), or oral contraceptives, 
menopausal status. Dietary information (in addition to alcohol) was obtained from repeated 
FFQs. To reflect overall diet quality, a diet score (without alcohol) was calculated based on 
the 2010 Alternative Healthy Eating Index (AHEI), where a higher score denotes better overall 
dietary quality (31). In addition, the frequency of sugar-sweetened beverages consumption 
and candy consumption were added as covariates, since moderate alcohol consumption has 
been related to lower intake of sugar-sweetened beverages and candy (32, 33).
Statistical analysis
Primary analyses
We conducted two sets of analyses to examine the bidirectional associations between alcohol 
consumption and HRQOL (PCS and MCS). In the first analysis, we examined the association 
between alcohol consumption and HRQOL two years later. For example, we used alcohol 
consumption in 1991 to predict HRQOL scores in 1993, and then alcohol consumption in 
1995 to predict HRQOL scores in 1997. The following alcohol consumption categories were 
used: former drinkers, long-term abstainers, and infrequent (0.1-1.24 g/d), light (1.25-4.9 
g/d), moderate (5.0-19.9 g/d) and moderate to heavy drinkers (≥ 20 g/d). We used infrequent 
drinkers as the reference group. In the second analysis, we examined the association between 
HRQOL (quintiles of PCS and MCS) and alcohol consumption (continuous, g/d) two years 
later. In total, there were three cycles for both directions of the association (Supplemental 
Figure 9.1). 
In both sets of analyses, the following covariates were included in the model: age, race, 
region of residence, body mass index, smoking status, physical activity, energy intake, marital 
status, living arrangement, parity, employment status, working rotating night shifts. This model 
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was called the lifestyle-adjusted model. A second model, the morbidity-adjusted model, was 
further adjusted by arthritis, diabetes mellitus, hypertension, hypercholesterolemia, asthma, 
premenstrual syndrome, antidepressant use, anxiolytic use, regular analgesic use, oral 
contraceptive use and menopausal status. Finally, a third model, referred to as the diet-
adjusted model, was further adjusted for the Alternative Healthy Eating Index score without 
alcohol, sugar-sweetened beverages consumption, and candy consumption. 
To account for the effect of previous outcomes on current ones, we further adjusted for 
baseline outcome variables (HRQOL in the first analysis, alcohol consumption in the second 
analysis) in each model.  For example, when we used alcohol consumption in 1995 to predict 
HRQOL scores in 1997, we additionally adjusted for HRQOL scores in 1993.
Because each individual contributed repeated measures of HRQOL and alcohol consumption, 
we used generalized estimating equations (GEE; “PROC GENMOD” in SAS) with an identity 
link and exchangeable correlation matrix to account for the correlation of within-person 
repeated measures. Models that used linear mixed models yielded very similar results.
Secondary analyses
We examined the potential non-linear relation between alcohol consumption and PCS and 
MCS non-parametrically with restricted cubic splines (34). Tests for non-linearity used the 
likelihood ratio test, comparing the model with only the linear term to the model with the linear 
and the cubic spline terms.  Results using loess smoothers and fractional polynomials yielded 
similar findings.
In addition, we examined the association between alcohol consumption and the 8 HRQOL 
subscales two years later with GEE models. The same covariates were used as in the primary 
analysis. 
Because no single summary score for HRQOL exists in the SF-36, we examined the 
associations between alcohol consumption and “overall HRQOL” using both PCS and MCS. 
In these, we defined “good HRQOL” as having both a high PCS and MCS score and “poor 
HRQOL” as having both a low PCS and MCS score (defined as being above the 60th percentile 
for good HRQOL and below the 40th percentile for poor HRQOL). These cut off levels were 
chosen a priori to yield ~15% of women in the good and poor HRQOL groups. GEE models 
were used (PROC GENMOD in SAS with a Poisson distribution and a log link) to calculate 
odds ratios (OR) for good and poor overall HRQOL vs. being not in one of these categories 
(the ‘intermediate’ group). 
In addition to examining total alcohol consumption as a primary outcome variable, we 
separately examined the likelihood of being a drinker and the amount of alcohol consumed 
among drinkers, we examined the association between PCS and MCS and the prevalence 
ratio of any alcohol consumption with GEE models (PROC GENMOD in SAS with a Poisson 
distribution and a log link). Former drinkers were excluded in this analysis.
All analyses were performed using SAS software, version 9.2 (SAS Institute, North Carolina). 
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A two-tailed P value of 0.05 was considered statistically significant.
Results
Alcohol consumption and subsequent HRQOL
Baseline characteristics
Supplemental Table 1 summarizes the characteristics of participants in the Nurses’ Health 
Study II by baseline alcohol consumption in 1991. Women drinking higher amounts of alcohol 
had a lower BMI and higher physical activity. They were less often unemployed, married or 
with children. Prevalence of hypertension, hypercholesterolemia, osteoarthritis, diabetes, and 
asthma was lower among women drinking alcohol up to a moderate dosage (5-19.9 g/d). 
However, a regular use of analgesics was more common in higher alcohol consumers. 
Alcohol consumption and subsequent PCS
In Table 9.1, the associations between alcohol consumption and subsequent PCS and MCS 
are reported. The diet-adjusted model showed that alcohol consumption was associated with 
higher PCS scores in a dose-response relationship, with women consuming ≥20 g/d having 
the highest PCS scores compared to the infrequent drinkers reference group (β=0.83 ± 0.11, 
P<0.001). After further adjustment for previous PCS scores, the association between alcohol 
consumption and PCS was attenuated. The dose-response relationship was only evident 
up to a moderate dose of 5-19.9 g/d (β=0.33 ± 0.07, P<0.001, for moderate vs. infrequent 
drinkers). For comparison, in the lifestyle-adjusted model (also adjusted for previous PCS), 
a 1-unit increment in BMI was associated with a decrement of 0.20 in PCS score, and a 
1-year increment in age was associated with a 0.10 decrement. Furthermore, smoking was 
associated with a decrement of 0.93 in PCS score (current vs. never smokers). The non-linear 
dose-response relationship between alcohol intake and PCS was confirmed in a restricted 
cubic spline (Figure 9.1, test for non-linear relationship P<0.001). 
Alcohol consumption and subsequent MCS
The diet-adjusted model showed that light to moderate alcohol consumption was not 
associated with higher MCS scores compared to infrequent drinking. However, compared 
to infrequent drinkers, women drinking ≥20 g/d had a lower MCS score (β=−0.36 ± 0.15, 
P=0.017), and long-term abstainers had a higher MCS score (β=0.34 ± 0.08, P<0.001). After 
additional adjustment for previous MCS, only moderate to high alcohol consumption remained 
associated with lower MCS (β=−0.34 ± 0.15, P=0.027). This was further confirmed by results 
from a restricted cubic spline, which showed an inverse linear relation between alcohol 
consumption and MCS (P=0.032). 
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Alcohol consumption and subsequent HRQOL scales and overall HRQOL 
The associations between alcohol consumption and eight scales of the SF-36 are shown in 
Supplemental Figure 9.2. Compared to infrequent drinkers, abstainers and former drinkers 
scored lower on all scales while moderate drinkers (5-19.9 g/d) scored higher on all scales, 
except for role-emotional and mental health. Moderate to heavy drinkers (≥20 g/d) scored 
higher on role-physical and vitality, but lower on role-emotional and mental health.
Moderate drinkers had a lower likelihood of poor overall HRQOL (OR=0.90 [0.84-0.97]) and 
a higher likelihood of good overall HRQOL (OR=1.09 [1.02-1.16]) as compared to infrequent 
drinkers (diet-adjusted model, additionally adjusted for previous PCS and MCS). 
Figure 9.1. Non-linear dose-response relationship between alcohol consumption and subsequent 
physical component summary (PCS) scores. 
Data derive from a restricted cubic spline GEE model (lifestyle-adjusted model) in alcohol consumers. The model is 
adjusted for previous PCS, age, physical activity, energy intake, body mass index, smoking, marital status, employment 
status, night shift work, race, region, living arrangement, parity. Alcohol consumption is winsorized on the 99.5 percentile. 
The 95% confidence interval (CI) is indicated by the gray cloud. P<0.001 for test for non-linear relationship. 
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HRQOL and subsequent alcohol consumption
Baseline characteristics
Supplemental Tables 2 and 3 summarize the characteristics of the participants in the Nurses’ 
Health Study II by baseline PCS and MCS scores. Women with lower PCS and MCS scores 
had higher BMI and energy intake and lower physical activity. In addition, they more often 
worked rotating night shifts and used antidepressants. Women with lower PCS scores were 
older, while women with lower MCS scores were younger.  
PCS and subsequent alcohol consumption
Table 9.2 provides the associations between PCS and MCS and subsequent alcohol 
consumption. Subsequent alcohol consumption was higher in women with higher initial PCS. 
Compared with the lowest quintile of PCS, women in the highest quintile consumed 0.58 ± 0.06 
g alcohol per day more (P<0.001, diet-adjusted model). After further adjustment for previous 
alcohol consumption, the association was attenuated; the difference in alcohol consumption 
between the highest and the lowest quintile was 0.53 ± 0.05 g/d. 
To further investigate this positive association between PCS and subsequent alcohol 
consumption, we analyzed if the association was also evident amongst alcohol drinkers only. 
In addition, we analyzed the association between PCS and the likelihood of drinking alcohol. 
Amongst alcohol drinkers, women in the highest quintile consumed 0.40 ± 0.08 g alcohol per 
day more than women in the lowest quintile (P<0.001). The association between PCS scores 
and subsequent alcohol consumption was linear, with higher PCS scores associated with 
higher alcohol consumption in a dose-response manner (P<0.001, Figure 9.2). 
We next tested the association of PCS with likelihood of any alcohol intake. In the diet-
adjusted model we observed a linear association for PCS: women with a higher PCS score 
had a higher chance of drinking (OR=1.11 [1.10-1.13], P<0.001 for highest vs. lowest quintile). 
Further adjustment for previous alcohol intake did not change the results.
MCS and subsequent alcohol consumption
No association was found between MCS scores and subsequent alcohol consumption in both 
diet-adjusted models with and without adjustment for previous alcohol consumption (highest 
vs. lowest quintile: -0.03 ± 0.06 and 0.03 ± 0.05 g/d, respectively).  
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Discussion 
This large longitudinal cohort provides evidence that the association between alcohol 
consumption and HRQOL is bidirectional. Moderate alcohol consumption was associated with 
better subsequent PCS, but not with subsequent MCS. In the reverse direction, we observed 
an association between higher PCS and higher subsequent alcohol consumption. MCS was 
not related to subsequent alcohol consumption. 
Comparison with other work
Our study confirms previous studies that have reported a positive association between 
moderate alcohol consumption and physical health-related quality of life. We observed a 
non-linear dose-response relationship between alcohol consumption and 2 years later PCS, 
with highest PCS scores in women drinking moderately. A similar association was observed 
between alcohol consumption and scales of PCS, i.e. physical functioning, role-physical, 
bodily pain and general health. Previous studies also reported higher scores for PCS and its 
scales in moderate drinkers as compared to long-term abstainers or light drinkers (1, 2, 5, 
15). Although the association found in this study is consistent with previous studies, persists 
after multivariate adjustment, and remains consistent through PCS scales, the strength of 
the association was modest. The 0.33-units higher PCS score observed in moderate alcohol 
drinkers was comparable to women with a 1.7 unit lower BMI or 3.5 years younger age in our 
sample.
We observed no association between alcohol consumption and MCS. This has been 
investigated by two other (cross-sectional) studies. Valencia-Martin et al. (2013) did not 
find an association in male and female adults, whereas Chan et al. (2009) reported higher 
MCS scores in moderate drinkers in men only. However, several studies reported a positive 
association between moderate alcohol consumption and scales of MCS, such as mental 
health (1, 15), vitality (1, 2), and social functioning (1, 15). This parallels the higher vitality and 
social functioning scores in moderate drinkers observed in the present study. 
Overall, the likelihood of having a good HRQOL in both physical and mental domains was 
highest among moderate drinkers. A similar positive association between moderate alcohol 
consumption and quality of life (3, 14), subjective wellbeing (35), subjective health (7) and life 
satisfaction (3) has been reported. Since for SF-36 there is no measure available in which 
PCS and MCS sores are integrated, we created this overall score to explore the association 
between alcohol and overall HRQOL. However, this overall score has limitations, because 
PCS and MCS are designed to be uncorrelated.
To our knowledge, this is the first study showing a positive association between PCS per se 
and subsequent alcohol consumption. However, previous studies have reported an association 
between subjective health status and alcohol use. Specifically, suboptimal health has been 
related to quitting or reducing alcohol consumption (17, 36). Additionally, abstainers have 
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more characteristics related to a poor health status compared to light or moderate drinkers 
(37). However, after excluding abstainers and former drinkers from the analysis, the positive 
relationship between PCS and subsequent alcohol consumption persisted. 
MCS was neither associated with subsequent alcohol consumption nor the likelihood of 
drinking alcohol. This finding contrasts with the study of Bell & Britton (2014), which showed 
an inverse association between MCS and change in alcohol consumption in 6,330 mainly male 
British civil servants. Participants with good mental health appeared to reduce their alcohol 
consumption, whereas people with poor mental health increased their alcohol consumption 
or maintained high alcohol consumption. We cannot directly compare our results to theirs, as 
most women (~70%) did not change their alcohol consumption between measures conducted 
4 years apart. 
Figure 9.2. Linear dose-response relationship between physical component summary (PCS) 
scores and subsequent alcohol consumption. 
Data derive from a restricted cubic spline GEE model (lifestyle-adjusted model) in alcohol consumers. The model is 
adjusted for previous alcohol consumption, age, physical activity, energy intake, body mass index, smoking, marital 
status, employment status, night shift work, race, region, living arrangement, parity. PCS scores are winsorized on the 
99.5 percentile. The 95% confidence interval (CI) is indicated by the gray cloud. P<0.001 for test for linear relationship. 
164
Chapter 9
Limitations
Some limitations of our study warrant consideration. First, alcohol intake was self-reported by 
a semi-quantitative FFQ, which generally causes underreporting of alcohol intake, especially 
at higher levels of alcohol (38). However, a validation study in nurses showed a high correlation 
between alcohol consumption from the FFQ and four one-week dietary recalls and HDL-C, a 
strong biomarker of alcohol intake (22). 
Second, the time lag of 2 years between alcohol consumption and HRQOL measurements 
may have introduced misclassification bias, since changes in alcohol intake or HRQOL could 
have occurred during that period. However, alcohol intake and HRQOL both tended to be 
stable over 4 years, as most women did not change their alcohol intake and average changes 
in PCS and MCS were small. Therefore, we do not expect this to have a large influence on 
our results. 
Third, the distribution of the PCS and MCS scales was not as widespread as the distribution 
of the US general population. In particular, the standard deviations were somewhat smaller 
(SD~9 vs. SD of 10). However, average PCS and MCS scores were comparable to US 
population data for women of 35-44 years (51.9 and 49.1 in our sample vs. 51.7 and 47.8 
in the US population, respectively), indicating that the women in the cohort had HRQOL that 
was comparable to other American women of their age (39). We excluded women who were 
pregnant in a given cycle from that time period, but the fact that pregnant women could re-
enter the cohort in the next cycle was an important advantage of our longitudinal design.
Fourth, although we controlled for a large number of health behavior factors and socio-
demographic factors, residual confounding remains possible. Particularly, limited information 
was available on socioeconomic status, sleep quality, and disorders such as depression and 
anxiety. However, related covariates such as antidepressant and anxiolytic medication use, 
and socio-demographic factors (race, region, marital status, employment status and night 
shift work) were examined in the model. In addition, our study populations primarily consisted 
of white educated US women with higher and more homogeneous socioeconomic status. 
Therefore, we expect that the influence of residual confounding on our results will be limited. 
However, this may potentially limit generalizability to other ethnic groups and socioeconomic 
groups (as well as males). 
Finally, a limited number of participants were heavy alcohol consumers (>40 g/d). Therefore, 
we could not examine the association between heavy drinking and HRQOL and results are not 
generalizable to heavy alcohol consumers.
Conclusion
In summary, this study supports the presence of a bidirectional relation between alcohol 
consumption and health-related quality of life. Among young and middle-aged women, 
greater alcohol intake (up to ~1 serving daily) was associated with a small improvement of 
physical health-related quality of life two years later, and vice versa. No significant relation 
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was observed between moderate alcohol consumption and mental health-related quality of 
life in either direction, although drinking ≥20 g/d was associated with lower mental health-
related quality of life. 
These results indicate the importance of exploring bidirectional associations in studies 
concerning alcohol consumption. Additionally, the current American guidelines on alcohol 
consumption are to consume alcohol in moderation (up to 1 drink per day for women) if alcohol 
is consumed (40). Our results are in agreement with these guidelines: moderate alcohol 
consumption may be beneficial for physical health-related quality of life, whereas drinking 
more than 1 drink per day may be harmful for mental health-related quality of life.  
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Supplemental data
Supplemental Figure 9.1. Schematic overview of the study design.
Solid arrows indicate the relationship between alcohol consumption and health-related quality of life 2 years later; 
Dashed arrows indicate the relationship between health-related quality of life and alcohol consumption 2 years later. 
HRQOL, health-related quality of life; SF-36, the 36-Item Short Form Health Survey; FFQ, food frequency questionnaire.
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Supplemental Table 9.1. Characteristics of the study population at 1991 by alcohol consumption 
categories.
Alcohol consumption category
Abstainer Former drinker
Infrequent 
drinker 
(reference)
Light 
drinker
Moderate 
drinker
Moderate/ 
heavy 
drinker
Alcohol consumption, g/d, range 0.0 0.0 0.1 - 1.24 1.25 - 4.9 5.0 - 19.9 ≥20
Alcohol consumption, g/d, median 0.0 0.0 0.9 2.7 8.8 29.8
No. of participants 14258 10353 7621 14589 9824 1490
Age, years 38.4 (3.4) 36.5 (4.9) 37.3 (4.3) 37.1 (4.4) 37.2 (4.5) 38.2 (4.1)
Race, white, % 94.7 95.8 97.6 97.8 98.0 98.5
Region
-    Northeast, % 29.9 33.2 34.4 37.1 36.1 34.2
-    Midwest, % 37.0 35.8 35.2 32.7 28.4 23.4
-    South, % 19.4 16.2 15.5 14.8 15.8 19.0
-    West, % 13.0 14.2 14.3 14.9 18.8 22.4
-    Non-U.S., % 0.7 0.7 0.6 0.5 0.8 1.0
Unemployed, % 10.2 7.7 6.9 6.6 6.8 6.1
Working rotating night shifts, % 22.0 23.6 22.3 21.9 20.6 18.7
Currently married, % 81.1 75.0 75.8 73.2 70.0 67.6
Parity (0 vs. ≥1 children), % 79.6 73.8 73.5 69.8 63.4 58.8
Physical activity, MET-h/weeka 17.9 (24.4) 19.4 (25.7) 20.4 (26.2) 22.1 (27.8) 24.3 (30.1) 23.2 (28.2)
Smoking status
-    Never, % 77.8 66.1 66.0 61.0 50.7 35.4
-    Past, % 14.1 20.8 21.0 26.1 32.1 33.8
-    Current, % 8.1 13.1 13.0 12.9 17.2 30.8
Body mass index, kg/m² 25.8 (6.2) 25.6 (6.0) 24.9 (5.5) 24.3 (5.1) 23.4 (4.1) 23.7 (4.2)
Energy intake, kcal/d 1736 (545) 1726 (543) 1711 (525) 1772 (535) 1815 (533) 1925 (546)
AHEI-2010 score (0-100)b 43.3 (10.7) 43.6 (10.8) 44.3 (10.4) 45.2 (10.3) 45.8 (10.0) 44.3 (10.1)
Oral contraceptive use, % 79.2 84.0 85.3 86.4 88.8 88.3
Postmenopausal status, % 5.2 4.9 4.7 4.0 3.3 3.9
Self-reported conditions
-    Hypertension, % 5.0 5.0 4.2 3.3 2.9 5.2
-    High cholesterol, % 11.3 12.1 11.1 10.1 8.8 10.2
-    Osteoarthritis, % 5.4 5.3 5.0 4.2 3.9 4.7
-    Rheumatoid arthritis, % 1.1 1.2 1.0 1.0 0.8 0.2
-    Diabetes, % 1.4 1.0 0.7 0.6 0.2 0.3
-    Asthma, % 8.2 7.9 7.9 7.4 6.9 8.2
Regular analgesic usec, % 41.9 45.8 45.2 45.1 46.0 50.4
Values are means (SD) or percentages and are standardized to the age distribution of the study population.
a Met-h indicates metabolic equivalent hours; b AHEI, Alternative Healthy Eating Index without alcohol consumption; 
c using analgesics at least twice a week.
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Supplemental Table 9.2. Characteristics of the study population at 1993 by physical component 
summary (PCS) scores.
Quintiles of physical component summary scores
Q1 Q2 Q3 Q4 Q5
MCS, range (median) 8-46 (41) 47-52 (50) 53-55 (54) 56-58 (57) 59-75 (60)
No. of participants 9301 9864 10145 13153 10711
Age, years 40.1 (4.1) 39.8 (4.1) 39.6 (4.2) 39.4 (4.2) 39.2 (4.3)
Race, white, % 96.7 96.7 96.8 96.9 97.0
Region
-    Northeast, % 32.5 33.0 33.5 34.9 35.5
-    Midwest, % 34.6 35.1 35.1 33.1 31.8
-    South, % 17.0 16.8 16.4 16.1 15.5
-    West, % 15.2 14.4 14.3 15.2 16.7
-    Non-U.S., % 0.7 0.7 0.7 0.7 0.6
Unemployed, % 10.1 5.5 5.2 6.0 6.1
Working rotating night shifts, % 14.2 14.3 13.0 11.9 12.5
Currently married, % 73.1 76.3 77.7 77.4 73.0
Parity (0 vs. ≥1 children), % 71.3 73.7 73.7 74.4 73.4
Living alone, % 12.1 10.2 10.5 10.7 13.1
Physical activity, MET-h/weeka 17.5 (24.8) 18.1 (23.4) 19.2 (24.4) 23.0 (29.0) 24.3 (30.8)
Smoking status, %
-    Never, % 62.3 62.8 65.2 66.1 64.3
-    Past, % 24.0 23.8 23.4 23.6 25.5
-    Current, % 13.7 13.4 11.4 10.3 10.2
Body mass index, kg/m² 28.3 (7.6) 26.8 (6.3) 25.5 (5.5) 24.2 (4.5) 23.6 (4.0)
Energy intake, kcal/d 1794 (533) 1777 (519) 1760 (515) 1728 (507) 1710 (503)
AHEI-2010 score (0-100)b 43.4 (10.3) 43.6 (10.1) 44.2 (10.2) 45.1 (10.3) 45.5 (10.3)
Oral contraceptive use, % 85.6 85.2 85.3 84.4 85.2
Postmenopausal status, % 10.0 7.3 6.2 5.3 4.9
Self-reported conditions
-    Hypertension, % 12.6 8.3 6.0 4.0 2.8
-    High cholesterol, % 23.5 18.8 15.5 11.9 11.4
-    Osteoarthritis, % 20.7 10.7 6.0 3.3 2.3
-    Rheumatoid arthritis, % 4.4 1.9 0.9 0.5 0.4
-    Diabetes, % 3.0 1.7 1.0 0.5 0.3
-    Asthma, % 16.7 10.9 8.3 6.9 6.0
Antidepressants use, % 27.1 14.8 10.5 8.3 11.6
Regular analgesic usec, % 61.6 47.1 33.6 24.1 20.1
Values are means (SD) or percentages and are standardized to the age distribution of the study population.
a Met-h indicates metabolic equivalent hours; b AHEI, Alternative Healthy Eating Index without alcohol consumption; 
c using analgesics at least twice a week.
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Supplemental Table 9.3. Characteristics of the study population at 1993 by mental component 
summary (MCS) scores.
Quintiles of mental component summary scores
Q1 Q2 Q3 Q4 Q5
MCS, range (median) 0-42 (35) 43-49 (47) 50-53 (52) 54-56 (55) 57-71 (58)
No. of participants 12913 11337 11368 9782 7774
Age, years 39.4 (4.2) 39.5 (4.2) 39.5 (4.2) 39.7 (4.2) 40.1 (4.1)
Race, white, % 96.7 97.0 96.9 96.9 96.8
Region
-    Northeast, % 33.0 34.3 34.9 34.1 33.8
-    Midwest, % 33.5 33.6 34.3 34.3 33.3
-    South, % 17.0 16.0 15.7 16.3 16.7
-    West, % 15.8 15.4 14.4 14.5 15.5
-    Non-U.S., % 0.6 0.7 0.7 0.8 0.6
Unemployed, % 6.5 5.6 6.0 6.6 8.2
Working rotating night shifts, % 15.0 13.6 12.2 12.0 11.5
Currently married, % 69.8 75.5 78.8 78.3 77.3
Parity (0 vs. ≥1 children), % 72.7 74.1 74.7 73.9 70.7
Living alone, % 14.0 11.4 9.7 10.2 10.7
Physical activity, MET-h/weeka 19.0 (25.5) 19.4 (25.4) 20.4 (26.9) 21.6 (27.4) 24.4 (31.1)
Smoking status, %
-    Never, % 61.0 63.4 65.4 66.4 66.8
-    Past, % 23.7 24.4 24.2 23.9 24.1
-    Current, % 15.3 12.2 10.4 9.8 9.1
Body mass index, kg/m² 26.0 (6.2) 25.6 (5.8) 25.4 (5.7) 25.1 (5.6) 25.5 (6.0)
Energy intake, kcal/d 1772 (527) 1757 (515) 1747 (512) 1731 (508) 1742 (510)
AHEI-2010 score (0-100)b 43.8 (10.2) 44.1 (10.2) 44.2 (10.2) 45.0 (10.3) 45.7 (10.3)
Oral contraceptive use, % 86.2 85.3 85.0 84.2 84.1
Postmenopausal status, % 7.5 6.3 6.5 5.8 6.7
Self-reported conditions
-    Hypertension, % 8.3 6.5 6.1 5.0 6.1
-    High cholesterol, % 18.7 16.8 14.7 13.8 13.7
-    Osteoarthritis, % 9.9 8.2 7.2 6.3 8.8
-    Rheumatoid arthritis, % 1.6 1.5 1.3 1.4 1.6
-    Diabetes, % 1.4 1.2 1.1 1.2 1.2
-    Asthma, % 11.0 9.6 8.7 8.4 8.9
Antidepressants use, % 25.0 14.1 9.9 8.3 8.0
Regular analgesic usec, % 41.6 38.0 33.7 30.9 33.4
Values are means (SD) or percentages and are standardized to the age distribution of the study population.
a Met-h indicates metabolic equivalent hours;  b AHEI, Alternative Healthy Eating Index without alcohol consumption; 
c using analgesics at least twice a week.
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Chapter 10
The research presented in this thesis focused on the acute and long-term effects of 
moderate alcohol consumption on emotional well-being, and on its possible connections with 
physiological determinants and health outcomes. This final chapter starts with an overview of 
the main findings, followed by a section on methodological considerations, a discussion of the 
findings and a comparison with other studies. Finally, implications and suggestions for future 
research are given.
Main findings
The main findings of the studies conducted and described in this thesis are summarized and 
presented in Table 10.1. 
Acute effects on emotional well-being
First, it was shown that moderate alcohol consumption may acutely lead to an improvement 
of emotional well-being shortly after consumption (chapter 2-5). Happiness scores increased 
shortly after alcohol consumption, but only in those situations in which an unpleasant mood 
state had been created in an artificial way. The mood effects of alcohol consumed with a meal 
were found to follow a biphasic pattern. Sympathetic nervous system activity increased in 
parallel to the stimulating effects of alcohol (chapter 2). Circulating endocannabinoids were 
not influenced by alcohol consumption, and showed an inconsistent correlation with mood 
states. However, they were highly correlated with plasma free fatty acids and cortisol levels 
(chapter 3).
Furthermore, we showed that moderate alcohol consumption increased subsequent indicators 
for reward of savoury foods. This suggests that the effects of alcohol on the reward system 
may lead to an increased rewarding value of certain foods. 
Both in a resting and a stressed state, moderate alcohol consumption caused a further decline 
in plasma cortisol as compared to situations in which no alcohol was consumed. Moderate 
drinking also resulted in a more pronounced decline of plasma ACTH, the inflammatory marker 
IL-8 and percentage monocytes in blood during stress recovery, suggesting that moderate 
alcohol consumption shorty after a stressor improves stress recovery and may also modulate 
a stress-induced inflammatory response.
Short-term influence on physical well-being
We showed that moderate alcohol consumption may positively influence acute and short-term 
physical determinants related to emotional well-being, apparently in a gender-specific manner 
(chapter 6-8). Moderate alcohol consumption acutely attenuated meal-induced oxidative 
stress (chapter 6). Furthermore, short-term moderate alcohol intake reduced fetuin-A levels 
in men but not in women (chapter 7). Our meta-analysis showed that only in women, short-
term moderate alcohol consumption tended to improve insulin sensitivity and reduced fasting 
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insulin levels (chapter 8). This suggests that alcohol consumption may influence different 
pathways and intermediates in men and in women leading to a reduced type 2 diabetes risk.
Long-term association with emotional and physical well-being
In chapter 9 we showed that moderate alcohol consumption was associated with a better 
physical health-related quality of life, but not with a better mental health-related quality of life.
Methodological considerations
In this section we consider some methodological issues that are important to take into account 
before the results are being discussed and interpreted. Acute intervention studies, short-term 
intervention studies and longitudinal observational studies will be discussed separately.
Acute intervention studies 
Study design
All acute intervention studies described in this thesis used a randomized crossover design, 
allowing within-subject comparisons. A possible issue in crossover studies, in which subjects 
receive a stress intervention or perform a task twice, is that a learning effect may occur, 
which may interfere with the treatment. This was also observed in our study; the second 
time subjects conducted a mental stress test, the test did not induce as much stress as it did 
the first time, because subjects had learned to adapt to the type of stressor applied (1-3). 
Therefore, we decided to use data from the first treatment day only, and analysed the data 
as if it was a parallel study. We have checked the influence of a learning effect in our other 
studies by adding ‘period’ as a factor in the statistical models and found that learning effects 
did not occur.  
Blinding and expectation effects
We used different alcoholic beverages, varying from wine to beer to spirits. All intervention 
studies were placebo-controlled, using the most comparable control study substance available 
in order to study pure alcohol effects and to blind the subjects to the alcohol condition. This is 
important, since expectancy effects may induce part of alcohol’s behavioural effects (4-10). 
The magnitude of the expectancy effects, however, is varying largely between individuals, 
outcomes and experimental settings (7). For example, drinking in a group induces more 
pronounced expectancy effects as compared to drinking alone (9). Expectancy effects seem 
to be large for outcomes like aggression, sexual arousal and stress reduction (5, 7). In our 
studies on mood and food reward, the subjects were blinded for the alcohol treatment. 
However, blinding might not have been complete due to the physiological and behavioural 
effects of alcohol. Indeed, most participants guessed correctly whether they consumed alcohol 
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or not. Although subjects were drinking alone, which may have reduced expectancy effects, a 
certain influence of expectancy in our results should be taken into account during interpretation 
of the results.
Dose and blood alcohol concentration 
The amount of alcohol used in the acute intervention trials varied between 30 gram in women 
and 20 to 26 gram in men. These dosages were chosen to induce a specific blood alcohol 
concentration (BAC), taking into account gender differences and influence of food intake. In 
the study in women, alcohol was served with a meal, which reduces the BAC. Here, average 
peak BAC was 0.53‰ w/v (11.5 mmol/L). In the study in men, average peak BAC was almost 
similar, 0.52‰ w/v, although less alcohol was consumed (20 g alcohol). A BAC of 0.5‰ w/w 
corresponds with the Dutch legal limit for drinking and driving for experienced drivers (0.2‰ 
for inexperienced drivers). In addition, we chose these BACs because of the behavioural 
effects we expected, i.e. stimulant-like effects (euphoria, arousal) and tension-reduction 
effects (11, 12). 
Study population
The subjects that participated in the studies described in this thesis were all healthy adults. 
They were all non-smokers, habitual moderate alcohol consumers, without a (family) history 
of alcoholism. In one study female participants were included, whereas the other two studies 
used men. Since men and women have different emotional and physiological responses 
on food intake and on stress (13-17), the findings on mood in women cannot be directly 
generalized to men, and the findings on food reward and stress recovery cannot be directly 
generalized to women. Nevertheless, gender did not influence the mood effects of alcohol 
in another study (11). Therefore, it seems unlikely that the findings on mood are limited to 
women. 
Outcome measures 
We used both subjective and objective measures to study the influence of alcohol on emotional 
well-being in our interventions. As subjective measures we used mood questionnaires and 
appetite, food liking and food wanting ratings (visual analogue scales). Subjective measures 
are generally seen as the gold standard for evaluating behavioural outcomes like mood and 
food reward. Nevertheless, it should be noted that with subjective measures it is not the 
behaviour itself that is measured, but the person’s perception of his or her behaviour (18). 
Furthermore, large inter-individual differences in behavioural effects of alcohol are known (11, 
19). Therefore, it is important to compare within-subject measurements.
In the study on mental stress where we did not compare outcomes within subjects, we did 
not include subjective measures but focused on the physiological outcomes. This prevented 
us from comparing physiological outcomes directly with subjective feelings of tension and 
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anxiety. 
However, in the other trials we combined subjective and objective to explore physiological 
mechanisms. As objective measures for mood we used indicators of autonomic nervous 
system activity (skin conductance, heart rate variability). The autonomic nervous system is 
thought to play a role in mood regulation. Its activity has been related to the arousal dimension 
of mood, such that sympathetic nervous system activity correlates with high arousal mood 
states. This indicates that physiological markers, such as indicators of autonomic nervous 
system activity, may provide insight in the underlying mechanism of effects of alcohol on well-
being.
 
Short-term intervention studies 
Study design
All short-term intervention studies described in this thesis (including the intervention studies 
in the meta-analysis) used a randomized controlled design. Except for one study which had a 
parallel design in the meta-analysis, all studies had a crossover design. In short-term trials, a 
disadvantage of the crossover design is the risk of carry-over effects. We adjusted for these 
effects by adding treatment order to the model. We did not observe an effect by treatment 
order, and therefore we concluded that the results were not influenced by carry-over effects. 
However, most of the studies included in the meta-analysis did not indicate if the results were 
influenced by carry-over effects. Therefore, the findings from the meta-analysis on insulin 
sensitivity may have been influenced by carry-over effects if effects of alcohol consumption in 
one treatment period were still present in the alcohol-free treatment period and interfered with 
the effects from the alcohol-free control in this period. This would have resulted in attenuation 
of the alcohol effect.
Study population
Participants in the studies consisted of both men and women. The influence of alcohol on 
oxidative stress was only tested in men. Our findings on oxidative stress are therefore not 
directly generalizable to women, although one other study by Hartman et al. (2005) observed 
also an increase in lipid oxidation in women (20). The influence of alcohol on fetuin-A and 
insulin sensitivity were measured in both men and women, and gender-specific effects were 
observed. The potential influence of age on alcohol’s effect on oxidative stress, fetuin-A and 
insulin sensitivity needs further clarification. 
Alcohol dosage and intervention duration
Alcohol doses used varied between the different studies in this thesis. Doses were in the 
range of 15 - 40 g alcohol daily. This would be equal to 1.5 - 4 Dutch units or around 1 - 3 
U.S. units, which exceeds current recommendation for moderate consumption. Because the 
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intervention period was relatively short, compared to sustainable moderate drinking in life, 
we chose to use an alcohol amount in the upper range of moderate consumption (25 - 40 g 
alcohol per day). We also included studies using doses up to 40 g alcohol per day in the meta-
analysis and categorized these as moderate alcohol consumption. Our intervention studies 
were conducted in experimental settings with the aim to explore the physiological determinants 
of emotional well-being, and they are therefore not meant to be translated directly into public 
health advices. 
The duration of intervention was on average ~5 weeks for studies measuring insulin sensitivity 
in the meta-analysis. The intervention duration of other studies varied between 3 and 6 weeks. 
These durations may not have been long enough to result in detectable changes in insulin 
sensitivity in men, and of fetuin-A in women. However, we observed that the outcomes of the 
studies were generally not influenced by duration, suggesting that study duration has been 
sufficiently long. 
Outcomes
The short-term trials described in this thesis included several different outcome measurements 
for oxidative stress, inflammation and insulin sensitivity. 
Markers of oxidative stress were determined using previously validated assays. Although 
there are many markers available to measure oxidative stress, they all have their limitations 
(21). Therefore, we chose multiple measures of oxidative stress that reflect different aspects. 
We measured total Trolox equivalent antioxidant capacity (TEAC) because it could be 
related to the antioxidant capacity of the wine and dealcoholized wine used in the study and 
because changes in TEAC reflect acute effects. A limitation of TEAC is that outcomes cannot 
be interpreted quantitatively but only for comparison of antioxidant status between groups. 
Therefore, the TEAC observed in our study, cannot be quantitatively compared to findings in 
other studies. An advantage, however, is that it is a good measure of the total activity of all 
antioxidants in plasma, including non-S-H containing antioxidants and unknown antioxidants 
(22). Antioxidants act together, and therefore the measurement of total antioxidant capacity 
gives a better reflection of antioxidant balance and yields more valuable information as 
compared to measuring single antioxidants. F-2 isoprostanes are the most widely used 
biomarker of oxidative stress and are generally accepted as the best currently available 
biomarker of lipid oxidation. Changes in urinary F2-isoprostanes may reflect changes in lipid 
oxidation by chronic oxidative stress (23). Therefore, we used this biomarker to evaluate the 
effect of long-term alcohol consumption on lipid oxidation. However, F2-isoprostanes are 
oxidative products of arachidonic acid, and outcomes may thus be influenced by nutritional 
intervention studies affecting the arachidonic acid concentration in tissues. 
The intervention studies included in the meta-analysis measured insulin sensitivity in different 
ways, with only two of them using the gold standard; the euglycemic hyperinsulinemic clamp 
technique. All other studies used indirect measures for insulin sensitivity, but these measures 
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gave similar outcomes as those using the gold standard. Therefore, overall findings are not 
expected to be influenced by the predominant use of indirect measures. 
Long-term observational studies 
Compared with acute and short-term intervention studies, findings from longitudinal 
observational studies are more appropriate to generalize to a larger population, as they are 
based on a more heterogeneous sample population and measuring the natural development 
of a trait in a real-life setting. 
The observational study described in this thesis had several strengths, such as repeated 
measurements by follow-up and a large sample size. However, the study had, as with many 
longitudinal observational studies, also certain limitations. Since these are already discussed 
in detail in chapter 9, only some limitations that are specific for longitudinal studies in alcohol 
research on well-being will be addressed here.
Reference group
In our study we used infrequent drinkers as the reference group instead of abstainers. The 
abstaining group may be mixed with people who stopped drinking due to illness, former 
alcohol abuse or because of interaction with their medication. This concerns the ‘sick quitters’ 
hypothesis, which was first proposed by Shaper et al. (1988) (24). The inclusion of ‘sick 
quitters’ in the abstaining group may cause a higher incidence of disease or a lower quality of 
life among abstainers as compared to moderate alcohol consumers. In our study on quality 
of life we separated long-term abstainers from former drinkers to exclude potential sick-
quitters from the abstainers. However, in many high-income countries, alcohol consumption is 
normative and long-term abstainers differ from current drinkers in socio-demographic status 
and other health determinants. Therefore, potential confounding is higher in studies using 
long-term or lifetime abstention and thus it appears to be a better approach to use light or 
infrequent drinkers as the reference group, as we did in our study. 
Assessment of alcohol intake
Alcohol intake was assessed with a semi-quantitative food frequency questionnaire (FFQ). 
Self-reported alcohol intake has been shown to be generally underreported, especially at 
higher levels of alcohol consumption (25). Nevertheless, a validation study showed a high 
correlation between alcohol consumption from the FFQ and four one-week dietary recalls 
(r=0.90). Furthermore, self-reported alcohol intake by the FFQ was linearly associated with 
HDL-cholesterol concentrations (r=0.40), which is a strong biomarker of alcohol intake (26). 
This means that the FFQ for assessment of alcohol intake is a valid method for ranking 
subjects according to their intake rather than for estimation of absolute amounts.
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External validity and interpretation of the findings 
The aims of this thesis were 1) to further explore the acute effects of moderate alcohol 
consumption on emotional well-being and the association between habitual alcohol 
consumption and emotional well-being and 2) to provide more insight in the influence of 
moderate alcohol consumption on physiological determinants and health outcomes related 
to emotional well-being.
Emotional well-being
Beneficial effects of moderate alcohol consumption on acute emotional well-being have been 
shown previously (4, 12, 27-31). An overview of these effects is presented in chapter 1 (Figure 
1.2). In accordance with previous studies (11, 29, 30, 32, 33) we observed a biphasic response 
in mood when alcohol was consumed with a meal, showing first stimulation effects, followed 
by sedative effects (chapter 2). Though, the onset of sedative effects occurred immediately 
after consumption instead of at the peak BAC. These delayed sedative effects may have 
been due to an increased tiredness induced by food intake. The tension reducing effects of 
alcohol are suggested to be dose-dependent (12). Our study may not have shown a reduction 
in tension because of the slightly higher dose (30 g alcohol) used, although we did observe a 
stronger decline in cortisol after alcohol consumption (chapter 3). Surprisingly, mood was only 
improved when alcohol was consumed in a created unpleasant ambiance in which subjects 
had a lower mood state. This suggests that moderate alcohol consumption may improve 
emotional well-being only when a person is not feeling happy. 
Furthermore, we showed that moderate alcohol consumption increased subsequent food 
reward of savoury foods (chapter 4). With this study we showed that, in addition to the research 
available on the rewarding effects of alcohol itself, alcohol increases the rewarding value of 
intake of certain foods, thereby increasing the enjoyment of eating. An increased rewarding 
value of eating may contribute to the improvement of emotional well-being induced by alcohol.
In line with research showing the stress dampening effects of alcohol when consumed before 
a mental stressor, we observed an improved stress recovery when alcohol was consumed 
after the stressor. This implies that alcohol may attenuate stress, either when it is consumed 
before or after a stressor (chapter 5). Together, these results suggest that moderate alcohol 
consumption may have a buffering effect on emotional well-being, such that moderate alcohol 
consumption only acutely improves emotional well-being in case it is disturbed. Furthermore, 
emotional well-being may be further improved via alcohol’s enhanced enjoyment of other 
rewarding behaviours. 
A positive association between habitual moderate alcohol consumption and well-being has 
been suggested by cross-sectional studies. In our longitudinal observational study, moderate 
alcohol consumption was associated with better health-related quality of life in women 
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(chapter 9). However, this effect was only shown for physical health-related scales, vitality 
and social functioning, and not for the mental health and role emotional scales. The last two 
were actually scored lower in women drinking more than 20 gram alcohol (2 Dutch units) per 
day. Some studies did show a positive association between moderate alcohol consumption 
and mental health (both scale or summary score) (34-36). This difference may be explained 
by the use of other study populations, designs and reference categories in these studies. 
A good health-related quality of life contributes to well-being. Nevertheless, the positive 
effects of moderate alcohol consumption on short-term emotional well-being do not seem to 
influence long-term emotional well-being via an increased mental health-related quality of life 
in this young/middle-aged population. Whether other aspects of emotional well-being, such 
as life satisfaction and finding purpose and meaning in one’s life are increased by habitual 
moderate alcohol intake requires further investigation. The acute effects of moderate alcohol 
consumption on emotional well-being may, however, translate into a better long-term physical 
well-being. 
Physiological determinants and health outcomes
Whether alcohol consumption improves markers of oxidative stress and insulin sensitivity has 
been investigated in several intervention trials. Most trials showed that red wine consumption 
increases antioxidant capacity, but whether this was due to the polyphenols or alcohol in the 
wine was not clear. We showed that red wine consumption acutely attenuated meal-induced 
oxidative stress as compared to dealcoholized red wine. This indicates that the reduction of 
meal-induced oxidative stress is an effect of alcohol per se or a combined effect of alcohol 
and polyphenols in red wine (chapter 6). This is in agreement with the effects observed for 
moderate alcohol consumption and inflammation, suggesting that probably both alcohol and 
polyphenols possess anti-inflammatory effects (37). However, our study showed that the 
improved oxidative capacity was not maintained after short-term daily alcohol intake in healthy 
subjects. In line with other studies, short-term daily alcohol intake was even found to increase 
lipid oxidation (20, 38). Nevertheless, both a high intake of polyphenols and moderate alcohol 
consumption have been related to a lower risk for cardiovascular mortality (39, 40). It appears 
that alcohol only reduces oxidative stress when it is consumed with food that induces oxidative 
stress, such that alcohol may restore oxidative balance. The contribution of alcohol to an 
oxidative balance may be one of the mediating factors in alcohol’s effect on diseases as 
cardiovascular disease and type 2 diabetes. 
The apparently protective effect of moderate alcohol consumption on type 2 diabetes has 
been well described in two meta-analyses (41, 42). The mechanism behind this reduced risk 
for type 2 diabetes is not completely clear yet. In recent observational studies, fetuin-A has 
been proposed to play a role in this association (43-45), but the effect of alcohol intake on 
fetuin-A was not yet investigated. We showed that moderate alcohol intake reduced fetuin-A 
levels in men (chapter 7). Thereby we provided evidence for a mediating role of fetuin-A in the 
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reduction of type 2 diabetes risk by moderate alcohol consumption in men. Insulin sensitivity is 
another factor that may explain the association, but intervention studies reported inconsistent 
results. Our meta-analysis showed that this inconsistency may be due to gender differences, 
because only in women moderate alcohol consumption tended to improve insulin sensitivity 
and reduced fasting insulin levels (chapter 8). This is in line with observational studies showing 
a larger prospective effect of alcohol on type 2 diabetes in women than in men. Together, 
these results provide evidence for potential mediators explaining the reduced risk of chronic 
diseases, such as type 2 diabetes, by moderate alcohol consumption. An improved oxidative 
balance and reduced innate inflammatory response may also explain part of the association 
suggested between alcohol consumption and reduced risk of diseases such as rheumatoid 
arthritis (46-48). 
Public health implications
The results presented in this thesis underline that moderate alcohol consumption has acute 
beneficial effects on emotional well-being, by enhancing mood, inducing the rewarding value 
of food, and facilitating mental stress recovery. In addition, the results show that moderate 
alcohol consumption may improve short-term physiological determinants and physical 
outcomes related to emotional well-being, as shown by a reduction of oxidative stress and 
fetuin-A, and an improvement of insulin sensitivity. Finally, the results suggest that the 
beneficial effects of moderate alcohol consumption on short-term emotional well-being are 
probably not translated into an improved long-term emotional well-being, although they may 
translate into better long-term physical well-being.
The significance of well-being and quality of life as a public health concern has been endorsed 
for over half a century. Already in 1948 the WHO stated that health is ‘a complete state of 
physical, mental and social well-being and not merely the absence of disease or infirmity’ (49). 
Furthermore, in 1995, the WHO stressed the importance of assessing and improving people’s 
well-being (50). Therefore, the results from this thesis would best be interpreted within this 
framework of health. Because people are living longer than before, it is important to look 
beyond physical diseases and mortality. However, public health guidelines on alcohol intake 
have so far been focused primarily on risk of mortality, morbidity and injuries. An average daily 
intake of one to two alcohol beverages is associated with the lowest risk of all-cause mortality 
(51) mainly attributed to a reduced risk of cardiovascular disease (40). The lowest risk of type 
2 diabetes has been observed around two alcoholic beverages per day (41, 42), while every 
glass of alcohol increases the risk of breast cancer (52). The risk of injuries and violation rises 
with heavier alcohol intake (53). 
Ours and previous research on the relation between alcohol and well-being showed that 
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there is a J-shaped association, with moderate alcohol consumption being associated with 
better well-being. We showed that for physical well-being the optimal alcohol consumption 
would be around 20 gram per day, whereas emotional well-being decreases with daily intakes 
higher than 20 gram per day. In addition, we showed that moderate alcohol consumption may 
immediately improve emotional well-being. Higher doses of alcohol are known to result in 
unpleasant behavioural effects. Taking into account influences of alcohol on both physical and 
emotional well-being, from acute to long-term, the current guidelines for alcohol consumption 
are in line with effects on mortality and disease outcomes.  
The current American and Dutch guidelines on alcohol consumption, if any alcohol is consumed 
at all, are to consume alcohol in moderation (up to 1 drink per day for women and 2 drinks per 
day for men) (54, 55). Our results are in agreement with these guidelines: moderate alcohol 
consumption may be beneficial for physical well-being, whereas drinking above moderate 
may be harmful for emotional well-being. 
There are several risk groups who are advised not to drink at all by the U.S. National 
Institute of Alcohol Abuse and Alcoholism and the Netherlands Health Council: children and 
adolescents, women who are pregnant or planning to get pregnant, individuals with specific 
medical condition or taking medications that may interact with alcohol, individuals planning to 
engage in activities that alertness and skills, or individuals who cannot restrict their drinking to 
moderate levels or are recovering from alcoholism (55, 56). 
Research has also shown that people with a family history of alcoholism have an altered 
response to alcohol consumption, including attenuated stress and mood responses (57-60). 
This may make them more at risk to heavy drinking and alcohol abuse. Therefore, it would be 
better to restrict alcohol consumption in this high-risk group.   
Recommendations for future research
Moderate alcohol consumption and stress adaptation
The research presented in this thesis suggests that alcohol may improve emotional well-
being. We showed that moderate alcohol consumption reduces stress and tension shortly 
after intake. However, the question whether alcohol consumption improves short-term (e.g. 
after several weeks) stress resilience remains unanswered and requires further investigation. 
Several studies reported that repeated exposure to the same stressor leads to a reduced 
HPA-axis mediated stress response (1-3). The adaptive capacity of a person to respond to 
stressors experienced during life may influence the vulnerability to stress-related disorders on 
the long term. Stress adaptation involves activation of neural, cardiovascular, neuroendocrine 
and immune systems. In case these systems are not turned down efficiently after the stressor 
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or fail to respond adequately to the stressor initially, this may have consequences for the 
systems involved. For example, chronic overactivation of the cardiovascular system can 
lead to hypertension, whereas chronic overactivation of the neuroendocrine system can 
lead to depression (61, 62). The current high incidence of stress-related disorders, such as 
depression, coronary heart disease, type 2 diabetes and ulcerative colitis, warrants more in-
depth investigation of stress resilience. This could include further studies on the influence of 
alcohol consumption on stress resilience. The latter should preferably be carried out following 
an integrated approach, in which all involved systems are evaluated. This includes, but is not 
limited to subjective measures of stress and mood, and physiological measures of autonomic 
nervous system, blood pressure, HPA-axis and immune system.   
Bidirectional association between alcohol and mental stress
Many observational studies investigated the association between stress and alcohol 
consumption. These studies suggest that high work stress or stressful experiences may induce 
drinking and alcohol abuse (63-65). Our research showed that alcohol consumption may 
help to reduce stress shortly after drinking, suggesting that moderate alcohol consumption 
might also reduce stress in the long-term. Therefore, it is important to investigate whether 
the association between stress and alcohol consumption is bidirectional. Societal disease 
burden due to high perceived mental stress load is increasing. This underlines the relevance 
of further investigation into cause-effect relationships between stress and lifestyle factors, 
including moderate alcohol consumption and other dietary habits. 
Interestingly, Vasse et al. (1998) showed that in situations of high perceived stress, abstainers 
were more likely to be absent due to sickness than moderate drinkers (66). Therefore, also the 
possible associations between alcohol, stress and illness are of interest, as moderate alcohol 
consumption may not only reduce the perceived stress burden, but could also modulate 
stress-related illness. 
Epigenetic effects of moderate alcohol consumption
The last several years, the importance of flexibility and adaptability as components of health 
has been increasingly recognised. This led to a renewed definition (in 2011) of health, namely 
‘the ability to adapt and to self-manage’ (67). This development coincides with new insights 
into mechanisms by which DNA can adapt to environmental influences, such as stress and 
inflammation, via epigenetic regulation (68). Epigenetic events have been defined as ‘the 
structural adaptation of chromosomal regions so as to register, signal or perpetuate altered 
activity states’ (69). Alcohol consumption has been shown to cause epigenetic changes via an 
increased NADH/NAD+ ratio, the formation of reactive oxygen species (ROS) and of acetate 
resulting from alcohol metabolism (70). For example, heavy alcohol consumption has been 
shown to influence epigenetic factors related to dysregulation of the immune system (71). 
However, moderate alcohol consumption, in contrast to heavy alcohol consumption, has 
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been suggested to influence the immune system in a positive way (37). Therefore, moderate 
alcohol consumption may result in beneficial epigenetic changes as well. Exploring the 
epigenetic changes induced by moderate alcohol consumption may provide further insight in 
the underlying mechanisms of the observed positive effects of moderate alcohol consumption 
on the immune system and metabolism. This could also generate a better understanding 
of the underlying mechanisms by which moderate alcohol consumption reduces the risk for 
diseases, such as type 2 diabetes and cardiovascular disease. 
Physiological mechanisms explaining the relation between alcohol and type 2 diabetes
Despite the extensive evidence on the association of moderate alcohol consumption with a 
reduced risk of type 2 diabetes (41, 42), the underlying mechanisms are still not completely 
understood. The research in this thesis underlines that moderate alcohol consumption may 
influence different pathways and intermediates possibly involved in the reduced risk of type 
2 diabetes in men and women. Several factors and processes have been identified that may 
mediate this relation, such as insulin sensitivity, inflammatory processes, effects of lipids and 
adiponectin (72). The relation was suggested to be explained for ~25% by adiponectin in 
middle-aged women (73). Future research should preferably include intervention trials in which 
the effect of moderate alcohol consumption on different pathways and mediators is studied in 
parallel, in relation to type 2 diabetes risk. These intervention trials should preferably use the 
gold standard of insulin sensitivity (the euglycemic hyperinsulinemic clamp technique) and 
include both men and women to investigate gender-related differences in mechanisms.  
Concluding remarks
In conclusion, research presented in this thesis has added to our existing knowledge on the 
acute effects of moderate alcohol consumption on emotional well-being in common situations, 
such as consumption with a meal or in a mentally stressed state. In addition, we have further 
elucidated the influence of moderate alcohol consumption on physiological determinants 
related to emotional well-being, such as oxidative stress, inflammation and insulin sensitivity, 
and its gender-related differences. Finally, we provided new insights in the association 
between moderate alcohol consumption and physical and mental-health related quality of life.
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Moderate alcohol consumption has been suggested to contribute to emotional well-being. 
However, several knowledge gaps remain, in particular on the effects of moderate alcohol 
consumption on emotional well-being in common drinking situations. Furthermore, it is not 
well understood to what extent alcohol-induced emotional well-being influences physical well-
being. 
This thesis aimed to further explore the acute effects of moderate alcohol consumption on 
emotional well-being and the association between habitual alcohol consumption and emotional 
well-being. Next, this thesis aimed to provide more insight into physiological determinants that 
may be related to alcohol-induced emotional well-being.
Acute effects on emotional well-being
Alcohol is often consumed around mealtimes. Despite the evidence that moderate amounts 
of alcohol can improve well-being shortly after consumption, the effects of moderate alcohol 
consumption with a meal are not well understood. Therefore, we have investigated the influence 
of moderate alcohol consumption with dinner on mood in women (chapter 2). Happiness 
scores increased shortly after alcohol consumption, but only in those situations where an 
unpleasant current mood state was induced. The results suggest that alcohol consumption 
with a meal acutely improves well-being, but in an unpleasant ambiance only. 
Endocannabinoids have been suggested to play a role in the behavioural effects of alcohol. 
Therefore, we examined the effects of mood changes induced by a meal ambiance and 
moderate alcohol consumption on plasma endocannabinoids and some N-acylethanolamine 
congeners in women (chapter 3). Circulating endocannabinoids were not influenced by 
alcohol consumption, and showed an inconsistent correlation with mood states. These 
findings do not suggest, at least under these conditions, that plasma endocannabinoids are 
important for mood regulation. 
When alcohol is consumed before or with a meal, it increases food intake. Despite the well-
known rewarding properties of alcohol itself, the effects of alcohol on the reward response of 
subsequent food intake have not been measured before. In chapter 4 we described whether 
alcohol increases food intake by increasing food reward in men. Indeed, data obtained showed 
that moderate alcohol consumption is able to increase subsequent intake and rewarding value 
of savoury foods. 
Although several studies have shown a stress-dampening effect of alcohol when consumed 
before a mental stressor, data on such an effect of alcohol when consumed after a stressor 
are limited. Therefore, we investigated whether moderate alcohol consumption shortly after a 
mental stressor attenuated the stress response and stress-related immune response in men 
(chapter 5). Moderate alcohol consumption shortly after a stressor improved the recovery 
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of cortisol and ACTH. Furthermore, the inflammatory marker IL-8 and the percentage of 
monocytes were decreased after alcohol consumption. This implies that alcohol may improve 
stress recovery and that it may modulate a stress-induced inflammatory response.
Short-term influence on physical well-being
To further explore the effect of moderate alcohol consumption on physiological determinants 
of emotional well-being, we investigated the influence of moderate alcohol consumption with 
a meal on postprandial plasma total oxidative capacity and NF-κB (nuclear transcription factor 
playing an important role in inflammation) levels in men (chapter 6). Here we found that a 
moderate amount of alcohol acutely attenuated meal-induced oxidative stress.  
There is a clear association between habitual moderate alcohol consumption and a lower risk 
of type 2 diabetes. However, the acute effects of moderate drinking on inflammatory status 
and insulin sensitivity, two factors that might explain this relation, are poorly understood. To 
determine the effects of several weeks of moderate alcohol consumption on inflammation 
makers and insulin sensitivity, we conducted two studies. In chapter 7 we described post 
hoc analyses on alcohol’s influence on fetuin-A in three randomized intervention studies in 
both men and women. Additionally, we conducted a meta-analysis on intervention studies 
measuring the influence of short-term alcohol consumption (≥2 weeks) on insulin sensitivity 
and glycemic status (chapter 8).
Short-term moderate alcohol intake reduced fetuin-A levels in men but not in women. Our 
meta-analysis showed that in women only, short-term moderate alcohol consumption tended 
to improve insulin sensitivity and reduced fasting insulin levels. This suggests that alcohol 
consumption may influence different pathways and intermediates in men and in women, 
leading to a reduced type 2 diabetes risk.
Long-term association with emotional and physical well-being
The association between habitual alcohol consumption and well-being has thus far mainly been 
measured by cross-sectional studies, which demands for further substantiation by prospective 
observational studies. We therefore investigated the bidirectional association between alcohol 
consumption and health-related quality of life in a longitudinal study in women (chapter 9). 
Moderate alcohol consumption was associated with a better physical health-related quality of 
life, but not with a better mental health-related quality of life.
The main findings, methodological considerations and interpretation of findings of the studies 
described in this thesis are discussed in chapter 10. In this chapter, also directions for further 
research and implications for public health are mentioned.
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In conclusion, data presented in this thesis add to the existing knowledge on acute 
improvement of emotional well-being by moderate alcohol consumption in common situations, 
such as consumption with a meal or during a mentally stressed state. In addition, we further 
elucidated the influence of moderate alcohol consumption on emotional well-being related 
physiological determinants, such as oxidative stress, inflammation and insulin sensitivity. 
Finally, we extended evidence on the association between moderate alcohol consumption 
and physical and mental-health related quality of life.
Lay summary in Dutch
(Samenvatting voor niet-ingewijden)
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De invloed van matige alcoholconsumptie op het geestelijk en 
lichamelijk welbevinden
Alcohol wordt al sinds mensenheugenis gedronken, vooral om te ontspannen en 
plezier te hebben. Het drinken van alcohol heeft daarnaast ook duidelijke effecten op de 
gezondheid: overmatige alcoholconsumptie heeft sterke gezondheidsnadelen, terwijl matige 
alcoholconsumptie daarentegen overwegend 
gezondheidsvoordelen heeft. De afgelopen jaren 
is er vooral veel onderzoek gedaan naar de invloed 
van alcoholconsumptie op chronische ziekten, 
zoals hart- en vaatziekten en type 2 diabetes. De 
invloed van alcohol op het geestelijk welbevinden 
is nog niet duidelijk voor veel voorkomende 
drinkmomenten, zoals het drinken van een glaasje 
alcohol bij de maaltijd, of na een stressvolle dag 
op het werk. Ook is nog onvoldoende bekend 
wat de invloed is van matige alcoholconsumptie 
op gezondheidsparameters die gerelateerd zijn 
aan het geestelijk welbevinden. Een langdurige 
periode van stress kan bijvoorbeeld leiden tot meer 
ontstekingsfactoren in het bloed en een lagere 
insulinegevoeligheid. Dit zijn twee belangrijke 
factoren voor het ontstaan van type 2 diabetes. 
Het doel van dit proefschrift is daarom tweeledig:
1. Het verder onderzoeken van de invloed van matige alcoholconsumptie op het geestelijk 
welbevinden. Dit is gedaan door middel van interventiestudies naar de directe effecten op 
het geestelijk welbevinden en door middel van een bevolkingsonderzoek naar de relatie 
tussen matige alcoholconsumptie en de kwaliteit van leven op de lange termijn.
2. Meer inzicht verkrijgen in de effecten van matige alcoholconsumptie op 
gezondheidsparameters die gerelateerd zijn aan geestelijk welbevinden. Dit is gedaan 
met interventiestudies en een meta-analyse waarin de effecten van alcoholconsumptie 
op oxidatieve stress, fetuin-A en insulinegevoeligheid zijn onderzocht.
Invloed op geestelijk welbevinden
We hebben door middel van drie interventiestudies de directe effecten van matige 
alcoholconsumptie op het geestelijk welbevinden onderzocht. Bij interventiestudies wordt aan 
Definitie van matige alcoholcon-
sumptie:
Onder matige alcoholconsumptie 
verstaat de Nederlandse Gezond-
heidsraad:
Maximaal één standaardglas alcohol 
per dag voor vrouwen en maximaal 
twee standaardglazen per dag voor 
mannen. Eén standaardglas wijn, 
bier of gedistilleerd bevat ongeveer 
10 gram alcohol.
Alcoholconsumptie in Nederland:
Volwassen mannen en vrouwen drin-
ken in Nederland gemiddeld respec-
tievelijk 1,6 en 0,9 glazen per dag.
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een relatief kleine groep mensen een bepaalde stof of behandeling gegeven. In de beschreven 
onderzoeken werden alcoholhoudende en alcoholvrije dranken aan de proefpersonen 
gegeven. Vervolgens werden de effecten op stemming, stress en de beloningsgevoelens 
van het consumeren van voeding gemeten. In de onderzoeken kwamen de proefpersonen 
meerdere keren naar de testlocatie om de testen een keer te doen met alcoholhoudende 
drank en een keer met alcoholvrije drank. De volgorde hiervan was willekeurig. De resultaten 
na het drinken van alcoholhoudende of alcoholvrije dranken werden vergeleken om te kunnen 
bepalen wat de effecten van alcohol zijn. 
Om de invloed van matige alcoholconsumptie op het geestelijk welbevinden op de lange 
termijn te onderzoeken, hebben we de relatie tussen dagelijkse alcoholconsumptie en de 
kwaliteit van leven in een groot bevolkingsonderzoek onder Amerikaanse vrouwen onderzocht. 
Effect van alcohol op stemming
In het eerste onderzoek kregen 28 vrouwelijke proefpersonen bij een avondmaaltijd 3 glazen 
bruisende witte wijn of alcoholvrije bruisende witte wijn te drinken. Dit deden zij in een gezellige 
of ongezellige kamer die de proefpersonen in een goede of slechte stemming bracht. Hierdoor 
konden wij onderzoeken of alcoholconsumptie de stemming anders beïnvloedt wanneer men 
alcohol drinkt in een positieve of negatieve stemming. In hoofdstuk 2 en 3 beschrijven we de 
resultaten van dit onderzoek. Direct na het drinken van 3 glazen bruisende witte wijn gaven 
de proefpersonen in vragenlijsten aan vrolijker te zijn. Dit was echter alleen wanneer de wijn 
in een ongezellige kamer werd gedronken en niet wanneer deze in een gezellige kamer werd 
gedronken. 
Effect van alcohol op het genieten van eten
In het tweede onderzoek kregen 24 mannelijke proefpersonen een mix van wodka en 
sinaasappelsap of alleen sinaasappelsap te drinken (hoofdstuk 4). Hierna werd met een 
vragenlijst op de computer getest of ze op dat moment meer zin hadden in zoete, hartige, 
vetrijke of vetarme snacks (‘wanting’). Ook werd getest hoe lekker ze de snacks op dat 
moment vonden (‘liking’). Deze twee componenten bepalen samen het beloningsgevoel; hoe 
belonend het eten van voeding wordt ervaren (‘rewarding value’). Een half uur na het drinken 
van de alcoholhoudende of alcoholvrije drank kregen ze een lunch waarbij ruim voldoende 
eten aanwezig was, zodat ze konden eten tot ze verzadigd waren. De belegproducten waren 
gelijkelijk verdeeld volgens de zoete, hartige, vetrijke en vetarme categorieën. Na het drinken 
van alcohol hadden de proefpersonen meer voorkeur voor hartige producten en aten ook 
meer van het hartige beleg, voornamelijk van het vetrijke hartige beleg.
Effect van alcohol op stress
In het derde onderzoek kregen 24 mannelijke proefpersonen 2 blikjes bier of alcoholvrij bier te 
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drinken na het uitvoeren van een mentale stresstest. Deze stresstest bestond onder andere 
uit het geven van een presentatie over de eigen sterke en zwakke punten. Deze presentatie 
werd gefilmd, en acteurs waren ingehuurd om kritische non-verbale signalen te geven aan 
de proefpersonen om de stress nog verder te verhogen. De resultaten van dit onderzoek 
zijn beschreven in hoofdstuk 5. De mentale stresstest zorgde voor een verhoging van de 
stresshormonen cortisol en ACTH, die weer daalden nadat de stresstest voorbij was. Er was 
een sterkere daling te zien van de stresshormonen cortisol en ACTH na het drinken van bier 
dan na het drinken van alcoholvrij bier na de stresstest. Ook werden er ontstekingsfactoren 
gemeten die tijdelijk vrijkomen bij stress. Twee van deze factoren, interleuking-8 (IL-8) en 
het percentage monocyten (van de totale hoeveelheid witte bloedcellen), waren lager na het 
drinken van bier dan na het drinken van alcoholvrij bier.
Langdurige alcoholconsumptie en kwaliteit van leven
Met data van een groot bevolkingsonderzoek dat is uitgevoerd onder Amerikaanse vrouwen, 
hebben we de relatie tussen matige alcoholconsumptie en de kwaliteit van leven onderzocht 
(hoofdstuk 9). Kwaliteit van leven wordt gedefinieerd als het functioneren van personen op 
fysiek, psychisch en sociaal gebied zoals zij dat zelf ervaren. In het bevolkingsonderzoek 
zijn met een vragenlijst de lichamelijke en psychische aspecten van de kwaliteit van 
leven gemeten. De alcoholconsumptie (in glazen alcohol per week) is gemeten met een 
voedselfrequentie-vragenlijst. Matige alcoholconsumptie was gerelateerd aan een betere 
kwaliteit van leven voor het lichamelijke gezondheidsaspect hiervan, maar was niet aan het 
psychische gezondheidsaspect.
Invloed op lichamelijk welbevinden
De effecten van matige alcoholconsumptie op het lichamelijk welbevinden zijn onderzocht 
met interventiestudies en een meta-analyse. Deze interventiestudies zijn vergelijkbaar qua 
opzet met de eerder beschreven interventiestudies. In de interventiestudies werd voor een 
aantal weken alcoholhoudende of alcoholvrije drank gedronken om de korte termijn effecten 
op gezondheidsparameters van het geestelijk welbevinden te meten. Een meta-analyse is 
een onderzoek waarbij de resultaten van alle studies (in dit geval interventiestudies) over 
een onderwerp worden samengevoegd zodat de uiteindelijke uitkomst betrouwbaarder is. De 
kwaliteit van de interventiestudies wordt meegenomen en de resultaten van de studies worden 
gewogen, zodat studies met secuurdere resultaten meer invloed hebben op de uiteindelijke 
uitkomst van de meta-analyse.
Effecten van alcohol op oxidatieve stress
Tijdens de stofwisseling ontstaat een kleine hoeveelheid oxidanten of reactieve 
201
Samenvatting voor niet-ingewijden
zuurstofverbindingen. Dit is een normaal verschijnsel. Oxidatieve stress is een 
stofwisselingstoestand waarbij er meer oxidanten vrij komen dan gebruikelijk. In een 
interventiestudie kregen 19 mannelijke proefpersonen bij hun avondmaaltijd thuis 4 weken 
lang rode wijn of alcoholvrije rode wijn te drinken. Na deze 4 weken kwamen ze naar TNO 
voor een testdag waar ze bij een maaltijd weer dezelfde wijn te drinken kregen. Voor en 
na deze maaltijd werd gemeten hoe goed het bloed in staat is om oxidanten onschadelijk 
te maken (‘totale antioxidant capaciteit’). Ook werd de hoeveelheid NF-κB in het bloed 
gemeten, een stofje dat meer aanwezig is bij oxidatieve stress en die de productie van 
ontstekingsfactoren stimuleert. De resultaten van het onderzoek zijn beschreven in hoofdstuk 
6. De totale antioxidant capaciteit was hoger na de maaltijd met rode wijn dan na de maaltijd 
met alcoholvrije rode wijn. Daarnaast was de hoeveelheid NF-κB verhoogd na de maaltijd 
met alcoholvrije rode wijn, terwijl de hoeveelheid NF-κB in het bloed onveranderd was na de 
maaltijd met rode wijn. Dit wijst op een lagere oxidatieve stress na het drinken van rode wijn 
bij de maaltijd.
Effecten van alcohol op insulinegevoeligheid
Insulinegevoeligheid is de gevoeligheid van de weefsels, zoals lever en spieren, voor insuline. 
Insuline zorgt ervoor dat glucose in de weefsels komt. Een verlaagde insulinegevoeligheid 
kan een voorspeller zijn van type 2 diabetes. In deze meta-analyse zijn de resultaten van 14 
interventiestudies meegenomen waarin het effect van tenminste 2 weken alcoholconsumptie 
op de insulinegevoeligheid en de controle van de bloedsuikerspiegel is gemeten. De resultaten 
hiervan zijn beschreven in hoofdstuk 8. Matige alcoholconsumptie verhoogt mogelijk de 
insulinegevoeligheid bij vrouwen.
Effecten van alcohol op fetuin-A
Fetuin-A is een stofje dat door de lever gemaakt wordt en de insulinegevoeligheid verlaagt. 
Daarnaast is het gerelateerd aan een slechter functioneren van het immuunsysteem. In 
drie interventiestudies met wijn, bier en wodka en hun alcoholvrije variant, is in mannen en 
vrouwen het effect van een aantal weken matige alcoholconsumptie op fetuin-A onderzocht 
(hoofdstuk 7). In de studie met mannen was er een verlaging van fetuin-A door matige 
alcoholconsumptie, maar niet in de studies met vrouwen. 
Algemene discussie
Tot slot wordt in hoofdstuk 10 een kort overzicht gegeven van de belangrijkste bevindingen 
van dit proefschrift. Ook worden de voor- en nadelen van de gebruikte onderzoeksmethoden 
besproken en worden de gevonden resultaten vergeleken met eerdere bevindingen in de 
wetenschappelijke literatuur. Vervolgens wordt de relevantie van de uitkomsten voor de 
volksgezondheid beschreven. Tenslotte worden suggesties gedaan voor verder onderzoek 
202
Lay summary in Dutch
op het gebied van matige alcoholconsumptie en geestelijk en lichamelijk welbevinden. 
Kortom, dit proefschrift heeft de kennis over de invloed van matige alcoholconsumptie op het 
geestelijk en lichamelijk welbevinden uitgebreid door aan te tonen dat:
1. Matige alcoholconsumptie op korte termijn het geestelijk welbevinden kan verbeteren. 
Dit volgt uit een directe verbeterde stemming in een ongezellige omgeving, een sterkere 
afname in stresshormonen na stress en het meer genieten van met name hartige 
voedingsmiddelen. 
2. Matige alcoholconsumptie op lange termijn gerelateerd is aan een betere kwaliteit van 
leven voor het lichamelijke gezondheidsaspect, maar niet gerelateerd is aan het mentale 
gezondheidsaspect van kwaliteit van leven bij vrouwen.
3. Matige alcoholconsumptie op korte termijn het lichamelijk welbevinden kan verbeteren. Dit 
volgt uit een verlaging van de maaltijd-geïnduceerde oxidatieve stress en de hoeveelheid 
fetuin-A bij mannen en een mogelijke verbetering van insulinegevoeligheid bij vrouwen.
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